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Abstract 
Nanotechnology has been an emerging field due to the promising properties of 
engineered nanomaterials, materials with at least one dimension less than 100 
nanometers. With increasing application of NPs, the risk of these novel materials to 
environment requires thorough investigation to prevent negative impacts. NPs have 
enormous variety due to combinations of chemical compositions, sizes, shapes, 
structures and surface modifications. Building predictive models that link NP properties 
to biological outcomes is the key to proactive safer NP design.  
 
High-throughput toxicity screening and investigating toxicity mechanisms are the 
common two strategies building towards predictive models of nanotoxicity. These two 
strategies work together: high-throughput assays facilitate preliminary screening of 
potentially toxic materials for further mechanistic studies to discover biomarkers and 
molecular pathways of interest, which will in turn be validated on multiple materials 
and organisms with high-throughput screening. My thesis work combines both 
strategies to develop high-throughput screening assays and mechanistic understanding 
at different molecular levels of how an environmental bacterium, Shewanella 
oneidensis MR-1, responds to various NP exposures. 
 
In this work, Chapter 1 reviews recent advances in analytical nanotoxicology and 
identifies four key areas that would further bring the field to its maturity. Chapter 2 
represents a comprehensive mechanistic study on bacteria responding to TiO2 NPs with 
UVA illumination. Chapter 3 uses gene expression to explore molecular response 
among two organisms at different trophic levels to positively and negatively charged 
gold NPs. Chapter 4 identifies that purification method can be one neglected source of 
apparent NP toxicity. A high-throughput bacterial viability assay that is free of NP 
interference is presented in Chapter 5. Finally, in Chapter 6, DNA damage is revealed 
as a toxicity mechanism for nanoscale complex metal oxide nanomaterials to bacteria.  
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Chapter 1 
Linking nanomaterial properties to biological outcomes: analytical 
challenges in nanotoxicology for the next decade  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from: 
Qiu, T. A., Clement, P. L., Haynes, C. L., Linking nanomaterial properties to biological outcomes: 
analytical challenges in nanotoxicology for the next decade, Chemical Communication, 2018, in 
preparation. 
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1.1 Introduction 
The development of nanotechnology has enabled advances in far-ranging fields. 
Though the full extent to which nanomaterials (NMs) will revolutionize society remains 
to be seen, a conservative assessment of their impact to date would find that NMs have 
made significant and lasting contributions to a number of fields, especially medicine, 
computing, and energy storage and production.1-4  
 
The explosion of nano-enabled products is made more impressive by the fact that the 
field is relatively new—arising in the second half of the twentieth century. At recent 
count, there are thousands of commercial products that contain NMs,5 not to mention 
industrial processes that use ENMs.6 To date, The Nanodatabase in Europe lists 3038 
products containing NMs, and The Project on Emerging Nanotechnologies has 
documented 1827 NM-containing consumer products.7,8 The rapid advance in 
nanotechnology over the past half-century is due in no small part to the National 
Nanotechnology Initiative funded by the government of the United States of America, 
championed by Mihail Roco and brought to fruition in 2000. In 2004, Roco outlined 
four generations of NMs: 1) passive materials that don’t differ too significantly from 
bulk materials but enhance bulk properties; 2) active nanomaterials which a comprise 
materials that are the active participants in processes; 3) 3-D nanosystems and systems 
of nanosystems; and 4) heterogenous nanostystems in which different individual 
components play roles in the performance of the whole.1 Over the past decades, as 
predicted, the complexity of NMs and related nanosystems has remarkably increased 
and will not stop expanding in the future. 
 
From the early days of the National Nanotechnology Initiative (NNI) it was clear that 
NMs would interact with living systems in engineered (e.g. medicine, agriculture, etc.) 
and incidental capacities.1,9 In light of this, wide-spread calls were made for 
understanding the environmental health and safety of NMs, and specifically for 
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understanding mechanisms of nanotoxicity at the molecular level.9,10 The study of the 
environmental health and safety of NMs has made great strides in recent years and 
provided key insights into chemical interactions between NMs and organisms of 
varying complexity. 
 
Pre-dating the NNI, a large community was interested in the human health implications 
of ultrafine particles and aerosols.10,11 This “zeroth generation” of nanotoxicologists 
was largely concerned with either natural NMs (e.g. asbestos) or unintentionally 
synthesized NMs (e.g. carbonaceous materials from combustion) and used language 
that may be unfamiliar to the current field, but their questions were the same: By what 
chemical mechanisms do nanoscale materials impact organisms? Are these interactions 
fundamentally different than those of small molecules? 
 
The first generation of nanotoxicologists heeded the call from the NNI and looked to 
answer how engineered NMs may impact cell lines and organisms. These groups 
studied the interactions between a wide range of NMs and organisms. In the process, 
those in the first generation of nanotoxicology identified some of the primary 
mechanisms of nanotoxicity and built foundational knowledge that current scientists 
rely upon when testing hypotheses, such as generation of reactive oxygen species 
(ROS). However, in this wide-open field, the NMs studied were often chosen for ease 
of access, either synthetically or commercially, rather than to systematically test 
hypotheses. Similarly, testing was performed on a number of cell lines and living 
systems, but the choices of biological systems were often arbitrary. Most limiting, 
groups, including our own, often used off-the-shelf tools developed for small molecule 
toxicology. It has now been well-documented that established tools, such as the MTT 
viability assay or fluorescence assays can suffer from false-positive or -negative due to 
properties of nanomaterials.12,13 
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We contend that the field of nanotoxicology is currently in its second generation. 
Choices of NMs and organisms used for exposures are more systematic, enabling 
analysis of trends across organisms or between types of nanomaterial.14-16 During the 
second generation of nanotoxicology, it has also been realized that there was huge 
discrepancy in nanotoxicity data acquired on similar materials, creating confusion and 
hindering accurate risk assessment of nanomaterials to both human health and 
environment.17,18 Unlike small molecules which are the objects of study in traditional 
toxicology, the unique properties of NPs could affect accurate measurement of 
nanotoxicity. For instance, the status of nanomaterials under different testing conditions, 
such as aggregation state and surface-adsorbed molecules (“corona”), could vary 
drastically from one testing medium to another and result in changes in observed 
toxicity.19 In addition, nanotoxicity assays are subject to the optical, catalytic and other 
properties that are specific for each kind of NM and lead to under- or over-estimation 
of toxicity.18 Solving these discrepancies has been a challenge to analytical chemists 
and toxicologists. Off-the-shelf tools started to be validated and new tools were 
developed.18,20 Methodologies for characterization of NM transformation in complex 
biological and environmental matrices and the nano-bio interface when NMs encounter 
biological system have been developed and will continue to grow in the future.21 
 
As nanotoxicology approaches the end of its second decade, the strong foundation built 
in the zeroth, first, and second generations has provided a launching point for chemists 
to better understand molecular mechanisms of nanotoxicity. A critical challenge that 
was started by the second generation of nanotoxicologists is to build predictive models 
that link nanoparticle physiochemical properties to the biological outcome of NM 
exposure in a quantitative manner. As we are entering the third decade of 
nanotoxicology, NMs are being designed and produced fast, and with increasing 
complexity, as predicted.1 Proactive establishment of safe NP design rules has never 
been as critical as it is right now. Ideally, a powerful predictive model can provide 
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information on potential toxicity and preliminary risk assessment of a theoretically 
designed NM, when the relevant parameters of this designed NM are input into the 
model. This grand challenge has motivated the field to explore various approaches to 
link the physiochemical properties of NMs to biological outcomes and build the desired 
predictive model. 
 
To build predictive models for the biological outcome of NP exposure, two general 
approaches can be taken: either creating libraries to test a significant amount of different 
exposure scenarios or exploring underlying mechanisms that potentially play roles 
across different scenarios and can be attributed to certain NM characteristics. The 
former approach relies on large-scale data generation and analysis usually through 
construction of NM or cell libraries, high-throughput assays, and statistical modeling. 
The mechanistic approach depends on bioanalytical techniques to characterize 
biological processes as thoroughly as possible. Such approaches can be either 
hypothesis- or discovery-driven. The two approaches contribute to predictive models 
in different ways. The data-demanding approach will provide a large amount of data 
points to better reveal the trends, while mechanistic information helps to reduce omitted 
variable bias and improve predictive power. Together, the two approaches give the 
foundation of predictive models. 
 
In this chapter, we have identified four analytical challenges that should be addressed 
in the third generation of nanotoxicity to better elucidate mechanisms of nanotoxicity 
and build predictive models that link NM/nanoparticle (NP) properties to biological 
outcomes. Here NMs and NPs are used interchangeably. The four challenges are: 1) 
shifting the paradigm of the mechanistic approach from correlation to causation, 2) 
overcoming NM interferences in in vitro toxicity assays, 3) connecting NP interaction 
to biological responses at the single-cell level, and 4) measuring the nano-bio interface 
in real-time and in situ with chemical information. The sections below detail the 
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motivations for each of these foci and discuss current work and methods that show 
promise in addressing these challenges. 
 
1.2 From correlation to causation: shifting paradigm of mechanistic approach 
Understanding mechanisms of NP toxicity means knowing the causal relationship 
among NP exposure, affected biochemical processes, and final biological outcomes 
(Figure 1.1). NPs for exposure can vary in their physiochemical properties, such as 
composition, size, charge, and surface modification/adsorption. Biochemical processes, 
the events on the cellular and molecular levels involving species such as protein and 
RNA, can be affected differently depending on the NP traits. Final biological outcomes, 
depending on the scope of the study, can be cytotoxicity for in vitro tests or whole-
organism outcomes such as survival and reproduction for in vivo studies. The causal 
relationships among these three variables are key to understanding how NPs affect 
biological organisms and furthermore, impact human health and environment. 
 
 
 
Figure 1.1 Causal relationships among NP properties, affected biochemical processes, 
and final biological outcomes. 
 
 
A common practice to reveal causal relationships is to control the properties of NPs, 
followed by measurements of NP-affected biochemical processes and whole-organism 
endpoints. In some early work from the Haynes lab, researchers synthesized and 
characterized either mesoporous silica nanospheres or graphene oxides varying in size, 
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pore character, composition, and/or surface modification, and found correlations among 
NP characteristics, their hemolytic activities, and cytotoxicity.22,23 With such studies, 
however, there are two things that may result in revealing only a correlative, rather than 
causal, relationship.  
 
When varying one NP property, it is extremely hard not to affect other traits as many 
physiochemical properties are interconnected, as stated extensively in a review.24 For 
example, to change size, it is likely that the coverage of surface modification and the 
capability of surface adsorption will change as well. These unintended and interlinked 
changes could act as confounding variables, meaning omitted factors that actually 
contribute to the causation and lead to inaccurate conclusions. Efforts to fill the gap 
include construction of NP libraries to systematically represent various combinations 
of NP properties,14,25,26 thorough characterization of NPs,24,27 and development of 
accurate descriptors that account for interconnected NP characteristics. Burello et al. 
extensively reviewed both theoretically and experimentally driven descriptors to 
portray NP properties that can be applied to establish NP quantitative structure-activity 
relationship (nano-QSAR) models.28 Using descriptors of NP characteristics, Singh et 
al. built nano-QSAR models that outperform previous studies with a robust, reliable 
ensemble learning approach.29 Lynch et al. further suggest mapping interlinked 
physicochemical properties into three principle components as overarching 
descriptors.30 Advances in NP synthesis, characterization, and statistical modeling will 
help nano-QSAR to move forward. 
 
Another limitation of the common practice lies in the lack of seeing the whole picture 
when measuring biochemical processes. Like an old Chinese proverb says, one cannot 
picture the whole leopard by peeking into a tube and only seeing a spot. Often in 
practice, due to the limited resources and time, several individual biochemical tests are 
done to probe toxicity mechanisms, mostly driven by specific hypotheses. Detection of 
8 
 
intracellular reactive oxygen species and metabolites, assays for various enzyme 
activities and membrane integrity, and measurement of changes in certain biomarkers 
such as DNA lesions and gene expression are all among popular assays for probing 
biochemical processes. However, performing individual functional tests is like looking 
at a leopard through a narrow tube. Spots are observed, and we may conclude 
correlations among several observations; however, with thousands of other events 
happening at the same time, we are likely to omit other important variables and thus 
cannot conclude causal relationships with limited observations. Failure to conclude 
causal relationships among biochemical processes and final biological outcomes may 
mislead efforts in future mechanistic studies and diminish the power of predictive 
models for nanotoxicity. 
 
One obvious way to gain a whole picture is application of –omics methods, part of 
system toxicology approaches.31 By definition, -omics refer to measurements on the 
whole collection of events in biological organisms. An -omics approach can be applied 
at different molecular levels including DNA (genomics, DNA adductomics), 
epigenetics (DNA methylation and histone modification), gene expression 
(transcriptomics), proteins (proteomics, redox and affinity proteomics), metabolites 
(metabolomics) and other molecules (lipidomics, glycomics). Various recent reviews 
have covered the application of -omics in analytical nanotoxicology and suggested that, 
combined with bioinformatic approaches like pathway analysis, -omics can help to 
identify perturbed pathways, discover new biomarkers, and form new hypotheses.32-35 
Schnackenberg et al. and Matysiak et al. outlined the application of metabolomic and 
proteomic approaches in nanotoxicology with an emphasis on human health risk 
assessment.36,37 In ecotoxicology, Revel et al. recently presented -omics as powerful 
tools in aquatic nanotoxicology.38 Integration of -omics at different molecular levels 
further adds the power of these system biology approaches. Pillai et al. revealed 
dynamic toxicity response of algae to silver NP exposure by integrating transcriptomics, 
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proteomics, and phenotype data.39 A recent review by Shin et al. discussed the 
integration of metabolomics and transcriptomics (“metabotranscriptomics”) in 
nanotoxicology.40 In the future, we expect increasing application of diverse -omics in 
nanotoxicology on both human health and ecological systems, especially integrated -
omics across different levels, to depict whole pictures of molecular mechanisms of NP 
toxicity. 
 
However, due to limitation of resources and complexity in performing -omics 
experiments, biochemical assays will most likely keep being methods of first choice 
when testing nanotoxicity. Thus, it is important to incorporate such individual assays in 
a framework that emphasizes the causal relationships among biological events. Adverse 
outcome pathways (AOP), a recently developed conceptual framework that links 
existing toxicological knowledge on biological events between a molecular initiating 
event (MIE) to an adverse outcome (AO) that is relevant to risk assessment, depict a 
series of causally related key events (KE) that span multiple biological levels (Figure 
1.2).41 The causal relationships between key events are defined as key event 
relationships (KERs). The AOP framework provides possibilities to integrate existing 
knowledge on different biological levels, predict toxicity pathways of new chemicals, 
and guide discovery of biomarkers, and is considered a promising way to reduce animal 
testing as it facilitates the extrapolation of chemical effects across species.42 
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Figure 1.2 Illustration of Adverse Outcome Pathway (AOP). (Reprinted with 
permission from Ref 41. Copyright 2010 Wiley InterScience.) 
 
Establishment of AOPs is fed by studies on toxicity mechanisms, including both 
individual toxicity tests and system toxicology approaches. Many efforts have been 
made to build AOPs for chemicals, and multiple databases have been developed, such 
as AOP wiki, AOP knowledge base, and Effectopedia. Using existing, but mostly 
fragmented, knowledge on nanotoxicity mechanisms, researchers have recently started 
developing AOPs for nanotoxicity. Vietti et al. reviewed toxicity literature of lung 
fibrosis induced by carbon nanotubes to draft an AOP on the fibrotic potential of 
CNTs.43 Knowledge gaps in toxicity mechanisms were identified while developing the 
AOP for CNTs. Instead of reviewing literature, Labib et al. developed an AOP for lung 
fibrosis upon MWCNT exposure based on in vivo transcriptomic data, showing the 
potential of -omics data being used to reveal causal relationships among events.44 Two 
challenges in building AOPs for nanotoxicity were pointed out by Gerloff et al.45 The 
first one is to identify characteristics of NPs that can initiate a molecular event. A great 
example is relating the oxidative potential of NPs to ROS generation as an MIE. As 
oxidative stress is proven to be an important mechanism for nanotoxicity, NP 
characteristics that lead to potential oxidative stress, such as bandgap and hydration 
energy, have been identified as predictors for nanotoxicity both experimentally and 
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theoretically.25,46-49 However, other traits that could potentially be related to MIEs are 
still vague and lacking sufficient evidence, leaving plenty of room for future research. 
The second challenge is that the nature of MIEs for nanotoxicity can be different from 
chemicals. While the molecular interactions at the nano-bio interface inform potential 
MIEs that initiate an AOP, the nano-bio interaction might be physical or mechanical, 
thus not necessarily a “molecular event”. The authors suggested that instead of using 
MIEs, the first key event following MIE, called initial KE, might be used instead as the 
first event in a nano-specific AOP. In their recent work, Gerloff et al. reviewed the liver 
toxicity induced by both chemicals and metal oxide NPs, and most importantly, 
suggested that establishment of an AOP should not be limited to nano-specific 
toxicology literature but also expand to established knowledge on chemical AOPs, as 
they may share downstream key events despite differences in MIEs and early KEs.45 In 
conclusion, when designing experiments, we encourage consideration of incorporating 
individual analytical tests in the framework of potential AOPs, which can help 
researchers to form reasonable hypotheses and integrate future new knowledge into the 
existing database of nanotoxicity. 
 
As mentioned at the very beginning of this section, a common practice for mechanistic 
study is to expose organism of interest with NPs of various properties and measure their 
toxicity response upon exposure. Uncommon for analytical chemists and toxicologists, 
manipulation of biological processes and components is a less used yet powerful 
approach to infer causal relationships between exposure and biological outcomes. As a 
great example, Jacobson and Gunsolus et al. revealed that lipopolysaccharides (LPS) 
on Gram-negative bacterial membranes are the primary binding site for AuNPs 
wrapped with positively charged polymers.50 To confirm that LPS is the binding site, 
researchers chemically depleted a fraction of LPS on the bacterial cell outer membrane. 
A significant decrease in NP-cell association was observed in LPS-depleted cells 
compared to normal cells. Combined with experiments on solid-supported LPS-
12 
 
containing lipid bilayers interacting with NPs, strong evidence showed that positively 
charged NPs interact with bacterial cells through LPS. Another example is to use a 
library of E. coli knockout mutants for toxicity screening; the mutants that are more 
sensitive than the wild type can inform important cellular functions and pathways in 
responding to nanomaterials.51,52 Similar to the concerns about controlling NP 
characteristics via synthesis, manipulating one biological variable might be 
accompanied by undesirable, yet inevitable, changes in other variables. Therefore, 
thorough characterization of manipulated processes and potentially affected processes 
is desired. Nevertheless, using tools from biochemistry, chemical biology, and 
molecular biology, biological processes and components can be controlled or blocked, 
providing evidence of toxicity mechanisms from another angle different from simply 
measuring responses upon exposure. Thus, we encourage analytical chemists and 
toxicologists to consider implementation of these available tools outside analytical 
chemistry through broader collaboration across chemistry and biology to gain 
complementary information to complete the picture of toxicity mechanisms. 
 
1.3 Overcoming NP interferences in in vitro toxicity assays 
There are many ways that NPs can interfere with an in vitro toxicity assay on biological 
endpoints. The intrinsic optical properties of NPs can interfere with many assays that 
rely on measuring changes in absorbance or fluorescence of molecular indicators for 
cellular activities. Due to their high surface reactivity, NPs can adsorb53 or react with 
assay reagents54 or release chemical species55 in testing media, altering the behavior of 
dyes and enzymes in assays. In some cases, catalytic NPs can cause side reactions such 
as ROS production. All these interferences contribute to discrepancies observed in 
nanotoxicity studies and has been extensively discussed.18,56-58 One analytical challenge 
in the field of nanotoxicology has been and will continue to be the development of 
toxicity assays that are free of NP interference and improvement of well-established 
toxicity protocols where interference cannot be avoided and neglected. 
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The optical interference, including absorbance and fluorescence, can be possibly 
corrected via proper control and background subtraction. Many well-established 
toxicity protocols have been re-validated on NPs, and optical interference from NPs in 
in vitro assays have been checked and taken into account in data analysis.59-64 However, 
background subtraction does not always work, especially when reagents (converted or 
not) react with NPs or side products from catalytic reaction of NPs. More well-
considered and complicated controls need to be done in this case. For instance, Semisch 
et al. found that copper ion released from CuO NPs caused the reduction of tetrazolium 
salt, the dye for the WST cytotoxicity assay.55 In this case, the WST assay is not proper 
to test the toxicity of CuO NPs, unless NP concentration for exposure is low enough 
that the interference from released copper ion can be neglected. Interference from 
catalytic properties can potentially be mitigated by controlling experimental conditions, 
such as avoidance of UV illumination for TiO2 NPs in the presence of assay reagents.65 
 
Studies have pointed out that NP interference cannot be predicted as it is highly specific 
to different assays and type and concentration of NP exposure.13,66 Thus, it is critical to 
include proper controls when designing each set of specific experiments. Rosslein et al. 
have provided a good example by using cause-and-effect analysis to design a well-
controlled MTS assay layout on 96-well plates, taking NP interference into account.67 
Drasler et al. discussed different controls that should be added for in vitro nanotoxicity 
studies, including measurement on (1) NPs alone dispersed in testing medium for 
background correction, (2) untreated cells with NPs being added at the end of the actual 
exposure to test if NPs interfere with converted reagents (such as formazan in the MTT 
assay), and (3) centrifuged supernatants from NM-exposed cells to remove NP 
agglomerates.17 In addition to the above controls, it is also beneficial to test if the 
reagents themselves will react with NPs without the presence of cells.54 Another factor 
that contributes to inaccurate conclusions in nanotoxicity is insufficient purification of 
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colloid suspensions. Apparent toxicity measured in an assay is thus not only due to 
nanoparticles but also leftover reagents in the colloidal suspension. Studies have shown 
that impurities from insufficient purification can dominate the observed apparent 
toxicity in standard assays, leading to over-estimation of nanoparticle toxicity.68-70 We 
thus suggest that the supernatant from NP suspensions following proper 
ultracentrifugation should always be included as a control in nanotoxicity assays. 
 
Besides implementation of adequate controls, researchers have been seeking analytical 
methods that are free of or less sensitive to NP interference. For mammalian cell lines, 
visualization of cell morphology under microscopy is considered a technique that 
complements cytotoxicity assays, but it is not sufficient to quantitatively measure 
toxicity endpoints. Colony counting assay for microbial cells is widely accepted as a 
standard microbial toxicity assay that is not affected by NP interference.17 Microbial 
cells are treated with NPs and spread onto solid medium; after overnight incubation, 
colonies grown from individual viable cells are counted as colony forming units (CFUs). 
As the biological endpoint is the number of visible colonies, it is unlikely that NPs will 
play a role in colony forming and counting beyond any bacterial toxicity that they 
display. However, both cell visualization and colony counting assays suffer from very 
low throughput and high labor demand. Haynes and coworkers recently developed a 
simple but effective assay for high-throughput bacterial nanotoxicity screening.20 After 
exposure, bacterial suspension is largely diluted into fresh medium to allow re-growth. 
Optical interference from NPs is negligible due to the large dilution, and the re-growth 
profiles are quantitatively related to the relative number of viable cells, thus viability. 
This assay is done on 96-well plates, allowing fast and robust bacterial toxicity 
screening. Respirometry, where oxygen consumption by a microbial population or other 
organisms is measured to reflect growth and viability, is another NP interference-free 
test, and the Haynes lab has frequently used it to perform reliable toxicity measurement 
on bacterial cells.71,72 
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Impedance-based measurements are promising in terms of overcoming NP interference 
with fast speed and high throughput.73-75 Impedance spectroscopy measures the 
resistance at electrode surfaces. Cells can attach to electrodes, and any change in the 
cell-electrode interface will result in changes in electrode capacity and resistance. Thus, 
impedance spectroscopy can be used to monitor changes in cell morphology, cell 
density, viability, and extent of cell adhesion. Otero-Gonzalez et al. developed a real-
time cell analyzer (RTCA) based on impedance spectroscopy and measured the 
response of human bronchial epithelial cells upon exposure of 11 different inorganic 
nanomaterials.76 Besides being interference-free, impedance spectroscopy is label-free, 
non-invasive, high-throughput and real-time. However, it should be noted that the 
biological meaning of impedance measurement is not as clear as other well-established 
cytotoxicity assays, making results hard to interpret and to compare with other 
biological endpoints. In addition, the versatility of impedance assays is limited as 
adhesion of cells onto the electrode surface is required to perform this assay. 
 
Researchers have also been expanding on using “biomarkers” instead of apical 
biological endpoints. In toxicology, a biomarker is a characteristic that can be measured 
that is indicative of the level of exposure, the extent of biological response, and toxic 
effect or susceptibility.77 Measurements on biomarkers are intrinsically at the molecular 
level and provide information on toxicity mechanisms. 
 
Genotoxicity assays that measure toxic effects on DNA have been used to evaluate the 
risk of nanoparticles, especially nanomedicines, and whether current genotoxicity 
assays are suitable for nanotoxicology has also been discussed.18,65,78 The Comet assay 
is a genotoxicity assay that measures DNA strand breakage using single-cell 
electrophoresis. After treatment of NPs, cells are embedded in agarose, lysed in situ, 
and released DNA is imaged after electrophoresis. Concerns about NPs directly reacting 
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with either naked DNA released from cells or lesion-specific endonucleases as reagents 
have been examined, and it is generally believed that Comet assay is adequate for NP 
genotoxicity, though caution still needs to be taken due to possible interferences.79-84 
The Ames test, chromosome aberration, and micronucleus assays were tested on AuNP 
genotoxicity, and authors concluded that the latter two assays are more suitable for NP 
genotoxicity test as chances are low for reagents to directly interact with DNA.85 
Further tests need to be done to validate genotoxicity assays, focusing on understanding 
interference and expanding genotoxicity assays from mammalian cells to microbes. 
 
Measurements at the mechanistic level beyond genotoxicity, such as gene expression, 
metabolite secretion, immunotoxicity, and changes in epigenetics have been explored 
and discussed recently as alternative ways to evaluate the toxicity of NPs.86 These 
measurements, while more complicated, are always free of NP interference because 
NPs are usually excluded during sample preparation and not present at the point of 
measurement. One challenge for these assays is to validate proposed biomarkers and 
relate the measurement at the molecular level to organism- or cell-level biological 
endpoints such as population survival. Elucidation of all biological processes related to 
one specific biomarker is also desired for biomarker validation. 
 
In conclusion of the aforementioned factors, toxicity evaluation of NPs should avoid 
relying on one single assay, especially when the assay might be subjected to NP 
interferences. Multiple assays on the same, similar, or related endpoints should be 
performed to confirm a certain effect. An example mentioned earlier is investigating 
AuNP genotoxicity using four different assays.85 While a fluorescence assay for ROS 
might suffer from NP interference, examining gene expression changes on ROS-related 
genes can be used to complement fluorescence assays.87 Even for cytotoxicity assays, 
it is good practice to use multiple assays to reach a more solid conclusion. In addition, 
standardized operating procedures across labs is also desired to minimize the 
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discrepancies in studies reported from different labs. Toxicity response is, to an extent 
that is not fully realized by the nanotoxicology community, surprisingly dependent on 
plenty of factors other than NP dosage, including cell density, cell status, assay 
background, reagent concentration, etc.24 Measurement on NP toxicity adds another 
layer of complexity in terms of dosimetry, as NPs can be quantified in different ways 
(e.g. mass/particle/surface area concentration).24 Piret et al. reported an inter-laboratory 
study on a series of in vitro cytotoxicity and pro-inflammation assays to test NP toxicity 
and examined potential sources of variation in these protocols.88 Standardized 
procedures among labs, plus as many details as possible being reported in publications, 
will help to find the source of discrepancy among different labs. 
 
1.4. Connecting NP interaction to biological responses at single-cell level 
In the first and second generations of studying nano-bio interactions, one dominant 
focus has been on the response of cell populations to NM exposure. Such ensemble 
approaches have been used widely in cell viability and functional assays. Easy-to-
perform, ensemble measurements have established strong foundational knowledge of 
the types of interactions between NMs and cells and the biological response by 
populations of cells to NMs. 
 
As we are approaching a new decade for nanotoxicology, many researchers have 
realized the importance of studies at the single cell level, due to the heterogeneity of 
both cell and nanoparticle populations. Xia et al. outlined that cell populations can vary 
cell-to-cell depending on genetic variations, different cell cycle phase, biochemical 
state (namely protein concentrations/bursts), and microchemical environments.89 
Nanomaterials, different than traditional molecular toxicants, could vary from one 
particle to another within a population in terms of size and structure; thus, the load of 
NPs within individual cells within a population can vary. Assessing NP effect on 
population level biological systems risks averaging out the real effect of NP exposure, 
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and results in difficulty distinguishing a bimodal response, where some cells respond 
weakly and others respond strongly, from a unimodal response in which all cells exhibit 
similar responses. The averaging of biological responses may hamper the development 
of molecular level insights into mechanisms of interactions and likely contributes to the 
high level of disparate data in nanotoxicology studies. Thus, it is critical to push past 
the limitation of population measurements towards single-cell level analysis. 
 
Two general categories of analytical methods are available to study NPs interacting 
with single cells: imaging-based and cytometry-based techniques. Imaging-based, i.e. 
microscopic, methods are frequently used to study NP uptake, co-localization and 
trafficking in cells, as they can resolve fine details of NPs interacting with sub-cellular 
components and monitor kinetics of NP-single cell interaction over time. While lacking 
structural and temporal information, flow cytometry and mass cytometry provides 
much higher throughput, better quantification, and possibilities to separate cells into 
sub-populations for subsequent studies. To correlate cellular responses to effective NP 
loads at a single-cell level, measurements of both NP uptake/localization and biological 
response needs to be achieved simultaneously on the same single cell. This represents 
one big challenge for analytical nanotoxicologists, and current single-cell techniques 
need to be expanded and integrated to achieve this goal. In this section, we highlight 
three recent studies that correlate cellular NP load to response on a single-cell level and 
discuss related recent analytical advances toward this goal. 
 
Case study: high-content imaging to correlate cellular NP load to single-cell response. 
Starting very early in the field of nanotoxicology, microscopy has been a powerful tool 
to study NP-cell interactions. Depending on the purpose of the study (co-localization, 
trafficking or quantification), the nature of biological samples (fixed or living cells) and 
the size of NPs (small or large), a whole collection of microscopy methods ranging 
from electron to optical microscopy can be potentially useful. Amongst all, 
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fluorescence microscopy is the most widely used based on its versatility and simplicity. 
Combined with a wide range of fluorescent dyes available to label cellular components 
and indicate cellular activity, fluorescence microscopy can co-localize NPs in fixed 
cells or track single particles dynamically in living cells, both at single-cell 
resolution.90-94 
 
Recent work from Manshian et al. made the first attempt to correlate the concentration 
of QDs at the single-cell level using high-content imaging with confocal microscopy.95 
High-content analysis (HCA) is a multi-color imaging-based technique frequently used 
for drug discovery.96 Using different fluorescent tags, multiple cellular phenotypes can 
be monitored with simultaneous readout, thus named as “high-content”. HCA has been 
applied to nanotoxicity studies. Jan et al. stained neural cells with four fluorescent dyes: 
Hoeschst for nuclei, TMRM for mitochondrial membrane potential, Fluor-4 for free 
calcium concentration, and propidium iodide for membrane integrity, to evaluate if a 
single cell is healthy, impaired or dying upon QD exposure.97 Other work using 
zebrafish embryos,98 fibroblast cell lines,99 and various other cell lines100 has 
demonstrated that HCA is a powerful tool to study cellular response at a single-cell 
level. Pushing it further, Manshian et al. simultaneously quantified the relative QD load 
of individual cells based on QD intensity and area in cells, and binned data on single 
cell biological responses into categories based on NP load (Figure 1.3). As a result, 
they found conflicting mechanisms such as apoptosis and autophagy in cell 
subpopulations with medium to high QD load at apparent sub-cytotoxic concentrations. 
Together with other work, this study revealed that cell populations do not respond to 
NPs uniformly, and the distribution of single-cell response is correlated to NP load per 
cell.  
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Figure 1. 3 (a) Histograms indicating the number of MSC cells per QD-load category 
and a representative image of MSCs exposed to 10 nM QDs. The population was 
divided into 10 categories spanning the range of determined QD load for individual 
cells. (b) Heatmap showing cell response in viability, autophagy and apoptosis clustered 
for each categories of NP load and representative HSC images for each kind of response. 
(Adapted from Ref 95 under the Creative Commons license.) 
 
The work highlighted above by Manshian et al. used microscopy to obtain data to 
correlate NP load to cell response at the single-cell level. Such microscopic studies can 
benefit from (1) precise quantification and dynamic tracking of NPs and (2) 
visualization of cellular processes with high resolution; both rely on the development 
of state-of-the-art microscopic techniques and the integration of multiple imaging 
techniques to obtain data about NP load and cell response simultaneously. Recently, 
Vanhecke et al. discussed in a review the most recent advances in quantifying NPs at 
single-cell levels,101 and Ivask et al. presented a comprehensive review on 
methodologies for NP-cell interactions.21 Generally, conventional optical microscopy 
is semi-quantitative for NP quantification, due to the diffraction limit, fluorophore 
quenching, optical interference from samples, etc. Confocal fluorescence microscopy 
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has been extensively used to visualize NPs with limited capability for NP quantification. 
Label-free optical methods have also been applied to image non-fluorescent NPs, such 
as hyperspectral imaging for QDs and AuNPs102,103 and Raman spectroscopy for carbon 
nanotubes and TiO2 NPs.104,105 Lasne et al. presented a home-built imaging system to 
track individual 5-nm gold NPs in living cells by detecting the laser induced scattering 
around a nanoabsorber (LISNA).106 
 
Beyond the optical diffraction limit, electron microscopy achieves resolution better than 
the size of NPs. Traditional biological transmission electron microscopy (bio-TEM) 
requires sample preparation including fixation and slicing into ultrathin sections, 
making quantification difficult unless 3D imaging can be re-constructed from 2D stacks, 
and even then, the small sampling volume presents challenges to quantitation.  
Advances in liquid cell TEM have enabled whole-cell imaging in aqueous medium, 
though its resolution still needs improvement.107 In addition, conventional bio-TEM is 
not able to clearly differentiate between high mass contrast stained cellular components 
and exogenous NPs.108 Dark-field TEM, applied for nanotoxicology in our group, helps 
to solve this problem by looking for the unique diffraction patterns from crystalline 
nanoparticles but not stained biological components.109  Besides electron microscopy, 
super-resolution imaging, a collection of optical imaging techniques that overcome the 
diffraction limit, has also been employed to acquire fine details on NP localization and 
trafficking in cells. A direct comparison was made between confocal fluorescence 
microscopy, stochastic optical reconstruction microscopy (STORM), and electron 
microscopy to co-localize NPs with organelles in HeLa cells, showing that previously 
unknown details at nanoscale resolution can be revealed by super-resolution 
microscopy.110 Using structural illumination microscopy (SIM), Gunsolus et al. 
revealed co-colocalization of QDs on the cell membrane of Gram-positive and Gram-
negative bacterial cells.111 Compared to electron microscopy, super-resolution 
microscopy provides possibilities to image live cells and multiple cellular components 
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along with NPs simultaneously, though requirements for particular fluorophore 
characteristics (e.g. photoswitchable dye for STORM) still limit universal application.  
 
Mass spectrometry imaging provides chemical information that is not available through 
optical imaging. Using a laser to ablate and vaporize surface materials of a sample, laser 
ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) uses ICP-MS for 
elemental analysis. LA-ICP-MS has been used for bioimaging of metals.112 As an 
example of its application in nanotoxicology, Elci et al. applied this technique to 
characterize the biodistribution of AuNPs in mice organs.113 However, LA-ICP-MS 
cannot differentiate (1) NPs and biomolecules if they contain the same element (e.g. 
carbon nanotubes), and (2) elements in different forms, e.g. AgNPs from Ag ions. Laser 
desorption/ionization mass spectrometry imaging (LDI-MSI) applies laser irradiation 
to ionize molecules on a sample surface and analyzes the generated ions with a mass 
analyzer. With the assistance of a solvent (“matrix”), matrix-assisted LDI-MSI 
(MALDI-MSI) allows detection of a wide range of biomolecules.114 Chen et al. mapped 
a carbon cluster fingerprint with MALDI-MSI to reveal the distribution of carbon 
nanomaterials in mice organs and tissues.115 By tuning laser fluency, LDI-MS was used 
to differentiate cell surface-bound and internalized AuNPs.116 Higher resolution MS 
imaging can be achieved by secondary ion mass spectrometry (SIMS), a surface 
analysis technique achieved by sputtering the surface of sample using highly focused 
primary ion beams and analyzing the ejected secondary ions. SIMS has been used to 
examine metabolites and nanoparticle distribution in single cells.117-120 Overall, mass 
spectrometry imaging provides good quantification of NPs and simultaneous 
determination of biological matrices through elemental and mass analysis. 
 
The power of correlative microscopy has been underutilized for NP-single cell 
interaction studies. Le Trequesser et al. assessed uptake of TiO2 NPs into individual 
primary human foreskin keratinocytes cells by using multimodal correlative 
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microscopy: fluorescence microscopy for sub-cellular compartments, scanning electron 
microscopy (SEM) for surface analysis, and ion beam analysis (IBA) for in-depth 
elemental analysis and in situ quantification of TiO2 NPs.121 Similarly, quantification 
of ZnO NP uptake, distribution, and dissolution was done by combination of ion beam 
milling, X-ray fluorescence microscopy, and SEM.122 A more complicated system 
where mass spectrometry imaging and super-resolution microscopy were integrated 
into a home-built microreactor called the “system for analysis at the liquid vacuum 
interface (SALVI)” was used to perform time-of-flight SIMS (ToF-SIMS) and 
structural illumination microscopy (SIM) on the same sample.118 SIM was used to 
characterize cells and guide subsequent ToF-SIMS analysis. ToF-SIMS identified lipid 
fragments and ion transport upon NP exposure and showed direct evidence of ZnO NP 
uptake as well. Multi-modal correlative microscopies provide details that complement 
each other from the same sample, showing numerous possibilities for studies on 
correlating the status of NPs in cells to biological responses at the single-cell level. A 
great example is from Liu et al., who used a combination of bright field microscopy, 
fluorescence microscopy, and AFM for estimation of NP load, cytoskeleton and ROS 
production, and single-cell mechanics, respectively.123 The level of NP uptake was 
related to changes in cell stiffness, ROS production, and damage to the actin network. 
Multimodal correlative microscopy, combined with other assays, provides information 
at multiple dimensions and thus helps to understand causal relationships between NP 
exposure and biological consequences. The power of multimodal correlative 
microscopy is yet to be fully exploited in nanotoxicology studies. 
 
Microscopy can also be combined with single-cell electrochemical analysis, whose 
application in nanotoxicity has been reviewed.73 The Haynes lab pioneered using 
carbon fiber microamperometry (CFMA) to monitor exocytosis from single mast cells 
and other cell types upon AuNP, AgNP and TiO2 NP exposure.124-128 Exocytosis is a 
highly conserved cell function across cell types and plays important roles in chemical 
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communication among cells. By using microelectrodes, the Haynes group was able to 
monitor the process of single-cell exocytosis and correlate changes in single-cell 
exocytosis to bulk measurements of NP uptake and cytotoxicity. Using a 
microelectromechanical system (MEMS)-based sensing array that can trap cells, Shah 
et al. presented a platform for electrochemical impedance spectroscopy of single cells 
and small cell populations upon metal oxide NP exposure.75 As slow speed might be 
one drawback of single-cell electrochemical measurements, MEMS systems with cell 
capturing capability and sensing arrays present a future direction for the integration of 
single-cell microscopic and electrochemical measurements with fast speed and 
relatively high throughput.129,130 
 
Case study: flow cytometry, and single-cell RNA-Seq for cells with varied QD loads. 
There are two circumstances beyond reach of imaging techniques despite their 
versatility: when analysis of millions of cells is desired or when single cells need to be 
separated first for subsequent analysis. Flow-based single-cell techniques, including 
flow cytometry, mass cytometry, and cell sorting have provided solutions for both 
research needs. Cells and particles are suspended in a fluid and pass through laser(s) in 
a fluid stream as separated single cells. Using different detectors, multiparametric 
detection of each individual cell’s optical characteristics such as light scattering and 
fluorescence can be achieved simultaneously. Coupled with ICP-MS, cytometry can 
perform elemental analysis on single cells, called mass cytometry. Originally, mass 
cytometry specifically referred to the detection of metal ion labelled antibodies in single 
cells131 but now researchers have adapted this technique for NP quantification in 
cells.132 Cell sorting techniques further allow the separation of single cells based on 
their characteristics, such as the amount of associated NPs and further analysis like 
single-cell -omics.  
 
Here, we highlight two studies to demonstrate the power of flow-based single-cell 
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techniques. The first study is from Toduka et al. where flow cytometry was used to 
correlate NP association and cellular response at the single cell level.133 Compared to 
microscopy, flow cytometry provided orders of magnitude higher throughput. Side 
scattering (SSC) was developed to evaluate NP association with mammalian cells134,135 
and bacteria71,136 and combined with fluorescence staining to determine cellular states. 
Pan et al. used SSC to gate a NP-loaded cell subpopulation and evaluate the states of 
these gated cells as healthy, apoptotic, or necrotic based on fluorescence staining on the 
same cell population.137 Pushing it further, Toduka et al. plotted SSC versus 
fluorescence induced by intracellular ROS after their simultaneous detection with flow 
cytometry upon metal oxide and Ag NP exposure. Results showed clear correlation 
between NP association and ROS production in single cells (Figure 1.4). With analysis 
of millions of cells, flow cytometry provides richer information than bulk experiments. 
Recent development of imaging flow cytometry further enables analysis of cell 
morphology and particle tracking.138 Such combination of microscopic and flow 
cytometry analysis makes it a powerful tool for future high-throughput and high-
content single-cell analysis for nanotoxicology, as it has been applied.139 
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Figure 1. 4 Contour plot patterns of SSC and DCF intensity showed correlation 
between NP association and ROS production in single cells. Reprinted with permission 
from Ref 133. Copyright © 2012 American Chemical Society. 
 
For more accurate quantification of NP association, as stated earlier, Yang et al. adapted 
mass cytometry for high-throughput quantification of AuNPs in single cells.132 
Compared to flow cytometry, mass cytometry showed higher sensitivity and lower 
limits of detection for measuring NP load. Combined with metal-chelated antibodies, 
cell types and NP load per cell were determined simultaneously for each individual cell. 
While achieving precise quantification and high sensitivity, mass cytometry removes 
information on the chemical status of elements, e.g. dissolved ions vs. NPs. In the future, 
integration of flow cytometry and mass cytometry on one platform is promising for 
giving precise and comprehensive information on NP-single cell interactions. 
  
Flow-based cell sorting techniques provide capability to separate and collect sub-
populations of cells for subsequent analysis. In fluorescence-activated cell sorting 
(FACS), individual cells in the fluid stream are given different electrostatic charges 
based on detected fluorescence and deflected to containers at different sides by passing 
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between two charged plates.140 Other optical characteristics can be used for cell sorting 
as well. As an example, Jacobson et al. used both fluorescence and side light scattering 
to sort live cells with AuNP association, and dark-field microscopy plus hyperspectral 
imaging was subsequently used to confirm that the sorted cells were associated with 
AuNPs.50 Another recent study by Mitchell et al. combined cell sorting techniques and 
single-cell -omics.141 Gene expression and transcriptomics have been extensively used 
in nanotoxicology on both prokaryotic and eukaryotic cell lines to reveal NP toxicity 
mechanisms, while studies on single-cell levels are scarce. In this study, a fluorescence-
activated cell sorter determined the level of QD load to each single cell based on QD 
fluorescence intensity and harvested the portions of cells associated with high or low 
level of QD load. Individual cells were then analyzed by single-cell RNA-Seq, an -
omics technique allowing global gene expression profiling in one single cell. Results 
showed that cells carrying lower QD loads responded with multiple strategies that are 
different for each QD type, while high loads of QD induced more uniformly, mostly 
down-regulated processes shared across QD types. This study clearly linked cellular 
NP association to gene expression profile, which would have been averaged and likely 
not observed in bulk experiments. As single-cell -omics are emerging in all -omics areas, 
including transcriptomics, proteomics, metabolomics, genomics and 
epigenomics,142,143 it is promising to combine them with flow cytometry and advanced 
cell sorting platforms130 and reveal otherwise unavailable details on the molecular level. 
 
1.5 Real-time and in situ measurements with chemical information at nano-bio 
interface 
The interface between NPs and biological systems is dynamic. The NP surface, the 
solid-liquid interface when NPs interact with surrounding medium, and the contact zone 
where the solid-liquid interface encounters a biological system are closely 
interconnected and constantly undergoing changes.19 Upon entering a new matrix, 
pristine NPs instantly gain new “identities” via interacting with surrounding molecules, 
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including chemical reactions and dissolution, biological transformation and physical 
adsorption of surrounding molecules, both in biological and environmental media.144,145 
NPs with the new “identity” then interact with biological systems like cell membranes. 
Such interactions can induce cellular responses, change the behaviors of cell 
membranes in contact with NPs, and further alter NP characteristics in turn. The 
dynamic nature of nano-bio interactions thus requires powerful physical and analytical 
tools for real-time and in situ measurements to resolve the kinetics of nano-bio 
interactions without disturbance. Depending on NPs’ pristine surface, surrounding 
environment, and biological systems, nano-bio interactions can be loose or tight, as 
non-specific as electrostatic interactions or as specific to certain binding sites as 
antigen-antibody binding.144 Understanding the chemical nature of nano-bio 
interactions will greatly contribute to the establishment of nano-QSAR and other 
predictive models. With all this in mind, an ideal technique to monitor the nano-bio 
interface should be both real-time and in situ, and the capability to provide chemical 
information would be a significant advantage. Here, we discuss techniques used for 
capturing the kinetics at the nano-bio interface on the two aforementioned interfaces: 
interactions between NPs and surrounding molecules in the medium and interaction of 
NPs with model membranes or biological systems. 
 
Measurement on NPs interacting with surrounding molecules. The new “identity” of 
NPs when entering a new matrix is decided by their pristine surface features, chemical 
reactions, physical adsorption, and biological transformation. Chemical transformation 
of NPs in aqueous medium includes dissolution, oxidation, ligand exchange, surface 
coating degradation, photocatalytic reactions, etc.145 Although not necessarily a “nano-
bio” interaction, chemical reaction accompanies bio-mediated reactions and physical 
adsorption and is an integral part of the process to form NPs’ new identity. Mechanisms 
of chemical reactions on NP surfaces, especially dissolution, photochemistry and 
catalysis, have been extensively studied.145-147 
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Attachment of surrounding molecules through physical adsorption ranges from ions to 
small molecules to biomacromolecules via forces including hydrodynamic, van der 
Walls, electrostatic and static interactions, plus hydrophobic effects.19 Physical 
adsorption has been widely studied in the context of human health144 and the 
environment,148 and is believed to be the main source of NPs’ identity in biological and 
environmental matrices. As a prominent example, the protein “corona”, referring to 
layers of tightly or loosely bound proteins on NP surfaces, has undergone extensive 
investigation in the past decade.149 A common practice to study the protein corona is 
separating NPs from aqueous matrices via centrifugation and stripping off the NP-
bound proteins for further analysis using methods such as gel electrophoresis and mass 
spectrometry. Such separation-based techniques have been used to study protein corona 
evolution at the time scales of minutes to hours.150-152 To study protein adsorption 
kinetics at a much shorter time scale, correlation spectroscopy has been used. Vilanova 
et al. used fluorescence correlation spectroscopy (FCS), a sensitive fluorescence 
technique to measure concentration and size of particles by monitoring fluorescence 
fluctuation in solution to estimate the fraction of protein binding to the NP surface and 
adsorption kinetics.153 Scattering correlation spectroscopy and surface plasmon 
resonance were also used for in situ measurement of protein interaction with gold 
NPs154,155 and del Pino et al. gave an extensive review on how kinetic parameters can 
be extracted from spectroscopic data.156  
 
While techniques based on absorbance, fluorescence, scattering (e.g. dynamic light 
scattering) and surface plasmon resonance can be used to determine kinetic parameters, 
chemical information is not available from these studies. Attenuated total reflectance 
Fourier transform infrared (ATR-FTIR) spectroscopy is a surface analysis technique 
capable of real-time and in situ characterization of surface dynamics with chemical 
information. ATR-FTIR utilizes the evanescent field of the total internal reflection (TIR) 
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of infrared radiation at the solid-liquid interface, and the surface sensitivity stems from 
the short penetration depth (at the magnitude of 1 micrometer) of the evanescent field. 
NPs are typically immobilized on the ATR crystal, and adsorption of molecules onto 
NP surfaces is monitored over time; specific functional groups in adsorbed molecules 
can be thus identified by examining detected IR absorption bands. Mudunkotuwa et al. 
has given a detailed review on the application of ATR-FTIR spectroscopy to investigate 
nanoparticle surface adsorption,157 and numerous studies have shown the application 
on probing NP surface adsorption of proteins158-160 and small molecules such as 
surfactants161 and phosphate.162 A vibrational spectroscopy, Raman spectroscopy also 
provides chemical information at the nano-bio interface. By using plasmonic NPs as 
substrates, surface-enhanced Raman spectroscopy (SERS) amplifies Raman signals 
near metallic substrates, thus it’s a great platform for probing nano-bio interactions. 
Bonifacio et al. systematically studied the SERS spectra of Ag and AuNPs in blood 
plasma and serum to fingerprint biological fluid composition.163 In another study, SERS 
spectra of serum albumin protein and cysteine adsorption onto AgNPs were acquired 
and compared with Raman spectra of free protein and cysteine, showing a strong 
decrease in S-S bond signal in the adsorbed protein.164 Micro Raman spectroscopy is 
also used to study NP interactions with small molecules such as ATP.165 Overall, the 
capability of both ATR-FTIR and Raman/SERS is yet to be explored for dynamicly 
probing NP surface adsorption of surrounding molecules, especially in complex 
matrices that contain multiple species. 
 
Solution nuclear magnetic resonance (NMR) has been a tool to examine protein and 
ligand adsorption onto NP surfaces. Binding and exchange of ligands on NP surfaces 
from small molecules to polymers and proteins can be characterized and quantified 
using 1H NMR, while NPs usually needs to be centrifuged or dried followed by re-
suspension for 1H NMR analysis. 166,167 Wang et al. achieved in situ measurement on 
protein adsorbing to 15-nm AuNP surfaces using solution 1H NMR and two-
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dimensional TROSY NMR with 15N labeled proteins.168 No centrifugation was needed 
prior to NMR measurement, and the measurement time was reduced to as little as 10 
min. Combined with data from a binding competition assay and results from other work, 
the authors concluded a three-step model for protein adsorption onto AuNP surface: 
reversible association at first, followed with rearrangement/reorientation, and finally 
irreversible binding via cysteine to AuNP surface. Using relaxation-based solution 
NMR, Ceccon et al. revealed the global motions and exchange kinetics on the 
microsecond scale for a model protein, ubiquitin, binding to negatively charged lipid 
nanoparticles (liposomes).169 Another NMR technique, solid-state NMR, has also been 
used to characterize the interactions between ligands and NP surfaces.170,171 Together 
with other spectroscopic methods, NMR represents a powerful technique to study the 
kinetics of molecule adsorption onto NP surface with chemical information. 
 
Measurement on nano-bio interaction with model membranes and cells. When NPs 
reach a biological organism, the first interface they will likely to encounter is a cell 
membrane.19 Thus, the interaction between NPs and membranes has been a focus for 
researchers interested in nano-bio interactions. The characteristics of the cell membrane 
can vary drastically among different organisms. For example, Gram-negative bacterial 
cell membrane features a large coverage of lipopolysaccharides (LPS), while the Gram-
positive bacterial cell membrane is covered with a thick peptidoglycan layer and 
teichoic acids. Membranes of most eukaryotic cells contain proteins, glycolipids and 
components other than phospholipids. Nevertheless, phospholipids compose the main 
structure of a cell membrane. Model membrane systems are manually constructed lipid 
bilayers to mimic real cell membranes. By tailoring the composition (e.g. ratio of 
different phospholipids and other components) and architecture (e.g. vesicle, planar 
supported bilayer, etc.), model membrane systems have been an effective approach to 
study cell membrane functions, the role of different membrane components, and 
membrane interactions.172 Naturally, this approach has been widely applied to 
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understand the interaction between NPs and membranes. A recent review by Rascol et 
al. has discussed in detail the application of model membrane systems for investigating 
nano-bio interactions.173 
 
Depending on the hypothesis of interest, three architectures are among the most 
commonly used model membrane systems: lipid bilayer vesicles, planar lipid bilayers, 
or supported lipid bilayers. Lipid vesicles, i.e. liposomes, are structurally the closest to 
real cells and range from tens of nanometers to hundreds of micrometers. Microscopy 
and dye leakage assays, in which vesicle-encapsulated dye molecules are released upon 
membrane disruption, can be used to assess lipid bilayer permeation upon NP exposure 
and NP association and colocalization with vesicles.174-177 Planar lipid bilayers can be 
tethered between two bridges to separate two chambers filled with electrolytic solution 
for capacitance measurements. Changes in planar lipid bilayers upon NP interaction can 
be probed via measuring changes in their capacitance.178 While these measurements on 
vesicle and planar bilayers provide visualization and dynamics of NP-membrane 
interactions, they are not quantitative in determining the extent of NP binding to model 
membranes and also lack chemical information. 
 
In contrast to free-floating lipid vesicles and tethered planar lipid bilayers, supported 
lipid bilayers (SLB) are formed on planar solid surfaces. The solid surface helps to 
stabilize the SLB, providing high flexibilities in tuning composition, architecture and 
fluidity of model membranes. Quartz crystal microbalance with dissipation monitoring 
(QCM-D) has been extensively used to quantify the extent of NP binding and 
membrane disruption as well.173,179,180 When mass is added to or removed from a 
piezoelectric crystalline quartz, changes in the quartz’s mechanical resonance 
frequency is proportional to the mass change. Using QCM-D, the deposition kinetics 
of graphene oxides on SLBs were determined.179 Combined with atomic force 
microscopy (AFM) and structured illumination microscopy (SIM), Melby et al. 
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explored the interaction of 4-nm AuNPs on model membranes that contained 
segregated domains.181 Besides QCM-D, AFM and other microscopies as well as 
electrochemical techniques are used for real-time and in situ measurement of membrane 
changes. Lu et al. showed fabrication and application of microfluidic lipid bilayer 
arrays for high-throughput electrochemical measurements on NP-membrane 
interactions.182 
 
As mentioned at the beginning of this section, the capability to provide chemical 
information on nano-bio interactions would be enlightening. While QCM-D and 
microscopic techniques complement each other as quantitative and qualitative 
measurements, sum-frequency generation (SFG) spectroscopy is a surface-/interface-
sensitive technique that performs real-time and in situ measurement on molecular 
symmetry. In two recent studies, the dynamics of inner and outer leaflets of lipid 
bilayers upon interacting with AuNPs183 or chitosan NPs184 were determined by 
collecting a time series of SFG spectra. Combined with ATR-FTIR, Hu et al. concluded 
that SLBs undergo a flip-flop movement upon AuNP interaction.183 A comprehensive 
study performed by Troiano et al. using SFG along with a series of other techniques 
determined the dynamics of positively or negatively charged AuNPs interacting with 
SLBs with different lipid compositions.185  
 
Currently, most model membrane systems are quite simple, consisting of a few 
phospholipids and occasionally incorporating other membrane components. Increasing 
the complexity of model membranes by adding more components such as 
lipopolysaccharides (LPS)50 and membrane proteins and exploring different 
composition ratios will bring the system closer to real cell membranes. Extracted cell 
membranes might also be used and compared with model membrane systems of 
controlled composition. In addition, spectroscopic methods that provide chemical 
information, such as SFG, ATR-FTIR, SERS and NMR, used in combination with 
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microscopy will further facilitate in situ measurement of the NP-membrane interface. 
As evidence from model membrane experiments has been used to complement both 
experimental data on cell-NP interaction186 and computational simulation,175,187 studies 
on NP-membrane interaction will continue to serve as a bridge that connects nano-bio 
interaction systems at different levels of complexity.  
 
1.6 Conclusion 
Analytical chemistry plays a big role in nanotoxicology, ranging from characterization 
of NP properties to measurement of biological response upon NP exposure. As we are 
entering the third decade of nanotoxicology, building predictive models between NP 
properties and biological outcomes for safe NP design is more critical than ever, as 
confusion and discrepancies prevent accurate assessment of NP toxicity due to the 
unique characteristics of nanomaterials. Herein, we identified four analytical challenges 
in nanotoxicology for the next decade, including shifting studies on nanotoxicity 
mechanisms from correlative to causative, overcoming NP interferences for accurate in 
vitro nanotoxicity assays, connecting NP interaction to cellular response at the single-
cell level, and developing a kinetic understanding of various nano-bio interfaces with 
chemical information. With these challenges in mind, analytical chemists will continue 
to contribute to solving puzzles in nanotoxicology and build predictive models together 
with wide collaboration with researchers in biology, materials science, and 
computational chemistry. 
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Chapter 2 
A mechanistic study of TiO2 nanoparticle toxicity on Shewanella 
oneidensis MR-1 with UVA illumination: bacterial growth, riboflavin 
secretion, and gene expression 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from: 
Qiu, T. A., Meyer, B. M., Christenson, K. G., Klaper, R. D., Haynes, C. L., A 
mechanistic study of TiO2 nanoparticle toxicity on Shewanella oneidensis MR-1 with 
UV-containing simulated solar irradiation: Bacterial growth, riboflavin secretion, and 
gene expression, Chemosphere, 2017, 168, 1158-1168.  
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2.1 Introduction 
The biocidal effect of titanium dioxide (TiO2) nanoparticles (NPs) has resulted in 
extensive development of TiO2-NP-based anti-microbial materials,
1-3 but also 
generated rising concern about the adverse effects of TiO2 NPs on non-target species in 
ecological systems. Previous studies have revealed toxicity of TiO2 NPs to ecologically 
relevant organisms, including algae, zebrafish, water fleas, and fish.4-7 The intended 
biocidal effects of TiO2 NPs, combined with the potential release of TiO2 NPs into the 
environment8,9 with anticipated increase in the usage of TiO2 NPs,
10,11 generates an 
emerging need to assess the ecological risk of TiO2 NPs on relevant organisms.
12-14 
 
Although released NPs can potentially affect all organisms within the food web, low 
trophic level organisms like bacteria are most likely to interact with released NPs due 
to their wide distribution and their localization in microenvironments where 
nanoparticles may accumulate. Quite a few studies have addressed the influence of TiO2 
NPs on bacteria species, but most of these studies focus on E. coli and other pathogenic 
bacteria.15-18 Shewanella oneidensis MR-1, an environmentally beneficial Gram-
negative bacterium of genus Shewanellae, has a unique dissimilatory metal-reducing 
capability to respire heavy metals, including Mn(III), Mn(IV), Fe(III), and Cr(VI).19,20 
With this capability, S. oneidensis MR-1 plays an important role in solubilizing metal 
salts for species throughout the food web as well as having a potential role in 
bioremediation of toxic elements in the ecosystem. Because of these environmental 
implications, S. oneidensis MR-1 has been employed to study toxicological response to 
environmental factors like pH, heavy metals and electron acceptors.21-24 Though to a 
very limited extent, it also has been employed as an environmentally relevant bacterial 
model in nanotoxicity studies as is done here.25-27 
 
Mechanistic studies of the adverse effects of toxic agents can provide important 
implications for the assessment of ecological risk and the prediction of toxicity. One of 
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the most studied mechanisms of TiO2 NP impact on biological systems is the generation 
of reactive oxygen species (ROS), which could potentially be a molecular initiating 
event in damage to cells by nanoparticles.4,18,28-30 As a photocatalyst, TiO2 NPs absorb 
photons and generate electron-hole pairs, and these charge carriers move to the NP 
surface; ROS can be generated during the reaction between the TiO2 NP surface and 
the surrounding aqueous medium.31 Previous work has shown that UV-illuminated 
TiO2 NPs exhibited higher toxicity across species than TiO2 NPs alone, and ROS 
generated by TiO2 NPs are believed to be the means by which TiO2 NPs kill bacteria.
15-
17 Li et al. built a linear correlation between the total ROS generation by metal oxide 
NPs, including TiO2 NPs, and the toxicity of these NPs to E. coli.
18 The production of 
intracellular ROS could result in subsequent cellular response including lipid 
peroxidation or DNA damage, either of which could be measured as endpoints.32 In S. 
oneidensis MR-1, the secretion of riboflavin is one important cellular endpoint that can 
be monitored. Riboflavin is a redox molecule that acts as an electron shuttle between 
the cell surface and external acceptors like metal oxide surfaces and plays a critical in 
cell-mediated metal reduction.33,34 The presence of riboflavin is also important in its 
role as a photosensitizer as it was found to generate ROS in a light-dependent manner.35 
In fact, previous research has demonstrated that the amount of S. oneidensis-secreted 
riboflavin increased as a cellular response upon TiO2 NP exposure.
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Efforts have been made to elucidate the molecular responses upon TiO2 NP exposure 
by monitoring changes in gene expression levels.36-39 Nanoparticles have been shown 
to cause changes in RNA expression levels in organisms varying from human cells to 
bacteria. Using gene expression levels to assess nanotoxicity can provide direct 
information on mechanisms of nanotoxicity and help identify biomarkers for future 
high-throughput nanotoxicity assessments.40,41 Although oxidative stress has been 
identified as one of the major toxicity mechanisms in other bacterial models with 
various nanoparticles,42,43 other modes of action have been revealed via gene expression 
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studies.36,44-47 Kubacka et al. revealed changes in the level of gene expression related to 
various pathways other than oxidative stress, including the activation of detoxification 
and repair pathways and a decrease in a pathway related to cell-cell communication, in 
a pathogenic bacterium upon TiO2-UV treatment.
36 Ideally, gene expression data, 
measured and correlated with other cellular responses and changes in cell population 
growth, could enable the construction of a sequential series of biological responses that 
can be used in the identification of adverse outcome pathways for nanoparticles and 
assist in risk assessment for TiO2 NPs.  
 
Herein, we used an integrated toxicology approach, from cellular responses on 
molecular levels to cell population change, to comprehensively explore the mechanisms 
of nanoparticle interaction with bacterial cells, using Shewanella oneidensis MR-1 as a 
model organism exposed to TiO2 NPs and concurrent UVA illumination. The impact 
of TiO2 NPs and UVA illumination on bacterial cell viability and population growth 
were monitored, followed by assessments of intracellular ROS generation and 
riboflavin secretion. Gene expression changes upon continuous nanoparticle and UVA 
exposure were also monitored at different time points. By combining several analytical 
methodologies to probe impacts from cell viability to gene expression, this work 
enables a mechanistic understanding of nanoparticle-bacterial cell interaction and 
brings an integrative scheme to assess the risk of nanoparticle exposure to the 
environment. 
 
2.2 Materials and methods 
 
2.2.1 Bacteria preparation 
LB broth (BD Difco, BD Diagnostics, Franklin Lakes, NJ), made by dissolving 25 
grams of pre-mixed LB broth powder (consisting of 10 g tryptone, 5 g yeast extract and 
10 g NaCl) in 1 liter of Milli-Q water followed by autoclaving, was used in this work 
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as the bacteria cell culture medium. S. oneidensis MR-1 was a kind gift from Professor 
Jeffery Gralnick, University of Minnesota Department of Microbiology and was stored 
at -80°C before use. Bacteria were inoculated onto a LB broth agar plate and incubated 
at 30°C for 24 hours or until visible colonies formed. Colonies were inoculated into 5-
15 mL of autoclaved LB broth in sterile culture tubes and grown overnight. 
 
2.2.2 Monitoring cell growth over time 
Bacterial growth curves were monitored by measuring the optical density (OD) of a 
bacterial suspension over time with different nanoparticle doses. After the bacterial 
suspension reached stationary phase, 200 μL of suspension was diluted with fresh 
autoclaved LB broth to a total volume of 5 mL to reach a diluted cell density of 
approximately 107 cells/mL. The diluted bacteria suspension was grown in a 30-32°C 
orbital shaker at 300 rpm for 6 hours either in the dark or under UV illumination with 
continuous exposure to 0, 1, 5, 10, 25, or 100 mg/L TiO2 nanoparticles. 200 µL aliquots 
were transferred periodically to a Costar® 96-well assay plate (Corning Incorporated, 
NY), and measurements of OD at λ = 600 nm (OD600) were recorded with a Synergy 
2 Multi-Mode Microplate Reader (BioTek, VT). Background due to nanoparticle 
extinction and assay plate wall absorbance was subtracted to generate normalized data, 
which was plotted and analyzed by Prism (GraphPad Software, CA). 
 
2.2.3 Monitoring cell oxygen uptake 
Cell growth was also characterized by measuring oxygen uptake by the cell suspension 
over time. A PF-8000 aerobic/anaerobic respirometer system (Respirometer Systems 
and Applications, LLC, Arkansas) was used to monitor oxygen uptake. This instrument 
consists of biological reaction vessels, a stirring base for mixing samples, and a control 
module that contains the pneumatic and electronic controls for oxygen or gas flow 
measurement. Bacteria were grown in LB broth to stationary phase and diluted 1:10 
into fresh autoclaved LB broth in reaction vessels to reach a total volume of 100 mL. 
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TiO2 nanoaprticles were added into the reaction vessels to a final concentration of 25 
mg/L or 100 mg/L. A tube filled with 1 mL 30% potassium hydroxide solution was 
inserted into each reaction vessel to absorb carbon dioxide released by bacteria aerobic 
respiration. The negative pressure created by oxygen consumption of bacteria was 
compensated by oxygen injection continuously to keep a constant pressure in the 
headspace of reaction vessel. Oxygen uptake was recorded automatically by the 
instrument, and each measurement was done in duplicate. 
 
2.2.4 G6PD cytotoxicity assay for cell viability 
Cell viability was measured using a commercial cytotoxicity assay, the Vybrant™ 
Cytotoxicity Assay Kit (Molecular Probes, OR), which uses an enzymatic fluorescence 
reaction to measure the glucose 6-phosphate dehydrogenase (G6PD) released from 
dead cells. Bacteria were first grown in LB broth overnight to stationary phase (OD600 
= 1.5-1.7) and then exposed to 100 mg/L TiO2 nanoparticles for 30 minutes, either in 
the dark or under UV illumination. The TiO2 NPs were sonicated for 30-45 minutes 
prior to exposure (same for all exposures in this study). Following exposure, 1 mL of 
bacterial suspension was centrifuged at 17,000 × g for 2 minutes, and the supernatant 
was collected for measurement. A resazurin/reaction 2X mixture was prepared 
following the kit’s protocol, and 50 µL of the mixture was added into 50 µL supernatant 
on a 96 well plate. The microplate was incubated at 37°C for 30 minutes in the dark 
before fluorescence readings were taken with excitation at 530 nm and emission at 590 
nm. Cell death was proportional to the intensity of fluorescence signal. The background 
fluorescence signal was obtained from a control group that only contained LB broth 
and the resazurin/reaction mixture, and this signal was subtracted from experimental 
fluorescence signals.  
 
2.2.5 Intracellular ROS generation measurement 
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Dichlorodihydrofluorescein diacetate (DCFH2-DA), which can be deacetylated by 
cellular esterases to a non-fluorescent intermediate that is later oxidized to fluorescent 
2’, 7’-dichlorofluorescin (DCF) upon reaction with ROS, was used as an indicator of 
ROS. DCFH2-DA was diluted to a 10 μM working solution using fresh LB medium. 
Then, 100 mL of bacterial suspension was grown to the stationary phase (OD600 = 1.5-
1.7) followed by centrifugation for 10 minutes at 1,500 ×g. After decanting the 
supernatant, the bacteria cell pellet was resuspended with 40 mL DCFH2-DA 10 μM 
working solution. The resulting suspension was then incubated at 30°C for 1 hour in 
the dark to avoid photo-oxidization of the ROS indicator. The bacteria suspension was 
centrifuged again at 1,500 ×g for 10 minutes, and the supernatant was removed. 8 mL 
of fresh LB broth was applied to wash the pellet three times and the cell pellet was 
diluted with 60 mL of fresh LB broth. 
 
TiO2 NP suspension was added to 2.94 mL of the final bacteria suspension to reach a 
NP concentration of 100 mg/L. 360 µL of bleach was used as a positive control as it 
can generate an excessive amount of ROS. The bacterial suspension was incubated in 
the dark for 15 minutes after TiO2 nanoparticle exposure, transferred to a 96 well flat 
bottom polystyrene reading plate (Corning Incorporated, NY) and then either exposed 
to UV illumination or kept in the dark for another 15 minutes. The fluorescent signal 
from the ROS indicator was excited at 488 nm and measured at 515 nm by a Synergy 
2 Multi-Mode Microplate Reader (BioTek, VT). 
 
A control experiment was done to explore the interference of TiO2 NPs on the detection 
of fluorescence of DCF, the fluorescent molecule converted from DCFH2-DA in cells. 
92.5 nM and 481 nM of DCF was diluted in fresh LB broth to generate fluorescence 
signals that are comparable to what were detected in bacterial suspension in the dark 
and under UV illumination, respectively. 100 mg/L TiO2 NPs were added to DCF 
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solution and mixed well, and the fluorescence signals were read using the same method 
as stated above. Five material replicates were done in this control experiment. 
 
2.2.6 HPLC measurement of riboflavin secretion 
Flavin secretion, an important function of S. oneidensis, was measured by HPLC 
analysis of bacterial suspension supernatant. First, bacterial suspensions were exposed 
to 100 mg/L TiO2 nanoparticles in the dark or under UV illumination. Then, 1 mL of 
bacterial suspension was collected from same tube after 30 min, 1 hour, or 6 hours, and 
centrifuged for 15 min at 5000 ×g. Exposure was done in triplicate. 200 μL of the 
supernatant was transferred to an amber HPLC vial with a 250 μL glass insert and 
placed on the autosampler of an Agilent 1200 HPLC (Agilent Technologies, CA). A 
Zorbax Eclipse XDB-C18 4.6 × 150 mm, 5 μm analytical column was washed with 
acetonitrile and equilibrated using mobile phase, a 70:30 mixture of 20 mM citric acid 
buffer (pH 3.3)/methanol. The injection volume was 30 μL, and isocratic elution was 
performed with a flow rate of 1 mL/min. Riboflavin was detected by a fluorescence 
detector after flowing through an Eclipse XDB-C18 4.6 × 12.5 mm, 5 μm analytical 
guard column, with excitation at 450 nm and emission at 530 nm. Riboflavin elution 
was achieved after approximately 6.7 min. 
 
2.2.7 RNA extraction 
RNA was extracted from bacteria cells exposed 25 mg/L of TiO2 nanoparticles and sent 
to the University of Minnesota Genomics Center (UMGC) at the University of 
Minnesota for quantitative real-time PCR analysis. A Direct-zol™ RNA MiniPrep kit 
(Zymo Research, CA), allowing quick and high-quality DNA-free RNA extraction and 
purification using spin columns, was used according to the manufacturer’s 
recommendations for total RNA extraction. Bacteria were grown in LB broth to 
stationary phase and exposed to 25 mg/L of TiO2 nanoparticles in the dark or under UV 
illumination in triplicates. At 0, 0.5, 1, and 6 hours after nanoparticle exposure and/or 
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UV illumination, 1 mL of bacteria suspension was centrifuged at 1500 ×g for 10 
minutes. The supernatant was removed, and the cell pellet was sufficiently resuspended 
in 800 µL of RNAzol®RT (Molecular Research Center, Inc., OH). The extraction kit 
protocol was followed using a centrifugation speed of 12,000 ×g with an on-column 
DNase I treatment at 30°C for 15 minutes. RNA was finally eluted from the column 
using 25 µL of DNase/RNase-free water at 16,000 ×g for 1 minute. The total RNA 
solution was normalized to 200 ng/µL and submitted for quantitative real-time PCR 
analysis. 
 
2.2.8 qPCR and data analysis 
Quantitative real-time PCR (qPCR) was done by the University of Minnesota 
Genomics Center using the same protocol and instrument described earlier 25. For each 
gene of interest, three sets of primers were designed using Universal ProbeLibrary 
ProbeFinder software, followed by validation of amplification efficiency. The primer 
pairs with the highest amplification efficiency for each gene were chosen for 
subsequent qPCR experiments. Table 2.1 shows a full list of genes investigated along 
with their corresponding functions and their primers used in qPCR experiments. The 
raw data was processed using the qPCR data analysis program, Miner,48 which applies 
an objective method to determine efficiency and the fractional cycle number (Ct) at 
threshold of individual PCR reactions. Ct values were determined using Miner 
program, and relative fold change was calculated based on the ΔΔCt method.49 Among 
two candidates, gyrB and recA, recA was chosen as the housekeeping gene due to a 
lower standard deviation in expression level. 
 
Table 2. 1 Target genes, corresponding functions, and their primers for qPCR 
experiment. 
Target gene 
Forward primer 
(5′–3′) 
Reverse primer (5′
–3′) 
Probe 
number 
Function Accession 
number 
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Fe/Mn superoxide 
dismutase (sodB) 
GCA ATG TTC 
GCC CTG ACT 
AC 
CCT GCG AAG 
TTT TGG TTC 
AC 
#95 Superoxide 
dismutase 
activity 
NP_718453
.1 
Diguanylate cyclase-
like protein (mxdA) 
CAT TTC GCA 
AGT TGA ACA 
CC 
CCA CAC CAA 
TAT GAC GCA 
AA 
#44 Indirectly 
modulate 
cyclic di-GMP 
(ref 68) 
NP_719709
.1 
Phage shock protein B 
(pspB) 
TTG ATT GCG 
AAA GCC GAT 
A 
ATC AAG AAT 
CGC CTC TAA 
GGT TT 
#46 Phage shock 
response 
NP_717416
.1 
Double-stranded DNA 
translocase (ftsK) 
GAT AGT CGA 
TGG CAT TGT 
GGT 
TAG GCT TAG 
TCG GCA CAG 
GT 
#142 Cytokinesis NP_717901
.1 
Catalase HPII (katB) GGC ATT GAT 
CCT GAT TCT 
TCT C 
TCC AAC GAG 
GGA AGT TAC 
CA 
#157 Catalase 
activity, 
oxidative stress 
NP_716697
.1 
Extracellular iron oxide 
respiratory system 
surface decaheme 
cytochrome c 
component (omcA) 
TCG ATT ATG 
GCA AAG TGC 
AT 
CGT GAC AGG 
CTG CAC AAT 
#28 Electron carrier 
activity 
NP_717388
.1 
DNA gyrase B subunit 
(gyrB) 
AGA ATG GAT 
CGA CGC CTT 
TA 
ATA CAG TAC 
GCC GCT GTT 
TTC 
#31 DNA 
replication 
NP_715653
.1 
Recombinase A (recA) GGT GAC TCA 
CAC ATG GGC 
TTA 
CCG CTA ACT 
TAC GCA TTG 
CT 
#136 DNA-
dependent 
ATPase 
activity 
NP_718983
.1 
2.3 Results 
 
2.3.1 TiO2 nanoparticle characterization 
Synthesis of acid-catalyzed TiO2 NPs followed by a 48-hour hydrothermal treatment 
was performed using a sol-gel method developed by Isley and Penn.50 Details can be 
found in the Supporting Information. The dynamic light scattering (DLS)- based size 
and ζ-potential of synthesized nanoparticles were measured in both Milli-Q water and 
LB broth before toxicity tests, and the results are summarized in Figure A.1.1. It was 
noted that upon re-suspension in LB broth, the hydrodynamic diameter increased 
drastically, with a significant peak shift in size distribution, indicating that TiO2 NPs 
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aggregated in LB broth. The large aggregation was also confirmed by hyperspectral 
microscopic images (Figure A.1.2); more information on hyperspectral imaging can be 
found in Supporting Information). Meanwhile, the absolute size of the primary TiO2 
NPs, determined from TEM images, did not change. This aggregation is expected based 
on the high concentration of salts and nutrients in LB broth.51 Changes in ζ-potential 
from positive to almost neutral in LB broth may result from both pH change (from 6.05 
of Milli-Q water to 7.30 of LB broth) and peptide adsorption onto the TiO2 NP surface, 
as LB broth contains high concentration of peptides. Stability results show that, once 
re-dispersed in LB broth, the aggregation status of TiO2 remains quite stable for 6 hours, 
the experimental time frame in this study. 
 
2.3.2 Effect of TiO2 NPs and UV illumination on cell growth 
Bacterial cell density (OD600) was monitored hourly upon 1, 5, 10, 25, or 100 mg/L 
TiO2 NP exposure, either in the dark or under continuous UV illumination. TiO2 NP 
extinction and LB broth background at 600 nm were subtracted from the original 
readings to obtain background-subtracted OD600 values, as plotted in Figure 2.1(a)(b). 
Data from 1 and 10 mg/L exposure followed the same trend but are not shown in the 
figure for clarity. Data from 3-hour time point were identified as outliers (ROUT 
method, Q=1.0%, GraphPad Prism)52 and excluded from further statistical analyses. In 
both cell growth curves in the dark and under UV illumination in Figure 2.1(a) and 
2.1(b), there appeared to be a dose-dependent negative effect of TiO2 NP treatment, a 
trend that was also supported upon analysis of the final cell density after 6 hours; this 
finding is consistent with precedent work.25 However, it should be noted that the optical 
density change, even with the highest nanoparticle dose (100 mg/L), was less than 10%. 
Thus, the effect of TiO2 exposure under these conditions can be considered minor. For 
the most part, no additional effect of UV illumination and TiO2 nanoparticle treatment 
was observed, with the exception of a few trials were the interaction of TiO2 and UV 
illumination was determined to be significant when testing final OD600 values using a 
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two-way ANOVA. Given the fact that (1) the significance was not repeated for all trials 
and (2) the difference in OD600 change was at most 14%, it is concluded that, overall, 
UV illumination and TiO2 nanoparticle treatment shows no interactive effect. 
 
 
Figure 2. 1 (a) (b) High concentrations of TiO2 nanoparticles (100 mg/L) inhibit 
Shewanella oneidensis growth in LB to a small extent both in the dark and under UV 
illumination. (c) TiO2 NP treatment has a dose-dependent negative effect on final cell 
density (two-way ANOVA, F(5, 24)=16.85, p<0.0001) though UV illumination did not 
show a significant effect. (d) Detailed analysis of the effect of UV and TiO2 exposure 
on the growth rate (K) at log phase and the increase in cell growth (ΔOD600) between 4 
and 6 hours. (e) Cell respiration was inhibited during 100 mg/L TiO2 nanoparticle 
exposure in the dark (Student’s t-test, p=0.0314). (f) Cytotoxicity assays following TiO2 
and UV exposure on S. oneidensis showed TiO2 nanoparticles, even at 100 mg/L, did 
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not kill cells compared to control groups. 
 
 
The first 4-hour of bacterial growth was identified as the log/exponential growth phase 
by fitting the logarithmic transformed cell number values using linear regression, and 
the growth rate K was calculated from the following equations: 
𝑁 = 𝑁0𝑒
𝐾𝑡 
log 𝑁 = (𝐾 log 𝑒)𝑡 + log 𝑁0 
𝐾 = ln 10 × 𝑠𝑙𝑜𝑝𝑒 = 2.303 × 𝑠𝑙𝑜𝑝𝑒 
where N is the cell number, calculated from optical density (1 Abs = 109 cells/mL), and 
N0 is the cell number at the beginning (0 hour). K (hour
-1) refers to the growth rate in 
the log phase, and e is the natural logarithm. Two-way ANOVA revealed a statistically 
significant difference in the growth rate, K, between dark and UV illumination 
(F(1,24)=20.87, p=0.0001); a Tukey post-hoc test showed that at 100 mg/L TiO2 dose, 
the growth rate K at log phase under UV illumination is statistically significantly lower 
than that in the dark (Tukey’s multiple comparison, p=0.0087). TiO2 exposure did not 
have any effect on bacterial growth rate in the log phase. 
 
After 4 hours, bacterial growth slowed as it entered the stationary phase; thus, the 
growth rate cannot be determined by the equations above. To explore the bacteria 
growth at this transition stage, the differences in OD600 values between the 4- and 6-
hour time points were calculated and used to represent the bacteria growth in this period 
(Figure 2.1(d)). Two-way ANOVA revealed that both UV illumination 
(F(1,24)=107.9, p<0.0001) and TiO2 concentration (F(5,24)=4.471, p=0.0051) have 
statistically significant effects on the bacterial growth at 4 and 6 hours. The positive 
effect of UV illumination on cell growth during 4-6 hours compensated for the slowed 
growth during the log phase induced by UV exposure, resulting in no significant effect 
of UV illumination on the final OD at 6-hour (Figure 2.1(c), two-way ANOVA, 
F(1,24)=0.2968, p=0.5909). Meanwhile, TiO2 treatment has a significant effect on the 
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final OD reading at 6-hour (two-way ANOVA, F(5,24)=18.13, p<0.0001), and a Tukey 
post-hoc test showed that 100 mg/L TiO2 NP treatment statistically significantly 
decreased the OD reading at 6-hours compared to control and other lower 
concentrations (Tukey’s multiple comparison, p<0.05). 
 
Oxygen uptake by the bacterial populations was also measured over time by monitoring 
oxygen uptake with either 25 mg/L (data not shown) or 100 mg/L TiO2 nanoparticle 
exposure. It should be noted that the respiration measurement was only performed in 
the dark due to the limitations of the instrument. Using the first derivative of the oxygen 
uptake curve, the maximum oxygen uptake rate (kmax) and the time point when the 
maximum rate was reached (tmax) were calculated. The quotient of kmax divided by tmax 
was calculated to represent bacterial oxygen uptake, as shown in the inset of Figure 
2.1(e). A decrease in the value indicates inhibition of bacterial oxygen uptake. A two-
tailed, unpaired student t-test showed that upon 100 mg/L TiO2 NP exposure, bacterial 
respiration was inhibited (p=0.0314), consistent with the growth curve results. 
 
2.3.3 Effect of TiO2 NPs and UV illumination on cell death 
A cytotoxicity assay was also applied to test bacterial cell viability upon TiO2 NP 
exposure and/or UV illumination for a short time period (30 min). Cells are known to 
release the cytosolic enzyme glucose 6-phosphate dehydrogenase (G6PD) upon cell 
damage. In the Vybrant cytotoxicity assay, G6PD is measured by a two-step enzymatic 
reaction that generates a red-fluorescent probe, resorufin. The results show that TiO2 
NP treatment, even at the highest dose considered herein (100 mg/L), did not increase 
cell death. Interestingly, two-way ANOVA indicated a significant effect of UV 
illumination on increasing cell viability (F(1,8)=14.70, p=0.005) after the 30-minute 
exposure. Considering the short time frame, this effect can be explained by an increased 
growth rate upon UV illumination in the first hour of bacterial growth (two-way 
ANOVA, F(1,24)=7.698, p=0.01, data not shown). No additional effect between 
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nanoparticles and UV illumination was observed on cell viability in the cytotoxicity 
assay. 
 
2.3.4 ROS generation affected by TiO2 NPs and UV illumination 
Bacterial cells were loaded with DCFH2-DA, a probe which can be converted to 
fluorescent DCF upon reaction with cellular esterases and ROS, to indicate the amount 
of intracellular ROS, followed by exposure of 100 mg/L TiO2 NPs and/or UV 
illumination. It was hypothesized that with the presence of TiO2 NPs, an increase of 
intracellular ROS level would be observed due to the photocatalytic properties of TiO2 
NPs. Surprisingly, the results (Figure 2.2(a)) showed that TiO2 NPs decreased the 
fluorescent signals, indicating that the amount of intracellular ROS had a minor, but 
statistically significant, decrease. To explore the source of this minor decrease in 
fluorescent signals, a control experiment was done to see if TiO2 NPs interfered with 
the DCF fluorescence. Results showed that it was very likely that the decrease in 
fluorescent signals was attributed to the optical interference of TiO2 NPs in suspension 
(Figure 2.2(b)). Thus, it was concluded that the treatment of TiO2 NPs, even at the 
highest dose here, did not induce changes in intracellular ROS level. The dramatic 
increase in ROS levels upon UV illumination was probably due to the photo-induced 
transformation of DCFH2-DA to fluorescent DCF,
53 as their magnitude was comparable 
to the positive control (data not shown). 
Figure 2. 2  (a) A minor decrease in fluorescence intensity was detected upon TiO2 
exposure both in dark and under UV illumination (Tukey’s multiple comparison test, 
p<0.05). (b) The presence of TiO2 NPs resulted in a minor, but statistically significant, 
decrease in the fluorescence of DCF (two-way ANOVA, F(1,16)=11.99, p=0.0032). 
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Star denotes the statistical significance between groups (Tukey’s multiple comparison 
test, p<0.05). 
 
2.3.5 Riboflavin secretion affected by TiO2 NPs and UV illumination 
 
Figure 2.3 Riboflavin secretion was affected by UV illumination at all time points 
(statistical significance not shown) and further decreased in the presence of TiO2 NPs 
after 0.5- and 1-hour exposure (two-way ANOVA and post-hoc Tukey’s test within one 
time point, p<0.05). Asterisks denote statistical significance. 
 
 
Riboflavin secretion upon TiO2 NPs and/or UV light exposure was examined at 
different time points (30 min, 1 hour and 6 hour) using HPLC. For all three time points, 
no change was observed in riboflavin secretion upon TiO2 NP exposure in the dark, 
even with the highest TiO2 nanoparticle dose in this study (100 mg/L). UV illumination 
significantly decreased the amount of riboflavin detected in the supernatant, mostly 
attributed to the photodegradation of riboflavin under UV light; it was confirmed by a 
control experiment that no riboflavin peaks were observed for a 4 µM solution of 
riboflavin after a 6-hour UV illumination (data not shown). Interestingly, there was a 
statistically significant interaction between the effects of TiO2 and UV on riboflavin 
secretion upon 0.5- and 6-hour exposure (two-way ANOVA, F(1,8)=9.694 and 8.633, 
p=0.0144 and 0.0188, respectively), indicating that the presence of TiO2 NPs further 
reduced the amount of riboflavin in the supernatant of the bacterial suspension. 
 
2.3.6 Effect of TiO2 NPs and UV illumination of gene expression 
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Figure 2. 4 Gene expression pattern of 6 different genes in S. oneidensis MR-1 upon 
TiO2 nanoparticle (25 mg/L) and/or UV exposure for different time periods. TiO2 NPs 
did not affect gene expression at this dose, and UV illumination induced minor effects. 
Asterisks denote statistical significance in post-hoc Tukey’s test (p<0.05). 
 
 
In the gene expression studies, 25 mg/L was used as the TiO2 NP dose as it was found 
to be the highest dose that did not induce inhibition in bacterial growth. Two-way 
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ANOVA and a post-hoc Tukey’s multiple comparison test was applied to log2-
transformed relative fold change values. gyrB and recA were included as candidates for 
housekeeping genes, and recA was finally chosen as the housekeeping gene after 
comparing the variation of the expression levels of these two genes. Results showed 
that TiO2 nanoparticle (25 mg/L) and UV exposure induced almost no effect on S. 
oneidensis MR-1 gene expression. Two-way ANOVA showed statistically significant 
effects of UV illumination on sodB expression at 0.5 hour (F(1,8)=5.367, p=0.0492) 
and 1 hour (F(1,8)=5.630, p=0.0451), mxdA expression at 0.5 hour (F(1,8)=10.05, 
p=0.0132), and pspB expression at 1 hour (F(1,8)=24.12, p=0.0012). In a post-hoc 
Tukey’s test (p<0.05), there was a statistically significant decrease in the expression 
level of the pspB gene in UV-illuminated samples when compared to either control or 
TiO2-treated samples in the dark. Overall, TiO2 NPs did not affect gene expression at 
the dose of 25 mg/L. 
 
2.4 Discussion 
 
2.4.1 Minimal inhibition of TiO2 NPs and UV illumination on S. oneidensis 
growth 
Measurements of cell growth, oxygen uptake, cell death, and intracellular ROS 
generation collectively indicated that UV illumination, even at high intensity, does not 
enhance the toxicity of TiO2 nanoparticles; this result forces us to reject our initial 
hypothesis that UV illumination would enhance the toxicity of TiO2 NPs by generating 
excess reactive oxygen species (ROS). This finding is also not consistent with previous 
research on other gram-negative bacteria species.15 Considering the fact that a very 
nutrient-rich medium, LB broth, was used in this study, it is possible that the ROS 
generated from TiO2 NPs are readily quenched by components in LB medium, such as 
peptides, making the external ROS level too low to damage the cell membrane and 
further impact intracellular ROS; this was further proved by the gene expression results 
(see below). In addition, as TiO2 NPs are not internalized by but are in close proximity 
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to the bacterial cells (Figure A.1.2), TiO2 NPs simply have no chance to directly 
generate ROS within the cell plasma. While TiO2 NPs, either in the dark or under UV 
illumination, still induced inhibition of bacterial growth at high dosage, we postulate 
that the inhibition of growth is mostly caused by adsorption of nutrients to TiO2 NP 
surfaces rather than ROS generation from TiO2 NPs, due to the fact that (1) UV 
illumination did not enhance the inhibition; (2) the inhibition began after log phase, 
when the growth started to be limited by the availability of nutrients in media; and (3) 
cell viability after short exposure was not decreased by the combination of TiO2 
exposure and UV illumination. Thus, in future research, a minimal medium will be 
more desirable than LB broth and might reveal toxicity in viability/growth that was not 
observed in this study. However, it is still possible that TiO2 NPs and UV illumination 
caused subtle effects that cannot be observed by only viability/growth measurements; 
this possibility was addressed by cellular function assessment and gene expression 
studies subsequently. 
 
2.4.2 Riboflavin level change upon TiO2 NP and UV exposure 
Riboflavin, a redox molecule secreted by S. oneidensis MR-1 cells, acts as an electron 
shuttle between the cell surface and external acceptors, like metal oxide surfaces.33,34 
However, the redox potential of TiO2 conduction band at pH 7 (-0.7 V vs. SHE
54) is 
considered too low for reduction by flavins (with a midpoint potential of -0.2 to -0.25 
V34). Thus, we were not expecting riboflavin level to increase upon TiO2 exposure; on 
the contrary, considering that fact that bacterial growth was inhibited by TiO2 NPs, the 
hypothesis was that riboflavin secretion would be somewhat inhibited, correlating with 
growth results. However, for all three time points, no change was observed in riboflavin 
secretion upon only TiO2 NP exposure, even with the highest TiO2 nanoparticle dose 
in this study (100 mg/L). This indicated that riboflavin secretion does not correlate with 
bacterial growth. A previous study showed that riboflavin secretion increased upon 24-
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hour TiO2 NP exposure in a dose-dependent manner;
25 this was not observed in this 
study, possibly due to the different time frame of these two studies. 
 
As expected, UV illumination induced a decrease in riboflavin amount in cell 
suspension drastically, probably due to the photodegradation of riboflavin upon UV 
exposure, as shown in control experiments and previous work;55,56 control experiments 
showed that no riboflavin peaks were observed after 6 hours under UV illumination for 
a 4 µM solution of riboflavin (data not shown). The degradation was not likely due to 
ROS as adding antioxidants, including N-acetylcysteine or glutathione, did not recover 
the riboflavin level in cell suspension (Figure A.1.3). Considering the fact that all 
riboflavin was degraded after a 6-hour exposure in control experiments, it seems that 
bacterial cells in suspension “re-establish” riboflavin levels to counteract depletion of 
riboflavin from UV illumination. In a previous study, electrochemical activities were 
observed in a mediator-less microbial fuel cell using Shewanella putrefaciens cells, 
indicating that cells established a level of mediators for electron shuttling.57 
Interestingly, TiO2 NPs further reduced the riboflavin level in addition to UV exposure, 
indicating some additive effect between UV illumination and TiO2 NPs on the amount 
of riboflavin outside cells. This additional effect may be due to changes in either cell 
riboflavin secretion or photodegradation of riboflavin outside bacterial cells. Studies 
have shown that riboflavin can be adsorbed on TiO2 surfaces, likely via the phenolic 
group, and photo-excited flavin can transfer electrons into the conduction band of 
TiO2.
58,59 Thus, it is possible that TiO2 NPs act as a mediator/catalyst in riboflavin 
photodegradation. 
 
2.4.3 Gene expression change upon TiO2 NP and UV exposure 
To further investigate subtle effects that cannot be observed by only viability/growth 
measurements, 6 genes related to oxidative stress, exopolysaccharide (EPS) synthesis, 
extracytoplasmic stress, cell division and metal-reducing pathways were included in 
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this gene expression study to test the hypothesized mechanisms of how bacterial cells 
respond to TiO2 NPs. Different mechanisms of bacterial stress response were addressed 
by these 6 genes. TiO2 NPs were hypothesized to kill bacteria via generating ROS under 
UV illumination,16 while previous transcriptional analysis displayed that a series of 
ROS-scavenging related genes were up-regulated upon UVA illumination.60 Thus, the 
katB gene, one of the peroxide response-inducible genes controlled by the redox-
sensitive transcriptional activator OxyR,61 and the sodB gene, a gene coding for Fe-
containing superoxide dismutase,62 were chosen to represent the cell responses to 
oxidative stress from excessive ROS potentially generated by TiO2 NPs and UV 
illumination. Analysis of the results using two-way ANOVA showed that the katB gene 
was not influenced by TiO2 NP and/or UV light exposure while UV illumination had a 
statistically significant effect on the expression level of the sodB gene after 30-min and 
1-hour exposure, but TiO2 NPs did not show any effect. This correlated with the 
observation from the intracellular ROS assay, where TiO2 NPs did not induce any 
increase in ROS level within bacterial cells. However, though the expression level of 
the katB gene did not change, it does not necessarily indicate a lack of oxidative stress, 
as other ROS-scavenging related genes may respond instead of the katB gene based on 
observations from previous work.60 Interestingly, the expression level of superoxide 
dismutase decreased instead of the up-regulation that we expected; this may indicate a 
decrease of oxidative stress from superoxide ions upon UV illumination, but the 
expression level change was very minor. Overall, the response from the katB and sodB 
genes did not implicate a role for oxidative stress as a result of TiO2 NP exposure. 
 
Cyclic di-GMP is an intracellular signaling molecule in a lot of bacterial species.63 
Biofilm formation, an important function of S. oneidensis that is related with bacterial 
interaction with mineral surface and electron transfer,64,65 was postulated to be 
controlled by cyclic di-GMP via production of EPS.63 In the same work, a ΔmxdA 
mutant exhibited strong defect in biofilm formation, followed by a further discovery 
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that the intracellular cyclic di-GMP level was indirectly modulated by MxdA in S. 
oneidensis MR-1.66 Based on these precedent studies, the mxdA gene, coding for a 
diguanylate cyclase-like protein, was chosen to indicate potential changes in biofilm 
formation. Two-way ANOVA analysis showed that after a 30-minute exposure, UV 
illumination had a statistically significant effect on the expression level of the mxdA 
gene, while no impact was observed upon TiO2 NP exposure. No effect was observed 
at longer time points. These results indicate the potential modulation of cyclic di-GMP 
within the cells, but this effect vanished as the exposure time lengthened with a time 
frame of 6-hour. Previous work indicated that the TiO2-exposed bacteria had slower 
biofilm growth with no change in the amount of EPS observed, and the mxdA gene 
showed no difference in expression level upon 1-hour and 6-hour TiO2 exposure.
25  
 
Filamentous phage infection, osmotic shock, and ethanol treatment have been shown to 
induce the response of phage-shock-protein (Psp) genes in bacterial cells.67-69 It was 
postulated that extracytoplasmic stress disrupts the membrane potential by dissipating 
the proton-motive force on cell membranes.67 As precedent work25 and microscopic 
images (Figure A.1.2) showed that TiO2 NPs were not internalized by but in proximity 
to the bacterial cells, it was reasonable to hypothesize that TiO2 NPs exert membrane 
stress to bacterial cells by associating with the bacterial membrane; thus, as part of the 
Psp response system, the pspB gene was chosen to reveal potential extracytoplasmic 
stress.67 Results show that pspB gene expression was down-regulated after 1 hour upon 
UV illumination, but no change was observed at other time points or upon TiO2 
exposure. Considering the role of PspB protein in Psp response, acting largely as a 
signal detector/transducer that detects extracytoplasmic signals and initiates the Psp 
response by binding to PspA protein, pspB gene expression might not be directly 
regulated upon membrane stress. Further experiments can be done using pspA or pspG 
as genes of interest, as they are the two genes that are regulated by PspF regulon 
following PspA protein binding to the PspB/C complex during the Psp response.69 The 
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down-regulation of pspB expression upon UV illumination is hard to interpret without 
additional information; no precedent work has reported change of pspB expression level 
upon UV illumination. Further experiments might include a membrane potential 
measurement upon TiO2 NP exposure and UV illumination to obtain more information 
on membrane stress. 
 
The other two genes of interest, ftsK and omcA, did not show any statistically significant 
changes upon TiO2 NP or UVA exposure. The FtsK protein actively pushes DNA 
through the closing division septum during bacterial chromosome segregation in cell 
division,70 so we expected the ftsK gene expression level to be a biomarker for bacterial 
growth. However, though S. oneidensis MR-1 displayed a growth inhibition upon TiO2 
NP exposure, the expression level of ftsK gene did not change. The OmcA protein is a 
part of the metal-reducing pathway of S. oneidensis MR-1, which is important for the 
bacterial respiration of oxidized metals like Fe(III) and Mn (IV). It is located on the 
outer membrane, and previous research shows that this protein is required for electron 
transfer from the inner membrane to the electron terminal acceptors via electron shuttles 
like flavins.71 Based on this information, we expected the expression level of the omcA 
gene to be indicative of riboflavin secretion. However, omcA gene expression level did 
not change upon exposure, and was not correlated with riboflavin secretion measured 
by HPLC. A better candidate for riboflavin biomarker might be a gene directly related 
with riboflavin biosynthesis (e.g. ribA/B, ushA).33,72 
 
It should also be noted that though there were some statistically significant changes in 
gene expression levels, the degree of change was relatively small in a biological context 
(smaller than 2). With a higher dose of 100 mg/L, one might see more change, but in a 
previous study, 100 mg/L of TiO2 nanoparticles also did not show any relative fold 
change larger than 2.25 Based on the result of this study, none of the genes can be 
considered as biomarkers for the inhibition of growth. For future work, the nqrF gene, 
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coding for Na-translocating NADH-quinone reductase, might be a candidate as a 
biomarker of cell respiration and growth.73,74 
 
2.5 Conclusions 
In this study, we showed that TiO2 nanoparticles inhibited the growth on Shewanella 
oneidensis MR-1 at high dosage but had no effect on cell viability, while concomitant 
UV-A illumination did not induce extra inhibition in growth. It is likely that the minimal 
impacts are due to the nutrient-rich medium used in this study. Because environmental 
systems are not likely to be nutrient rich, future work will examine effects in minimal 
medium that only contains minimal amount of salts.75 Further assessments on reactive 
oxygen species and riboflavin secretion indicated that TiO2 NPs induced neither 
intracellular ROS accumulation nor riboflavin secretion but had additive effect with 
UV-A illumination to further reduce the amount of riboflavin outside cells. Finally, we 
demonstrated that gene expression is a tool to explore NP toxicity mechanisms in 
combination with cell function, thus providing more information on how cells respond 
to NPs and understanding the subtle influences of NPs to the ecological systems.  
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Chapter 3 
Gene expression response of the Gram-negative bacterium 
Shewanella oneidensis and the water flea Daphnia magna exposed to 
functionalized gold nanoparticles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from: 
Qiu, T. A.*, Bozich, J. S.*, Lohse, S. E., Vartanian, A. M., Jacob, L. M., Meyer, B. M., 
Gunsolus, I. L., Niemuth, N. J., Murphy, C. J., Haynes, C. L., Klaper, R. D., Gene 
expression as an indicator of the molecular response and toxicity in the bacterium 
Shewanella oneidensis and the water flea Daphnia magna exposed to functionalized 
gold nanoparticles, Environmental Science: Nano, 2015, 2, 615-629.  
 
*T.A.Q. and J.S.B. contributed equally to this work. T.A.Q. contributed to all work 
regarding bacteria.  
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3.1 Introduction 
Engineered nanoparticles (NPs) are being produced to enhance a wide range of 
societally beneficial applications, from energy storage capacities and material 
durability to medical therapeutics and water treatment devices.1-3 These applications 
are possible because of the novel physiochemical properties NPs display, such as high 
surface area and reactivity as well as distinct surface chemistries, composition, and size 
distributions. It is, however, these same size-dependent physiochemical properties that 
may influence their biocompatibility.4-8 For example, size, shape, and core composition 
have been thought to mediate receptor-ligand binding rates, cellular phagocytosis, 
exocytosis, and cytotoxicity.9-12 Other studies suggest that NP surface charge is the main 
determinant of biological interactions, with positively charged particles being more 
toxic than negatively or neutrally charged particles.13-18  
 
These classifications of critical features that determine biological impact all focus on 
the NPs themselves. The differences in response across organisms or cell types is less 
often considered despite the fact that toxicological evaluations of the biological impacts 
caused by engineered NPs have revealed a wide range in responses across cell types or 
organisms considered.19-23 For example, Sohaebuddin et al. (2010)24 demonstrated that 
cell type determines the extent of response to nanomaterials with different composition 
and size. In another study using ZnO NPs, the EC50 differed by orders of magnitude for 
V. fischeri, D. magna and T. platyurus.25 Variation across cell systems and organisms 
makes it difficult to develop a common understanding of the properties of 
nanomaterials that may determine toxicity. Even for well-studied chemicals, such as 
pesticides, models that use general acute endpoint data to predict impacts often 
inaccurately estimate concentrations that cause effects across similar chemicals, and 
rarely are applicable across organisms.26,27 These studies have shown that a more 
mechanistic understanding of the impacts of chemicals at sublethal doses provides a 
more accurate description of impacts and better data for modeling these effects across 
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species. The goal of this study is to achieve a more mechanistic understanding of 
NP/organism interactions to facilitate efficient prediction of the impact nanotechnology 
will have on environmental health. Linking specific molecular mechanisms that are 
impacted by NPs across organisms will not only greatly aid in assessing the potential 
environmental impact of these materials but is also crucial to informing NP design for 
safe and sustainable development of nanotechnologies.  
 
Currently, the major proposed molecular mechanism for NP toxicity is oxidative 
stress.4,28-31 However, the exposures that produce oxidative stress in many studies are 
well above what is estimated to be the current or future environmental concentrations; 
long-term low dose exposures are the more likely scenario.32,33 In addition, the 
molecular mechanisms responsible for coping with oxidative stress are triggered upon 
exposure to a wide range of chemical species34,35 and are a natural biological response 
that does not necessarily lead to an adverse outcome.36 The focus on oxidative stress 
and lethal dose exposures makes it difficult to uncover other mechanisms that may have 
a greater predictive power for the environmental impact of NPs. Sublethal 
concentration-based exposures allow the cell to have a more natural perturbation by the 
contaminant that triggers subtle, but potentially specific, molecular responses.37,38 It is 
these more realistic exposure scenarios that will uncover more mechanism-based 
information to predict meaningful impacts across species.  
 
Molecular biomarkers provide a sensitive indicator of the response of an organism to 
stressors such as exposure to a toxicant in addition to providing information on the 
mechanisms that are impacted by exposure.37,38. Mechanistic information that can be 
tied to larger impacts on reproduction for example enhance the possibility of predicting 
negative outcomes where standardized toxicological tests, although valuable, have 
limited the ability to accurately predict the impact of emerging contaminants. 
Overreliance on these methods has led to risk assessment failures.39 Developing such 
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candidates for molecular biomarkers for NP toxicity will greatly aid in the rapid 
assessment and impact prediction for current and emerging nanomaterials across a wide 
range of organisms. Previously developed biomarkers, for example, vitellogenin, have 
been used for the successful determination of adverse outcomes of some classes of 
endocrine disruptors and their impacts on vertebrate reproduction.40-42 Metallothioneins 
are biomarkers used in organisms to detect toxic metal ion exposure, and they are 
known to respond to a wide range of metal-based contaminants associated with 
environmental pollution.43 Heat shock proteins, indicative of proteotoxic stressors, 
indicate sublethal cellular damage and respond in a dose-dependent manner to 
environmental stressors.44 Molecular biomarkers that provide mechanistic insight for 
grouping nanomaterials by their molecular level interactions, especially if they apply 
to effects seen across species, would provide insight for grouping nanomaterials by their 
molecular level interactions. Furthermore, they may indicate both nonspecific and 
specific modes of action as well as underlying mechanisms for toxicity of NPs with 
particular physiochemical properties.  
 
In this study, we examined several candidate biomarkers in two model species, the 
bacterium Shewanella oneidensis and the invertebrate Daphnia magna, that are 
associated with pathways of importance in these two species and determined how their 
expression related to the biological impacts of exposure to gold NPs (AuNPs) with 
positively or negatively charged surfaces. Shewanella oneidensis MR-1 is an 
environmentally beneficial Gram-negative bacterium with a unique metal-reducing 
capability to respire heavy metals; S. oneidensis plays an important role in the cycling 
of metal elements in the ecosystem as well as the bioremediation of toxic elements.45 
Daphnia magna is a designated toxicology and toxicogenomics model organism by 
multiple agencies (OECD, NIH and EPA), and is an environmentally relevant 
freshwater invertebrate that composes an integral part of freshwater food webs.46 
AuNPs were chosen as a model NP in this study due to the chemical inertness of the 
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gold core and our ability to readily control size,47 shape,48 and surface 
functionalization.49 Two ligands were used for AuNP functionalization, positively 
charged polyallylamine hydrochloride (PAH) and negatively charged 
mercaptopropionic acid (MPA).  
 
We explored genes in various molecular pathways in our two model organisms. Pairs 
of genes selected from each organism were selected to represent pathways encoding for 
similar cellular functions in two organisms, including oxidative stress, xenobiotic 
detoxification, protein folding, cellular electron transport, and cellular maintenance. In 
addition, genes in pathways related to reproduction in D. magna and to cell division, 
DNA repair and extracytoplasmic stress in S. oneidensis were also investigated. The 
goal was to determine 1) how the exposure to NPs with differing surface properties 
impacted each organism and how this differed from their respective ligand controls 2) 
if gene expression for these pathways were an indication of impacts seen in each 
organism 3) if exposure duration altered effects and gene expression measurements and 
if acute measurements of gene expression would provide an indication of chronic 
impacts 4) if gene expression for similar pathways across organisms would provide 
biomarkers that were predictive across species. The NPs used in this study were 
quantitatively and qualitatively characterized prior to and after exposure to assay media 
to aid us in understanding how alterations in NP physical properties may impact 
molecular pathways. Overall, this work aims to link molecular pathways to NP 
characteristics in two distinct environmentally relevant organisms. 
 
3.2 Experimental 
 
3.2.1 Functionalized AuNP synthesis and characterization 
All materials were used as received, unless otherwise noted. Gold tetrachloroaurate 
trihydrate (HAuCl4•3H2O), sodium borohydride (NaBH4), trisodium citrate, 3-
mercaptopropionic acid (MPA), and polyallylamine hydrochloride (PAH; Mw 15, 000 
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g/mol) were obtained from Sigma Aldrich. Ultrapure deionized water was prepared 
using a Barnstead NANOPURE water filtration system. PALL Minimate tangential 
flow filtration capsules for AuNP purification with 50 kD pore size was obtained from 
VWR. Transmission electron microscopy grids were obtained from PELCO (SiO on 
copper mesh). 
 
The 4.7 (± 1.5)-nm-diameter PAH-AuNPs were prepared by polyelectrolyte wrapping 
of ~4-nm-diameter citrate-coated AuNPs. The (4.3 ± 1.3)-nm-diameter MPA-AuNPs 
were prepared by direct synthesis. After synthesis, measuring and counting using TEM 
images determined size distributions. Detailed descriptions of the AuNP syntheses are 
given below. 
 
PAH-AuNPs (4.7 ± 1.5 nm). As a first step in synthesis of PAH-AuNPs citrate AuNPs 
were synthesized using previously reported procedures.47 In an aqua regia-cleaned 
round-bottomed flask, 5.0 mL of aqueous gold tetrachloraurate hydrate (HAuCl4•3H2O, 
10.0 mM) was combined with 1.5 mL of aqueous 0.1M sodium citrate and diluted to a 
final volume of 400 mL with ultrapure deionized water. The reaction mixture was 
stirred vigorously for 10 min. An aqueous solution of ice-cold 10.0 mM sodium 
borohydride (30.0 mL) was then added to the reaction mixture, while stirring continued. 
Following borohydride addition, the solution rapidly changed color to a deep brown, 
and then red-orange over the course of the first 10 minutes of stirring. The resulting 
AuNP solution was then stirred for a further 3.0 hours. The crude 4 nm Cit-AuNPs were 
then concentrated using a diafiltration apparatus, prior to polyelectrolyte wrapping.50 
Cit-AuNPs were then wrapped with polyallylamine hydrochloride (PAH) to prepare 4 
nm PAH- AuNPs, as previously described.51 Briefly, the concentrated Cit-AuNP 
solution was dispersed in 20.0 mL of a 1.0 mM aqueous sodium chloride solution to 
give a final AuNP concentration of approximately 20.0 nM. To each 20.0 mL of 
polyelectrolyte wrapping solution, 500 μL of 15 000 Mw PAH (10.0 mg/mL) dissolved 
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in 1.0 mM NaCl was then added. The wrapping solution was briefly mixed at vortex 
briefly and left to stand for 16 h. The PAH-AuNPs were subsequently purified by 
centrifugation and washing (55 min. at 18,894 × g), in ultrapure deionized water. The 
purified PAH-AuNPs were then concentrated in a diafiltration membrane.50  
 
MPA-AuNPs (4.3 ± 1.3 nm). MPA-stabilized AuNPs were prepared by direct synthesis 
with sodium borohydride according to previously reported methods.52 Briefly, a 500 
mL aqueous solution of HAuCl4 (1.5 mM) and MPA (3.0 mM) was prepared using 
ultrapure deionized water in aqua regia-cleaned round-bottomed flask. The pH of the 
growth solution was adjusted to approximately 8.5 by the addition of dilute aqueous 
sodium hydroxide and stirred at vortex for 10 min. 10.0 mL of a 0.1 M aqueous sodium 
borohydride solution was then added to the reaction mixture. The combined solutions 
rapidly changed color to a deep orange-brown, and the reaction mixture was stirred for 
a further 3 hours. The thiol-stabilized AuNPs were then concentrated and purified by 
diafiltration (40.0 volume equivalents of ultrapure deionized water in a 50 kD 
membrane).  
 
3.2.2 AuNP characterization and analysis 
Synthesized functionalized AuNPs were characterized in Milli-Q water, bacteria 
growth medium, and Daphnia medium using various analytical techniques, including 
TEM for absolute sizes (JEOL 2100 Cryo TEM), dynamic light scattering for 
hydrodynamic diameter (Brookhaven ZetaPALS), zeta-potential for surface charge 
(Brookhaven ZetaPALS), and UV-Vis localized surface plasmon resonance (LSPR) 
spectroscopy for particle concentration and aggregation (Mikropack DH-2000 UV-vis-
NIR Spectrometer). 
 
3.2.3 Free ligand suspensions  
Free ligands, MPA and PAH (Mw 15, 000 g/mol), were obtained from Sigma Aldrich. 
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MPA and PAH ligands are readily soluble in water and do not require a co-solvent for 
dispersion. The ligands were dissolved into Milli-Q water at a maximum concentration 
of 50 mg/L and diluted accordingly for free ligand toxicity control experiments. 
 
3.2.4 Shewanella oneidensis MR-1 cultivation and cell respiration assay 
S. oneidensis MR-1 cultivation. S. oneidensis MR-1 was obtained from Professor 
Jeffery Gralnick, University of Minnesota Department of Microbiology and was stored 
at -80°C before use. Bacteria were inoculated onto a LB broth agar plate and incubated 
at 30°C for 24 hours or until visible colonies formed. A minimal medium consisting of 
salts and buffering agent was used in this study. 0.68 g NaCl, 0.3 g KCl, 0.285 g 
MgCl2∙6H2O, 0.3975 g Na2SO4, 0.15 g NH4Cl, and 2.383 g HEPES (4-(2-hydroxyethyl) 
piperazine-1-ethanesulfonic acid) were dissolved in 1 liter of Milli-Q water. After 
autoclaving and cooling down, 0.0125 g Na2HPO4 and 0.0056 g CaCl2 were added per 
liter. Right before use, 1.86 mL sodium DL-lactate syrup (60% w/w, Sigma-Aldrich) 
was mixed with the minimal medium to make 100 mL of the final growth medium 
containing 129 mM sodium DL-lactate. Lactate was used as an additional carbon source 
to promote bacterial growth. Colonies formed on agar plates were inoculated into the 
minimal medium with lactate in sterile culture tubes and grown in a 32 °C orbital shaker 
at 300 rpm until OD600 ~0.25, the maximal optical density that Shewanella oneidensis 
MR-1 can reach in the minimal medium with lactate. 
 
Monitoring S. oneidensis oxygen uptake. The oxygen uptake of the bacteria 
population over time was monitored using a PF-8000 aerobic/anaerobic respirometer 
system (Respirometer Systems and Applications, LLC). Bacteria were grown in 
minimal medium with lactate until it reached OD600 ~0.25 and diluted 1:10 into that 
growth medium supplied with NP/ligands in reaction vessels that were kept in a 32 °C 
water bath. Exposures of PAH-NPs were conducted at 30, 100, and 5000 µg/L, and 
exposures of PAH ligand were 30, 100, 300, 600, 1000, 2000 and 5000 µg/L. In all 
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subsequent experiments and comparisons, a ten-fold mass concentration of PAH free 
ligand and an equivalent mass concentration of MPA free ligand were used as ligand 
controls, which was calculated to be an overestimate of possible total free ligand present 
in the suspension (See Appendix A.2.1 and A.2.2).53 A tube filled with 1 mL 30% (w/w) 
KOH solution was inserted into each reaction vessel to absorb carbon dioxide generated 
from cell respiration. The consumption of oxygen was compensated by continuous 
oxygen injection to keep the pressure constant in the headspace of the reaction vessels. 
Oxygen uptake was recorded every 10 minutes automatically for 24-48 hours by the 
instrument. The first derivative of oxygen uptake was plotted to identify the maximal 
oxygen uptake rate and the time of that maximum. To represent each cell oxygen uptake 
trace with a single value, the ratio of maximal oxygen uptake rate to the time when it 
reached maximal rate was calculated following the equation below: 
𝑅𝑎𝑡𝑖𝑜 =
𝑀𝑎𝑥𝑖𝑚𝑎𝑙 𝑟𝑎𝑡𝑒 (
𝑚𝑔
ℎ )
𝑇𝑖𝑚𝑒 𝑡𝑜 𝑟𝑒𝑎𝑐ℎ 𝑚𝑎𝑥𝑖𝑚𝑎𝑙 𝑟𝑎𝑡𝑒 (ℎ)
 
The ratio was then normalized to the average of control groups and represented as a 
percentage, where 100% indicates no inhibition of cell oxygen uptake.  
 
3.2.5 Daphnia magna cultivation and biological assays 
D. magna cultivation. Populations used in this experiment were cultivated at the UW-
Milwaukee School of Freshwater Sciences in the R. Klaper laboratory. Daphnia 
neonates used for the gene expression assays were collected from populations 
maintained in moderately hard reconstituted water (MHRW) incubated at 20°C on a 
16:8 light/dark cycle as designated by EPA protocols.54 Daphnia breeding populations 
were held at a concentration of 14 adult Daphnia per 1 L of media in glass beakers and 
were discarded once adults reached 28 days old. Daphnia were fed 50 mL freshwater 
algae (Pseudokirchneriella subcapitata) at an algal density of 400,000 algal cells/mL 
and 15 mL of dissolved alfalfa (Medicago sativa). Alfalfa stock was prepared by 
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suspending 405 mg of Alfalfa in 50 mL milli-Q water after 15 minutes of stirring and 
5 minutes of centrifugation at 3,829 × g.  
 
D. magna acute assay. Acute survival assays were carried out in a 48-hr static 
exposure. All exposures used 5 Daphnia neonates (24-48 hours old) per 100 mL of 
MHRW (control), NPs, or free ligands suspended in MHRW, bringing the total volume 
to 100 mL. A minimum of three replicates was carried out for each treatment, and 
survival was determined as percentage alive at 48 hrs. Exposures were carried out to 
determine sublethal concentrations of NPs and free ligands. Concentrations tested for 
NPs and free ligands are: 1, 5, 10, 50, 100 μg/L for PAH-AuNPs and PAH free ligand 
and 1, 5, 10 and 25 mg/L for MPA-AuNPs and MPA free ligand.  
 
D. magna chronic assay. Daphnia chronic exposures used 5 Daphnia neonates (24 - 
48 hours old) exposed to NPs or ligands for 21 days in a static renewal exposure, and 
triplicate assays were performed for each condition. A total of 5 neonates were placed 
in 94 mL of MHRW (control) or NPs/ligands where full media change out occurred 
three times per week. In chronic exposures, daphnids are supplemented with 4 mL of 
algae (Selenastrum capricornitum) and 2 mL of alfalfa (Medicago sativa) at each media 
exchange to bring the total volume to 100 mL. Concentrations tested in the chronic 
assay were: 1 and 5 μg/L for PAH-AuNPs and PAH free ligand and 5 and 25 mg/L for 
MPA-AuNPs and MPA free ligand. Reproduction and mortality were measured at each 
media exchange, and body size was recorded at the end of the exposure.  
 
Reproductive exposures adhered to the mortality and reproduction guidelines 
designated by the OECD (OECD guidelines 1998). Daphnids were kept at a 
concentration of 5 daphnids per 100 mL, and results were normalized to controls (i.e. 
daphnia exposed to only MHRW) to account for changes in reproduction and body size 
as these replicate exposures took place over a period of several months.  
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3.2.6 Gene expression exposures and RNA preservation 
Gene expression exposures were performed in parallel with bacterial oxygen uptake 
and D. magna survival and reproduction assays. 
 
S. oneidensis. Colonies from agar plates were inoculated in minimal medium supplied 
with 129 mM lactate until the bacterial suspension reached OD600 ~0.25. The bacterial 
suspension was adjusted to OD600 = 0.2 before AuNPs were added. The sublethal 
dosages, 30 µg/L of PAH-AuNPs and 300 µg/L of PAH ligand, and 5 mg/L of MPA-
AuNPs/ligands, were primarily used for gene expression studies; in addition, a 100 
µg/L dose of PAH-AuNPs was used to investigate two biomarker candidates, in order 
to provide further evidence to link molecular pathways to inhibition of bacterial oxygen 
uptake. After exposure, the bacterial suspension was incubated on a 32°C orbital shaker 
at 300 rpm for 1 hour or 6 hours. Cells were harvested by centrifuging at 1,500 × g for 
10 minutes, and then the pellets were sufficiently re-suspended into either 200 µL 
(PAH-AuNP/ligand) or 1 mL (MPA-AuNP/ligand) of RNAzol®RT (Molecular 
Research Center, Inc.) for cell lysis and RNA preservation.  
 
D. magna. Daphnia neonates (24-48 hours old) were exposed to NPs and free ligands 
in an acute exposure lasting 24 hours. All exposures used 10 neonates per 100 mL of 
MHRW (control) or NPs or free ligands suspended in MHRW (treatment) bringing the 
total volume to 100 mL. Exposures were carried out at sublethal concentrations of 
NPs/free ligands between 5-1000 µg/L depending on the NP/free ligand being 
considered. Sublethal concentrations for acute exposures were chosen based on 
previous study.13 Greater than three replicates were carried out for each treatment and 
concentration tested. At the end of the exposure duration, daphnids were collected and 
put in a 1.5 mL RNase-free eppendorf tube corresponding to their replicate number. 
Excess liquid was removed and daphnids were immediately flash frozen in liquid 
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nitrogen and stored at -80°C to await further processing. For D. magna chronic 
exposures, exposures were carried out at sublethal concentrations of NPs/free ligands 
between 5-5000 µg/L, and daphnids were collected at the end of the 21-day exposure 
period and preserved using the same method as the acute exposure samples. For all 
samples, RNA was extracted using TRIzol® for cell lysis and RNA preservation.  
 
3.2.7 RNA extraction, reverse transcription and real-time quantitative PCR 
A Direct-zol™ RNA MiniPrep kit (Zymo Research) was used for total RNA isolation 
and purification by spin columns. The manufacturer’s recommended protocol was 
followed using a centrifugation speed of 12,000 × g with an on-column DNase I 
treatment at 30°C for 15 minutes. RNA was finally eluted from the column at 16,000 
×g for 1 minute. Total RNA was characterized using a Thermo Scientific NanoDrop 
8000 and an Agilent 2100 Bioanalyzer for quality control. 
 
Total RNA was reverse transcribed into cDNA following the manufacturer’s protocols. 
Briefly, 100 ng of total RNA were incubated in the presence of either random primers 
(Promega) for S. oneidensis or oligo(dT)15 primer (Promega) for D. magna at 65°C for 
5 minutes. After cooling on ice for 1 minute, the SuperScript III reverse transcriptase, 
DTT, and RNaseOUT™ recombinant ribonuclease inhibitor (Life Technologies) were 
added into the mixture followed by incubation at 25°C for 5 minutes (this step was only 
for random primers), 50°C for 60 minutes, and 70°C for 15 minutes for primer 
extension. Once synthesized, cDNA samples were stored at -20°C. 
 
Target genes were chosen for both S. oneidensis and D. magna. Four pairs of genes in 
similar pathways related to stress response in the two organisms were selected, 
including gst (S. oneidensis)/gst (D. magna, same order for the following pairs) for 
xenobiotic detoxification, nqrF/nadh for electron transport, katB and sodB/cat for 
oxidative stress attenuation, and ibpA/hsp70 for heat shock response. To link to apical 
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endpoints, the vtg gene for D. magna reproduction and ftsK for bacterial cell division 
were also examined. Genes for actin (act) in D. magna and for 16S ribosomal RNA 
(16S) and RNA polymerase (rpoA) in S. oneidensis were monitored to consider 
NP/ligand impacts on basic organism machinery. In addition, stress response genes 
including pspB for extracytoplasmic stress, sodB for oxidative stress, and radA for 
DNA repair were also examined in S. oneidensis. Table 3.1 shows a full list of genes 
along with their corresponding functions. 
 
Primers for real-time quantitative PCR were designed by the PrimerQuest Tool 
(Integrated DNA Technologies). Two sets of primers were designed for each gene, and 
the one with efficiency closest to 1 was chosen to be the primer for subsequent real-
time PCR. Table 3.1 includes a full list of primers used in this study. 
 
Real-time quantitative PCR (qPCR) was performed on a StepOnePlus™ Real-Time 
PCR System (Life Technologies) using SYBR Green as the fluorescent intercalating 
dye (iTaq™ Universal SYBR® Green Supermix, Bio-Rad). For each qPCR reaction, 
cDNA and primers were mixed with the fluorescence dye following the manufacturer’s 
protocol. Starting with an initial 10 min denaturation at 95°C, real-time PCR repeated 
40 cycles of amplification, each of which was 15 s at 95°C followed by 30 s at 60°C. 
Fluorescence of SYBR Green was detected at the end of each cycle. All qPCR 
experiments were done in technical duplicates. 
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Table 3. 1 Target genes, corresponding functions, and their primers for qPCR. 
Shewanella oneidensis MR-1  
Target Gene Forward primer (5’-3’) Reverse primer (5’-3’) Function Accession Number 
Glutathione S-transferase (gst) GCA AAG CAT TCC AGC AAT TT GAC CTT CTT GCG TTT TGA GC Xenobiotic detoxification NP_720213.1 
Na-translocating NADH-quinone 
reductase subunit F (nqrF) 
CGC TTA CTC GAT GGC TAA CTA C GCA AGG CAG CGT CAA ATT AC Mitochondrial electron transport 
NADH to ubiquinone 
NP_716734.1 
Double-stranded DNA translocase 
(ftsK) 
TAC GAG TCG TGT TGC GAT AAA AAG GGC TGA CAC TGG AAT AAA Cell division NP_717901.1 
Catalase HPII (katB) GGC ATT GAT CCT GAT TCT TCT C TCC AAC GAG GGA AGT TAC CA Catalase activity; response to 
oxidative stress 
NP_716697.1 
16 kDa heat shock protein A 
(ibpA) 
GCA ACT CAG GTT ATC CTC CAT AC CGC TAC TGA TCT CAA GCT CTT C Response to heat; chaperone 
activity 
NP_717873.1 
16S ribosomal RNA (16S) TCA AGT CAT CAT GGC CCT TAC TAC GAC GAG CTT TGT GAG ATT 
AG 
Component of prokaryotic 
ribosomes 
NR_074798.1 
RNA polymerase alpha subunit 
(rpoA) 
TCG CAT CCT ATT GTC GTC TAT G CTT CTT GTA CGC CTT CCT TAC T DNA-directed RNA polymerase 
activity 
NP_715896.1 
ATP-dependent protease (radA) TTC GGC AAT TTT CCT CTC C ACA CCA CCA TGA CCA AGG AT DNA repair NP_716849.1 
Phage shock protein B (pspB) TTG ATT GCG AAA GCC GAT A ATC AAG AAT CGC CTC TAA GGT 
TT 
Extracytoplasmic stress NP_717416.1 
Fe/Mn superoxide dismutase 
(sodB) 
GCA ATG TTC GCC CTG ACT AC CCT GCG AAG TTT TGG TTC AC Removal of superoxide radicals NP_718453.1 
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Daphnia magna  
Target Gene Forward primer (5’-3’) Reverse primer (5’-3’) Function  
Glutathione S-transferase (gst) CAA CGC GTA TGG CAA AGA TG CTA GAC CGA AAC GGT GGT AAA Xenobiotic detoxification AF448500.1 
Dehydrogenase (nadh) GCA GGA AAC AAT AAG GCA AAC C GGT GGC ACA GAC CAT TTC TTA Mitochondrial electron transport 
and energy production 
ABD19473.1 
Vitellogenin (vtg) CTG TTC CTC GCT CTG TCT TG CCA GAG AAG GAA GCG TTG TAG Reproduction, sexual maturation 
and general stress 
BAE94323.1 
Catalase (cat) CAG GAT CAT CGG CAG TTA GTT CTG AAG GCA AAC CTG TCT ACT Oxidative stress attenuation  ACU81116.1 
Heat shock protein 70 (hsp70) CCT TAG TCA TGG CTC GTT CTC TCA AGC GGA ACA CCA CTA TC Response to heat; protein 
folding 
ACB11340.1 
β-Actin (act) CCA CAC TGT CCC CAT TTA TGA A CGC GAC CAG CCA AAT CC Cytoskeleton production and 
cell maintenance 
CAB99474.1 
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3.2.8 NORMA-Gene analysis of qPCR data 
Real-time quantitative PCR data were processed by the Miner55 program and NORMA-
Gene algorithm.56 Miner applies an objective analysis scheme to obtain the dynamic 
fluorescence threshold (R), threshold cycle number (Ct), and efficiency (E) for each 
qPCR reaction, instead of using the same threshold for all reactions. Data of normalized 
reporter signal (Rn) versus cycle number were extracted from amplification data 
exported from the StepOnePlus™ software as the input to the Miner program to obtain 
R, Ct, and E values for each reaction. R0, the initial fluorescent reporter signal, was 
calculated based on the equation below: 
𝑅0 = 𝑅 × (1 + 𝐸)
−𝐶𝑡 
Due to the change in housekeeping genes throughout experiments, NORMA-Gene, a 
qPCR normalization method based on target gene data, was applied to normalize the 
gene expression data and reduce the variation among replicates rather than using a 
single housekeeping gene. Using this technique, the geometric means of R0 values of 
technical duplicates were calculated as the average and were put into the NORMA-
Gene workbook generously provided by Dr. Yuya Hayashi. Normalized R0 values, 
which were the output of NORMA-Gene algorithm, were then further normalized to 
control groups by dividing the normalized R0 of treated groups by the geometric mean 
of normalized R0 values of control groups to obtain the relative fold change.  
 
3.2.9 Statistical analysis 
The normalized ratios from oxygen uptake traces were further subjected to statistical 
analysis. No normality and outliers were considered within this data set due to the 
limited sample size (N<5). The two-tailed Student’s t-test was performed on treated 
samples versus their respective control group with α = 0.05. GraphPad Prism 
(GraphPad Software, Inc.) was used for statistical analysis. 
 
Data from Daphnia acute studies failed to meet the assumptions of normality. Therefore, 
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the effects of NP and free ligand exposures on Daphnia survival, were compared to 
controls using the Student’s t-test for two-independent samples (N<3). Impacts on 
daphnid reproduction and body size were assessed using one-way ANOVA with 
Tukey’s multiple comparison tests after normality and variance homogeneity were 
determined (N>3). One round of statistically determined outliers was removed, and 
treatments were deemed significantly different than controls at probability value < 0.05. 
SPSS (IBM 2013).  
 
The relative fold change values of S. oneidensis gene expression were log2-transformed 
followed by the combination of control groups. Outliers were identified and excluded 
from the data set (ROUT algorithm, Q = 1.0%, Prism GraphPad), and post-hoc Tukey’s 
tests after ANOVA were performed to determine statistical significance among different 
treatments at one time point and one gene of interest. For the 16S and sodB genes upon 
100 µg/L PAH-AuNP exposure, as there was only one treatment, an unpaired t-test was 
used instead of ANOVA. Again, normality was not tested due to the limited sample size 
(N < 6). GraphPad Prism was used to perform statistical analysis. 
 
The relative gene expression data from Daphnia short-term and long-term gene 
exposures were normalized to controls and log2 transformed to fit a normal distribution. 
Outliers were removed prior to statistical analysis. Significant differences in relative 
expression were determined using one-way ANOVA with Tukey’s multiple comparison 
tests after normality and variance homogeneity were determined (p < 0.05) (N>3). 
SPSS (IBM 2013) was used to interpret data. 
 
3.3 Results 
 
3.3.1 Nanoparticle characterization 
TEM analysis of absolute size showed that the two AuNPs had very similar core size, 
while the hydrodynamic diameter of PAH-AuNPs in water was larger than MPA-
76 
 
AuNPs, possibly due to the polyelectrolyte wrapping (Table 3.2). It was notable that 
MPA-AuNPs showed increased hydrodynamic diameter and a peak shift in UV-vis 
extinction upon resuspension in growth medium, indicating the aggregation of MPA-
AuNPs, though the MPA-AuNPs still retained a negative surface charge in the growth 
medium (Table 3.2). The aggregation may result from elevated ionic strength in the 
growth medium or the pH change from slightly acidic Milli-Q water (pH ~6.3) to 
neutral growth medium (pH ~7.2). This aggregation might lead to altered NP toxicity, 
as previous studies have revealed.19,57 Similar behavior was not observed on PAH-
AuNPs, indicating more stability of PAH-AuNPs in growth medium than MPA-AuNPs 
(Table 3.2). 
 
Table 3. 2 Nanoparticle characterization. 
 PAH-AuNPs MPA-AuNPs 
 
S. oneidensis 
Media 
D. magna 
Media 
S. 
oneidensis 
Media 
D. magna 
Media 
bLSPR 
max
 (nm) (in H
2
O) 528 515 
LSPR 
max
 (nm) (in medium) 530 530 555 575 
d
core
 (nm) * 
4.7 ± 1.5 
(N ≥ 250) 
4.3 ± 1.3 nm 
(N = 501) 
D
h
 (nm) (in H
2
O) a200.2 ± 3.5 126.4 ± 3.7 
D
h
 (nm) (in medium) a159.5 ± 0.6 a79.43 ± 1.9 339.6 ± 21.9 364 ± 34.2 
ζ-Potential (mV) (in H
2
O) +68.5 ± 1.6 -17.3 ± 0.6 
ζ-Potential (mV) (in medium) +24.57 ± 5.6 +10.5 ± 4.8 -24.28 ± 3.2 -29.8 ± 1.3 
*Based on TEM analysis. See Figure A.2.1 for TEM images.  
a For polyelectrolyte wrapped particles, hydrodynamic diameter (Dh) determined by 
dynamic light scattering is not accurate. b Localized surface plasmon resonance (LSPR) 
wavelength of maximum peak value (max).  
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3.3.2 Shewanella oneidensis oxygen uptake 
PAH-AuNPs significantly affected bacterial oxygen uptake at 100 μg/L (unpaired t-test, 
t=9.895, df=5, p < 0.05) while its corresponding free ligand control, 1 mg/L of PAH 
free ligand elicited similar inhibition compared to control groups (unpaired t-test, 
t=4.222, df=6, p < 0.05) (Figure 3.1(c)). A concentration of 30 μg/L of PAH-AuNPs 
was chosen as the sublethal dose as this concentration produced no inhibition; this NP 
dose was paired with the 10-fold dose, 300 μg/L, as the corresponding PAH free ligand 
control. MPA-AuNPs did not inhibit bacterial oxygen uptake at the highest dose tested 
(5 mg/L), while the respective 5 mg/L of MPA free ligand demonstrated oxygen uptake 
inhibition (t=9.713, df=2, p < 0.05) (Figure A.2.2). 
 
As the oxygen uptake reflects bacterial population growth, the doubling time of 
bacterial growth at the exponential phase was calculated based on oxygen uptake traces 
(See Appendix A.2.3). Results showed that S. oneidensis had an average doubling time 
between 2 and 3 hours in the growth medium used in this study; thus, 1 hour was chosen 
as a time point for short-term exposure and 6 hours for long-term exposure in the 
subsequent gene expression studies. 
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Figure 3. 1 Impact of PAH-AuNPs and PAH ligand on (a) D. magna survival (%), (b) 
D. magna reproduction and (c) S. oneidensis oxygen uptake. Error bars represent 
standard error of the mean. Stars indicate significant difference compared to 
corresponding control groups (S. oneidensis, unpaired t-test, α=0.05, n≥2; D. magna, 
unpaired t-test, α=0.05, n≥3). Different letter designations in (b) indicate significant 
difference between groups (Tukey’s test, α=0.05). 
 
 
3.3.3 S. oneidensis gene expression response 
At the sublethal exposure dosages, differential expression levels of ten genes in S. 
oneidensis were observed at both 1-hour and 6-hour time points when comparing 
treatment and control. The general pattern of gene expression is summarized in the heat 
map (Figure 3.2(a)). 
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Figure 3. 2 Heat map of (a) S. oneidensis and (b) D. magna gene expression response. 
Sublethal dosages of AuNPs and their respective ligand control were used in the gene 
expression study, as shown in the figure. Genes encoding for similar cellular functions 
in two model organisms were underlined. 
 
In all cases, the differences in gene expression appear to be dominated by ligand rather 
than NP exposure. All changes in gene expression induced by ligand-NP combination 
were accompanied by the changes in their respective free ligand control, including 16S 
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(PAH, F = 18.33, df = 22, p < 0.0001), rpoA (PAH, F = 8.177, df = 31, p = 0.0001), 
pspB (PAH, F = 8.198, df = 22, p < 0.0003), and ibpA (MPA, F = 36.92, df = 22, p < 
0.0001) at 1-hour exposure (Figure 3.3(a)), and sodB (PAH and MPA, F = 10.06, df = 
22, p < 0.0001) at 6-hour exposure (Figure 3.3(b)). Exceptions are two NP-specific 
effects that were observed in sodB (PAH, F = 7.543, df = 22, p < 0.05) at 1-hour 
exposure and 16S (PAH, F = 3.238, df = 22, p < 0.05) at 6-hour exposure, where the 
free ligand control did not elicit similar effects as NPs when compared to control. For 
these two genes, S. oneidensis was exposed to a higher dosage (100 µg/L) of PAH-
AuNPs to explore the link to inhibition of oxygen uptake (Figure 3.4). The 16S gene 
expression decreased upon 100 µg/L PAH-AuNP exposure at 6-hour exposure 
(unpaired t-test, t=38.67, df=7, p<0.0001), while sodB gene expression did not show a 
significant difference compared to the control group at 1-hour exposure. 
 
Figure 3. 3 Selected gene responses in S. oneidensis upon AuNP/ligand exposure. Error 
bars showed standard error of the mean (PAH-AuNP, n=5; PAH ligand, n=4; MPA-
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AuNP/ligand, n=3). All figures follow the same legend, and the first bar in every figure 
indicates control group. Different letter designations between different groups indicate 
significant difference (Tukey’s test, α=0.05). 
 
 
Figure 3. 4 In S. oneidensis, 16S gene expression decreased upon 100 µg/L PAH-AuNP 
exposure at long-term exposure (6-hour), while sodB gene expression did not show 
significant difference compared to control group. Error bars showed standard error of 
the mean (n≥4). Both figures follow the same legend. Different letter designations 
indicate significant difference between groups (unpaired t-test, α=0.05). 
 
 
The difference in ligand-NP combination appears to be important in determining the 
differential gene expression pattern at 1-hour exposure, as only down-regulation was 
observed in PAH-AuNP exposure but only up-regulation was observed in MPA-AuNP 
exposure (Figure 3.2(a)). However, upon 6-hour exposure, the ligand-NP combination 
did not determine the gene expression pattern, as only down-regulation was observed 
for all treatments, regardless of the type of ligand (Figure 3.2(a)).  
 
Time frame is also an important factor in terms of gene expression response, as 
differential gene expression responses were observed at different time points. In the 
response to PAH-AuNP/ligand exposure, effects that were observed in the rpoA and 
pspB genes at 1-hour exposure diminished by the 6-hour exposure timepoint. More 
interestingly, for MPA-AuNP/ligand exposure, the expression level compared to control 
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at 6-hour exposure appeared to be opposite of the responses in 1-hour exposure, 
especially for MPA ligand exposure. 
 
 
3.3.4 Daphnia magna acute toxicity 
NP surface functionalization played an important role in acute toxicity in the form of 
daphnid survival, with positively charged PAH-AuNPs being orders of magnitude more 
toxic than the negatively charged MPA–AuNPs (Figure 3.2(a)). PAH–AuNPs 
significantly affected daphnid mortality, eliciting 40% mortality at 10 μg/L (U = 0, p < 
0.05).13 MPA–AuNPs did not significantly affect daphnid survival at the highest 
concentration tested, 25 mg/L (data not shown) (p > 0.05).13 The free ligands used in 
NP functionalization had no impact on daphnid survival at any concentration tested.  
 
3.3.5 Daphnia magna chronic toxicity  
Ligand-NP combination is also important in governing the chronic impacts on daphnid 
reproduction. Of the two NPs tested, PAH-AuNPs significantly decreased daphnid 
reproduction over the 21-day chronic exposure (Figure 3.2(b)) while MPA-AuNPs did 
not (data not shown). PAH–AuNPs significantly decreased daphnid reproduction by 15% 
at the highest concentration tested, 5 μg/L (F= 14.751, df= 23, p < 0.05). In comparison, 
PAH free ligand caused a statistically insignificant increase in daphnid reproduction at 
50 μg/L. As previously reported, 5 mg/L MPA free ligand increased daphnid 
reproduction by 14% (U = 4, p < 0.05, data not shown).13 
 
3.3.6 Daphnia magna acute gene expression response  
After a 24-h acute exposure, NP functionalization is also an important factor in 
determining Daphnia response at the gene level when exposed to PAH and MPA-
AuNPs, resulting in different gene expression patterns for cat, nadh, vtg, gst and hsp70 
(Figure 3.2). For Daphnia exposed to PAH-AuNPs, there was a significant 0.74 fold 
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decrease in the relative expression of hsp70 (F= 31.799, df= 49, P<0.05) compared to 
controls. Daphnia exposed to MPA-AuNPs caused a statistically significant 1.36 fold 
increase for hsp70 (F= 31.799, df= 49, P<0.05), 1.49 fold increase for nadh (F=29.066, 
df=55, p<0.05), 1.67 fold increase for gst (F=23.116, df=53, p<0.05) and 3.12 fold 
increase for vtg (F=11.556, df=47, p<0.05) over controls.  MPA-AuNP-exposed 
Daphnia had significantly different gene expression patterns than Daphnia exposed to 
PAH-AuNPs for nadh, vtg, gst and hsp70 (Figure 3.2 and 3.5). Notably, PAH-AuNPs 
caused a 0.33 fold increase in relative expression of vtg while MPA-AuNPs elicited a 
3.12 fold increase in relative expression of vtg (F=11.556, df=47, p<0.05). 
 
 
Figure 3. 5 Selected gene responses in D. magna upon AuNP/ligand exposure. Error 
bars showed standard error of the mean (n≥6 for all exposure). All figures follow the 
same legend. Different letter designations between different groups indicate significant 
difference (Tukey’s test, α=0.05). 
 
 
84 
 
The impacts of free ligands used in particle functionalization closely follow the gene 
expression patterns observed for their respective functionalized NPs at 24-hour 
exposure (Figure 3.2). Daphnia exposed to the PAH ligand showed no statistical 
difference compared to Daphnia exposed to PAH-AuNPs for all genes tested except cat 
(F= 8.640, df=55, p<0.05) and vtg (F=11.556, df=47, p<0.05). Each gene that showed 
a significant positive fold change in relative expression for Daphnia exposed to MPA-
AuNPs also showed a significant fold change in relative expression for the MPA free 
ligand treatment and did not significantly differ between the two.  
 
3.3.7 Daphnia magna chronic gene expression response 
Similar to the 24-hr acute exposure, AuNP surface functionalization played an 
important role in determining gene expression levels in Daphnia chronically exposed 
to AuNPs (Figure 3.2 and 3.5). For Daphnia exposed to PAH-AuNPs, there was a 
significant 1.33 fold decrease in the relative expression of vtg (F=16.592, df=42, p<0.05) 
and a significant 0.87 fold increase in the relative expression of act (F=9.68, df=42, 
p<0.05) over controls (Figure 3.5). MPA-AuNPs elicited a significant 1.24, 0.82 and 
0.93 fold decreases in the relative expression of hsp70 (F=9.294, df=42, p<0.05), cat 
(F=18.128, df=44, p<0.05) and nadh (F=14.9, df=44, p<0.05), respectively, compared 
to controls (Figure 3.2 and 3.5). Notably, for this treatment, there was a significant 2.2 
fold increase in the relative expression of vtg (F=16.592, df=42, p<0.05) over controls 
(Figure 3.2). A significantly different gene expression response was observed for 
several genes when AuNP treatments were compared. PAH-AuNP treatment elicited a 
positive fold change in the relative expression of cat, nadh and act while MPA-AuNP 
elicited a negative fold for these same genes. The greatest difference between these two 
treatments was observed for vtg. 
 
NP-specific impacts were observed in Daphnia chronically exposed functionalized 
AuNPs versus their respective PAH and MPA ligands as reflected in the gene expression 
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patterns (Figure 3.2 and 3.5). PAH-AuNP and PAH ligand caused a similar relative 
expression pattern in Daphnia for genes gst, hsp70, vtg and nadh, as no significant 
difference was observed among these conditions (Figure 3.2). However, PAH ligand 
caused 0.6-fold decrease in relative expression for act compared with the PAH-AuNP 
treatment that elicited a 0.98-fold increase in relative expression for act (F=9.68, df=42, 
p<0.05) (Figure 3.5). There were no significant differences between MPA ligand and 
MPA-AuNP treatments on Daphnia relative expression for all genes tested. 
 
3.4 Discussion  
Ligand-NP combinations differed in the extent of organismal apical endpoint impacts. 
Both model organisms were impacted to a greater extent by positively charged ligand-
NP combinations with differential sensitivities. PAH-AuNPs were determined to be 2-
3 orders of magnitude more toxic than the MPA-AuNPs for both S. oneidensis and D. 
magna. MPA-AuNPs caused no acute mortality in D. magna or inhibition on S. 
oneidensis oxygen uptake at the highest concentration tested (25 mg/L for daphnids and 
5 mg/L for bacteria (Figure A.2.2).13 PAH-AuNPs elicited mortality in D. magna at 
concentrations as low as 10 μg/L and decreases in reproduction at 5 μg/L (Figure 
3.1(a)),13 while S. oneidensis started to show respiratory inhibition at 100 μg/L (Figure 
3.1(c)). Electrostatic interactions could largely drive the differences in sensitivity to the 
differently charged particles, as both eukaryotes and prokaryotes have cell surfaces that 
are negatively charged.58,59 It is thought that, due to electrostatic interactions, positively 
charged NPs are more likely to interact with cell surfaces than negatively charged NPs. 
Goodman et al. observed similar differences in the toxicity of AuNPs functionalized 
with cationic and anionic side chains when exposed to mammalian cell lines and 
bacterial cells, 60 and Feng et al. demonstrated a similar correlation between toxicity 
and NP-cell association where increased NP-cell association was found for positively 
charged NPs compared to negatively charged NPs in bacteria. 61 In addition to 
electrostatic interactions, the low toxicity of MPA-AuNPs may be potentially explained 
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by the high degree of aggregation of MPA-AuNPs experienced in both organisms’ 
exposure media, thus reducing bioavailability (Table 3.2). Overall, similar differential 
toxicity of the two functionalized NPs was observed in our study in both model 
organisms, indicating these organisms may follow the same electrostatic mechanism 
for interacting with NPs despite having distinct membrane surface chemistry, and that 
the general response of whole organism may be extrapolated from the response of cell 
lines, although they differ in sensitivity.  
 
In some cases, the toxicity of select NPs may not be determined by their respective 
ligand alone, which demonstrates NP-specific organismal impacts. However, this 
nanoparticle specific effect was only true for D. magna, where the impacts to S. 
oneidensis could largely be attributed to the ligand itself and only at much higher 
concentrations. The differences in sensitivity observed for these two model organisms 
exposed to PAH-AuNPs may be due to the distinct differences in the cell surface 
chemistry of Gram-negative bacteria and the aquatic eukaryotes. Besides the 
cytoplasmic membrane, which are found in both bacterial and Daphnia cells, the Gram-
negative S. oneidensis bacterial cell also has an envelope that consists of a 
peptidoglycan-lipoprotein complex, periplasmic zone, and an outer membrane layer.58 
The outer membrane layer is the first barrier that NPs would encounter, and this lipid 
bilayer retains various amounts of embedded lipopolysaccharides (LPS).58 LPS are high 
molecular weight molecules with a basal lipid anchored in the lipid bilayer and a long 
negatively charged chain of polysaccharide. Recent work using S. oneidensis 
demonstrated that LPS is an important binding site for AuNPs.62 Compared to the 
animal cell membrane, the complex structure of the cell envelope in S. oneidensis may 
provide extra protection when NPs are in proximity to the cells, thus desensitizing 
bacterial cells to NP exposures. In addition, studies demonstrate that eukaryote cells 
have many more mechanisms for supramolecular and colloidal particle internalization 
(e.g. receptor mediated endocytosis, pinocytosis and phagocytosis) for both nano- and 
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macro-sized particles, while very few studies show plausible evidence of internalization 
of nanomaterials into bacterial cells.63-65 Furthermore, the manner by which multi and 
single-cellular organisms interact with NPs may also contribute to the difference in 
sensitivity. Daphnia actively accumulate NPs internally while bacteria only passively 
interact with NPs through random encounters on the surface. The difference in how NP 
interact and accumulate in two organisms may also result in the NP-specific effect 
observed in D. magna but not in S. oneidensis. PAH-AuNPs resulted in a decrease in 
Daphnia survival (10 μg/L) while the respective PAH free ligand control (100 µg/L) 
did not show any mortality (Figure 3.1(a)). However, when PAH-AuNPs elicited 
inhibition to bacterial oxygen uptake at 100 μg/L, the respective ligand control (1 mg/L) 
displayed a similar inhibition (Figure 3.1(c)). These biological differences and impacts 
of NP surface functionalization and free ligand type are further addressed by the 
presented gene expression study. 
 
Gene expression revealed insight into potentially unique molecular pathways that may 
be impacted upon exposure to NPs and may explain the differences in toxicity across 
different ligand-NP combinations and supported the mortality and respiration results 
indicating a particle-specific impact in Daphnia versus Shewanella. In both acute and 
chronic assays, Daphnia exposed to PAH-AuNPs elicited a significantly different gene 
expression pattern compared with Daphnia exposed to MPA-AuNPs, despite the two 
NPs having the same gold core. These differences were notable in the 24-hr acute 
exposure for hsp70, gst, vtg and nadh and in the 21-day chronic assay for hsp70, vtg, 
nadh, cat and act. Amongst the genes that responded, a positive relative fold change 
for act was unique to the PAH-AuNP treatment in the 21-day assay with respect to the 
ligand control. Actin (act) encodes for a protein important to cytoskeleton and muscle 
fibril production as well as other cell functions. Studies have linked an increase in 
protein concentration of actin as a compensatory mechanism to maintain muscular and 
cellular performance in times of environmental stress.66 In addition, studies have 
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indicated a high binding affinity of microparticles for actin67 and have shown that 
multiple NP types damage actin filaments in vitro.68-70 PAH-AuNPs could be 
potentially damaging muscle fibrils and cellular structure over long-term exposures in 
Daphnia and may be used as an indicator for stress to positively charged NPs, however, 
the relationship of this gene with apical endpoints impacted in Daphnia within this 
study remains unclear. Daphnia exposed to MPA-AuNPs only uniquely responded to 
the treatment with an increase in the relative fold change of gst at 24 hrs. This gene 
encodes for an enzyme glutathione S-transferase and is an important enzyme in 
xenobiotic detoxification as it conjugates compounds with glutathione and may be 
elevated in times of oxidative stress. Our previous studies observed gst induction in 
Daphnia dependent upon NP functionalization for fullerenes but only at concentrations 
that elicited significant mortality (> 5 mg/L).9 Like MPA-AuNPs, these NPs exhibited 
a high degree of aggregation and exhibited low toxicity in Daphnia. This may 
demonstrate an acute whole organismal response to a high amount of negatively 
charged NPs. Our more recent previous study examined adult daphnid guts exposed to 
4 nm PAH and MPA-AuNPs and their ligands at low concentrations (< 0.05 mg/L).18 
Here, we showed that significant amounts of ROS were produced for both MPA and 
PAH AuNPs and their respective ligands at the same concentrations. This leads us to 
believe that ROS production does not fully explain the adverse outcomes observed in 
our acute and chronic studies. Therefore, other mechanisms may be responsible for the 
observed impacts as Daphnia responded differently to MPA and PAH AuNPs but had 
similar amounts of ROS detected upon exposure to these treatments at the same 
concentrations. However, in our current study and the previous, gene expression 
patterns were different for the two ligand-NP combinations. These results suggest that 
pathways affected by NPs are strongly dependent upon NP surface properties. 
 
For S. oneidensis gene expression assays were again indicative of the observed apical 
endpoint impacts. Most of the gene expression responses for S. oneidensis were 
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provoked equally by the free ligand exposure and ligand-NP combination at both time 
points. While MPA-AuNPs did not show any impact that was specific to NPs, the 
decrease in expression of 16S at 6-hour exposure and sodB gene at 1-hour exposure 
were unique to the PAH-AuNP but not to PAH free ligand. The sodB gene encodes for 
one of the superoxide dismutase (SODs) that protect cells from deleterious reactions of 
reactive oxygen species;71 it has been previously reported that the sodB gene was up-
regulated upon S. oneidensis exposure to chromium (VI).72 More related, a previous 
study using 60-nm amino-functionalized polystyrene nanomaterial (PS-NH2-NPs) on 
E. coli single-gene deletion mutants showed that the ΔsodB mutant was more sensitive 
to the exposure of PS-NH2-NPs compared to the parent strain.
73 As PAH-AuNPs have 
a similar surface-functionalization of amine groups with PS-NH2-NPs, these results 
suggest that the sodB gene plays an essential role in bacterial cell response to amine-
functionalized nanomaterials, making it possible to use sodB as a biomarker for this 
specific NP surface functionalization. 16S ribosomal RNA (rRNA) is one of the three 
rRNAs, which are components of prokaryotic ribosomes. The rRNA transcription is the 
rate-limiting step in ribosome synthesis, and thus, directly correlates to protein 
synthesis and cell growth.74 Previous research has reported that rRNA degradation 
occurs during environmental stress, including oxidative stress and starvation.75-77 
Notably, it was also reported that rRNA is degraded due to a change in cell membrane 
permeability, potentially leading to the entry of RNase I, an endoribonuclease, from the 
periplasmic space into the cytoplasm.78,79 Extensive cell membrane damage can also 
result in the efflux of RNA due to the loss of plasma membrane integrity.80 Previous 
research has shown the disruption of membrane integrity in S. oneidensis cells upon 
PAH-AuNP exposure,61 correlating with the decrease in the expression of 16S. It should 
be noted that at 1-hour exposure, the respective PAH ligand control also elicited 
decrease in 16S expression, while at 6-hour exposure only PAH-AuNPs showed the 
effect; thus, the potential of 16S to be used as a biomarker that is specific for PAH-
AuNPs is limited to long-term exposures. In effort to link 16S and sodB gene response 
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to the apical biological endpoints, the gene expression level of these two genes was 
examined at a higher dosage (100 µg/L) that also caused inhibition in bacterial oxygen 
uptake (Figure 3.1(c)). While the sodB gene at 1-hour exposure did not elicit change 
in gene expression, 16S at 6-hour exposure showed a similar decrease upon 100 µg/L 
PAH-AuNP exposure (Figure 3.4), proving that 16S can be potentially used as a 
biomarker for the impact of PAH-AuNPs on bacterial oxygen uptake; future work will 
explore the adverse outcome pathway from the decrease in 16S rRNA expression to the 
inhibition of bacterial oxygen uptake, and we postulated the inhibition is mediated via 
reduced activity in protein synthesis. MPA-AuNPs did not induce a similar response of 
16S rRNA expression, or any other NP-specific response, indicating a distinction 
between the same AuNP cores functionalized with different surface ligands. 
 
Length of exposure had an impact on the effects seen in both species and on both gene 
expression and apical endpoints measured. Short-term exposures for both D. magna 
and S. oneidensis revealed that functionalized NP impacts on certain molecular 
pathways might be predicted by their respective ligand alone. Out of all S. oneidensis 
regulated genes, three genes stand out as potential predictors of NP impacts based on 
the ligand alone. These genes are pspB and rpoA for PAH-AuNP/ligand and ibpA for 
MPA-AuNP/ligand at 1-hour exposure, as they were influenced similarly upon 
exposure to both the ligand-bound AuNPs and the respective free ligand. For D. magna, 
three genes were most notable; these genes were hsp70 and vtg for PAH-AuNP/ligand 
and hsp70, vtg and nadh for MPA-AuNP/ligand. These results suggest that NP impacts 
on specific molecular pathways may be predicted based on response to the ligand alone. 
This finding is especially important for ligands or functional groups that are commonly 
used to achieve desired physiochemical properties for NPs. However, as demonstrated 
with our study, ligand-NP combinations did alter several genes that the ligand alone did 
not, and the concentrations of NPs that impacted apical endpoints, in particular PAH-
AuNPs, differed from that of the ligand. This diminishes the potential ability to use 
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ligand information alone as a predictor for NP toxicity; rather, the overall NP 
characteristics, including charge or size, may be more informative. 
 
Our study revealed that gene expression in acute exposures was not predictive of long-
term impacts or differences among treatments with respect to ligand versus 
nanoparticle-ligand combinations.  In addition, long-term exposure to NPs resulted in 
gene expression patterns that could not be predicted based on gene expression patterns 
from short-term exposures. Upon exposure to MPA-AuNP/ligand, both S. oneidensis 
and D. magna showed decreases in gene expression during short-term exposure and 
that this response flipped to mostly an increase in gene expression upon long-term 
exposure. Exceptions to this finding are observed in the decrease of 16S and sodB 
expression upon PAH-AuNP exposure in S. oneidensis and the increase of vtg gene 
expression upon MPA-AuNP exposure in D. magna, which show similar response in 
gene expression levels at both time points. Our results indicate that, although it is 
possible to predict long-term gene expression impacts based on short-term impacts, it 
is limited to select genes, which may downplay the significance of this finding. 
 
Gene expression responses across organisms provide an indication of how organisms 
are similar or different in their response to NP exposures. A notable signature shared 
across two organisms was the up-regulation of ibpA/hsp70 induced by MPA-AuNP and 
ligand for short-term exposures. Both ibpA and hsp70 encode for heat shock protein in 
S. oneidensis and D. magna, respectively. Heat shock proteins (Hsp) are a large family 
of proteins that help unfolded or misfolded proteins to fold correctly in vivo and are 
widely considered to be good indicators of proteotoxic stress.81,82 The up-regulation of 
heat shock protein induced by MPA-AuNPs and ligands potentially indicate the 
disruption of membrane proteins, provoking pathways that help adapt to change in 
chemical environment caused by introduction of NPs or ligands. This feature, shared 
by both organisms, potentially indicates a universal stress-response to negatively 
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charged NPs, making the genes encoding for heat shock protein a good candidate for 
predicting the effect of NPs based on the response to their respective ligands. However, 
MPA-AuNPs did not lead to any adverse outcomes at the concentrations we tested, 
which makes understanding the importance of this pathway within the context of our 
study difficult.  
 
3.5 Conclusion 
Molecular studies can tease out distinct modes of action for NP toxicity and help to 
develop biomarkers for assessing NP impacts on environmentally relevant endpoints. 
Using standard toxicological and gene expression assays, we revealed that: 1) the 
ligand-NP combinations determine the extent of impacts on organismal endpoints and 
the toxicity of select NPs may not be determined by their respective ligand alone; 2) 
depending on the organism considered, exposure to ligand-NP combinations may 
impact unique molecular pathways that differ from the ligand alone; 3) short-term 
exposures reveal that ligand-NP impacts on certain molecular pathways might be 
predicted by their respective ligand alone but the ability to predict long-term impacts 
may be minimal; and 4) examining gene expression responses across organisms may 
provide an indication of how organisms are similar or different in their response to NP 
exposures. Lastly, this study reveals that there are mechanisms other than oxidative 
stress for NP toxicity and that these may be elucidated using molecular level 
experiments and exposures that consider sublethal concentrations.  
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Chapter 4 
Quantification of free polyelectrolytes present in colloidal suspension 
reveals source of toxic responses for polyelectrolyte-wrapped gold 
nanoparticles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from: 
Qiu, T. A., Torelli, M. D., Vartanian, A. M., Rackstraw, N. B., Buchman, J. T., Jacob, 
L. M., Murphy, C. J., Hamers, R. J., Haynes, C. L., Quantification of free 
polyelectrolytes present in colloidal suspension, revealing source of toxic responses for 
polyelectrolyte-wrapped gold nanoparticles, Analytical Chemistry, 2017, 89, 1823–
1830. 
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4.1 Introduction 
Polyelectrolyte (PE) coating is an easily accessible method used to control the surface 
properties of both planar substrates and colloidal particles due to its simplicity and 
versatility and is of interest across many technological sectors.1-4 A standard PE coating 
process takes advantage of attractive electrostatics between opposing charges of the PE 
coating and substrate to create nanoscale PE layers on surfaces, which may be repeated 
for layer-by-layer assembly. Polyelectrolyte-wrapped nanoparticles (NPs) have been 
used for a variety of applications including drug delivery,5 Raman tags,6 and fuel cell 
catalysts.7 Because colloidal nanoparticles are often difficult to sediment due to their 
small sizes, immersive in situ presentation of the polyelectrolyte to the particle is the 
most widely used method to achieve colloid modification. In this technique, an excess 
amount of polyelectrolyte is usually introduced for each step of polymer deposition and 
then rinsed in an effort to remove excess polyelectrolyte.3 
 
An efficient purification step is necessary after polymer deposition, because leftover 
polyelectrolytes could disrupt the formation of subsequent PE layers for a traditional 
layer-by-layer assembly scheme or could act as problematic impurities in a final 
nanoparticle suspension product. Specifically, if colloidal nanoparticles are used in 
humans (e.g. for photothermal therapy)8 or released into the environment (e.g. for 
pollutant remediation),9 impurities may compromise nanoparticle functionality or cause 
unintentional biological effects. Indeed, numerous studies have shown that the apparent 
toxicity of nanomaterials can be traced to excess surface capping agents. For example, 
Alkilany et al. showed that the unbound capping agent, cetyltrimethylammonium 
bromide (CTAB), was responsible for the toxicological response caused by CTAB-
capped gold nanorod solutions,10 and Harper et al. demonstrated improved 
biocompatibility of gold NPs (AuNPs) functionalized with small peptides in zebrafish 
embryos by adding extra purification steps.11 Similarly, an extra purification step using 
anion exchange chromatography improved the performance of silica-coated AuNPs as 
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surface-enhanced Raman scattering substrates.12 
The most common purification method in polyelectrolyte wrapping of colloidal 
nanoparticles is centrifugation.3 After polyelectrolyte wrapping, the colloidal 
suspension is centrifuged, followed by the removal of supernatant and re-dispersion of 
the pellet. Pellets are usually rinsed several times to ensure the removal of excess 
polymers from the surface modification. However, centrifugation is labor-intensive, 
hard to automate, and not scalable; moreover, centrifugation can potentially induce 
particle aggregation and is not always achievable for particles with excellent colloidal 
stability. Diafiltration- or tangential flow filtration-based purification overcomes these 
shortcomings and has become a popular choice to purify nanoparticle dispersions from 
excess reagents, including small molecules and large polymers.13-15 A continuous 
filtration setup is used in such filtration devices (Scheme 4.1); the colloidal suspension 
continuously flows through a tube of dialysis membrane with a molecular weight cut-
off (MWCO) selected to elute small impurities while retaining the desired particle 
suspension. In a continuous flow reactor, diafiltration allows for scale-up and 
automation of purification steps, while following greener practices than 
centrifugation.16 Additionally, for nanoparticles with diameters of 5 nm or less, 
diafiltration provides a more practical purification strategy than centrifugation due to 
the high centrifugation speed needed to sediment small-diameter nanoparticles.  
 
Herein, we evaluated both centrifugation and diafiltration as purification strategies after 
polyelectrolyte wrapping of 4-nm-diameter gold nanoparticles using poly(allylamine 
hydrochloride) (PAH), a common polyelectrolyte used for colloidal stabilization as well 
as applications in cell encapsulation,17 nanofiltration membranes,1 and drug delivery.18 
PAH-AuNPs have been used for bacterial exposure in Chapter 3. In this chapter, we 
measured the amount of free PAH polymers that are unbound from the AuNP surface 
in PAH-AuNP suspensions; these measurements were motivated by unexpected levels 
of AuNP toxicity to bacteria in preliminary experiments. The toxicological response to 
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the PAH-AuNP suspension was examined using the bacterium Shewanella oneidensis 
MR-1 (S. oneidensis), a beneficial Gram-negative bacterium critical in geochemical 
nutrient cycling in ecological systems.19 The origin of distinct toxicological effects from 
PAH-AuNPs purified using different methods was revealed to be due to unbound PAH 
polymers, in spite of a properly sized MWCO of the dialysis membrane. Finally, we 
demonstrated that, by choosing a dialysis membrane with a higher MWCO or adding 
an extra ultra-centrifugation step, the PAH impurities can be minimized to increase the 
biocompatibility of PAH-AuNPs. 
 
Scheme 4. 1 Illustration of the two purification strategies used in this study and the 
three differently-purified PAH-AuNP samples. 
 
 
4.2 Experimental section 
 
4.2.1 Materials 
All materials were used as received, unless otherwise indicated. Poly(allylamine 
hydrochloride) (PAH; Mw 15,000 g/mol) was obtained from Sigma Aldrich. PAH (Mw 
3,000 g/mol) was obtained from Nittobo (catalog #PAA-03). All water used for NP 
synthesis, diafiltration, NMR, XPS and dialysis experiments was ultrapure deionized 
water collected from Barnstead NANOPURE water filtration systems (Resistance at 
least 17.8 MΩ·cm). All water used for nanoparticle characterization and bacterial 
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toxicity assays was Milli-Q water (Resistance 18.2 MΩ·cm) or autoclaved Milli-Q 
water. PallALL Minimate tangential flow filtration capsules with 50 kDa molecular 
weight cutoff (MWCO) were obtained from VWR. Dialysis tubing (50 and 300 kDa 
MWCO) for dialysis experiments was obtained from Biotech CE, SpectrumLabs 
(catalog #131384/131456). 
 
4.2.2 PAH-AuNP synthesis and purification 
PAH-AuNPs were synthesized by polyelectrolyte-wrapping of 4-nm-diameter citrate-
AuNPs using a typical flow reactor synthesis as described before (see Supporting 
Information for more details).14 After synthesis, the 3.2 L of as-synthesized PAH-AuNP 
nanoparticle solution was concentrated by tangential flow filtration through a 50 kDa 
MWCO capsule to a final volume of 25 mL (Scheme 4.1, left). The concentrated 
solution was washed by diafiltration with 2 L NaCl (1 mM), followed by 500 mL water, 
generating diafiltered PAH-AuNPs (d-PAH-AuNPs). 
 
To purify NPs via centrifugation, the as-synthesized PAH-AuNP solution was firstly 
concentrated by tangential flow filtration through a 50 kDa MWCO capsule to 100 mL. 
The concentrated PAH-AuNPs were centrifuged at 18,894 × g for 55 min at 4 °C, and 
the pellet was re-suspended in equal amount of nanopure water. The product at this 
stage was regarded as centrifuged PAH-AuNPs (c-PAH-AuNPs). After that, c-PAH-
AuNPs were purified by centrifugation a second time (18,894 × g for 55 min at 4 °C), 
and the pellet was re-suspended in an equal amount of autoclaved Milli-Q water, 
generating the double-centrifuged PAH-AuNPs (cc-PAH-AuNPs). 
 
4.2.3 Nanoparticle characterization 
All nanoparticles were characterized using UV-vis spectroscopy, transmission electron 
microscopy (TEM), dynamic light scattering (DLS) and ζ-potential measurement (see 
SI for details). The mass concentration of the AuNP suspensions was calculated based 
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on the UV-vis spectrum (see SI).20 For DLS, the intensity-weighted average diameter 
was reported as “Z-average”, and the mean diameter from the multimodal distribution 
was also reported. 
 
4.2.4 Drop plate counting for bacterial toxicity assay 
An adapted drop plate counting from the traditional plate-counting method was used to 
measure the bacterial toxicity of PAH-AuNPs and PAH polymer to Shewanella 
oneidensis MR-1 (see Appendix A.3 for more details).21  
 
4.2.5 Dose-response curve 
Dose-response curves for the three different types of PAH-AuNP as well as the PAH 
polymer-only sample were collected using the drop plate counting method described 
above. PAH polymer was weighed, dissolved in Milli-Q water, and diluted accordingly 
to prepare working solutions, and suspensions of the three different PAH-AuNP 
samples were also diluted in Milli-Q water from stock suspension. The bacterial 
suspension was exposed to 0, 0.3, 0.6, 1, 2.13, 4.3, 10 or 13.8 mg/L PAH polymer, 0, 
0.3, 1, 2.13, 4.60 or 30 µg Au/L d-PAH-AuNPs, 0, 30, 78.6, 131, 250, 300 or 600 µg 
Au/L c-PAH-AuNPs, and 0, 0.3, 0.6, 1.2 or 2.0 mg Au/L cc-PAH-AuNPs. 
 
4.2.6. Nuclear magnetic resonance (NMR) spectroscopy 
NMR samples were prepared from aqueous nanoparticle solutions in D2O (10 nM 
particle concentration for d-PAH-AuNP, c-PAH-AuNP, and cc-PAH-AuNP samples; 
130 μM for the free PAH sample). 1H NMR spectra were acquired using a Varian Unity 
Inova 500 MHz narrow-bore spectrometer. For aqueous nanoparticle samples prepared 
in D2O containing residual water, the large water peak was suppressed using 
presaturation. The presaturation delay for aqueous samples was 2 s and the acquisition 
time was 1 s, with a 2- or 4-step purge. Chemical shifts are reported in parts per million 
(ppm) and are referenced to the residual proton solvent peak. All NMR spectra were 
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processed using MNova. 
 
4.2.7 X-ray photoelectron spectroscopy (XPS) 
Particles were analyzed by XPS using a custom-built, ultrahigh-vacuum Phi XPS 
system with a base pressure of <2 x 10-10 Torr. X-rays were produced by an Al Kα 
source with quartz-crystal monochromator. Measurements were taken with pass 
energies of 46 eV (effective resolution 0.64 eV) and an electron collection angle of 45o 
with respect to surface normal. For analysis, nanoparticles were pelleted by 
centrifugation at 14,100 × g, and pellets were suspended in minimal nanopure water, 
drop-cast onto conductive silicon (P-doped, <0.004 Ω-cm resistivity), and dried at 
thickness such that signal from the underlying silicon was attenuated. Peak areas were 
determined in IgorPro by fitting to Voigt profiles. 
 
4.2.8 Quantification of unbound PAH in AuNP suspensions 
The amount of unbound PAH polymer was determined using a fluorescence assay. 
Fluorescamine fluoresces after binding to primary amines, and this dye has been 
previously used for primary amine quantification.22,23 A solution of fluorescamine was 
prepared by dissolving 0.01 g of fluorescamine (Sigma-Aldrich) in 10 mL acetonitrile 
to reach a concentration of 0.1% (w/v). A 0.05 M sodium borate buffer was prepared 
by dissolving 5.03 g Na2B4O7 in 500 mL Milli-Q water followed by pH adjustment to 
approximately 8 using 12 M HCl. To prepare samples for measurement, 20 µL of borate 
buffer was added for all measurements first, and 120 µL of the aqueous samples were 
mixed with borate buffer in a 96-well plate. Lastly, 60 µL of fluorescamine solution 
was added to the mixture. Negative controls were done on all plates where 120 µL 
Milli-Q water was added instead of samples. The reaction was incubated at room 
temperature for 5 minutes, and the fluorescence intensity was measured by a plate 
reader with Eex/Eem = 425 nm/480 nm. 
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A calibration curve was made for every experimental run. Three PAH stock solutions 
were made by dissolving weighed PAH polymer solid in Milli-Q water, and then 
diluting to 148.3 mg/L as three standard solutions. Aliquots of standard solutions from 
0 to 40 µL were mixed with Milli-Q water in the 96-well plate to reach a total sample 
volume of 120 µL. Calibration curves from three standard solutions were finally 
averaged to make a master calibration curve for all assays in the experimental run. 
 
To obtain unbound PAH polymer sample in AuNP suspension, PAH-AuNP suspension 
was diluted in Milli-Q water and ultra-centrifuged at 66,000 × g for 45 minutes at 4 °C 
to pellet all AuNPs. A PAH polymer solution in Milli-Q water of 350 mg/L was also 
ultra-centrifuged together with PAH-AuNP samples as a control. The supernatant was 
removed from the centrifuge tubes and then supernatants from c-PAH-AuNPs and cc-
PAH-AuNPs were concentrated using a Savant SpeedVac Concentrator. An aliquot of 
each sample was then subjected to the fluorescence assay, and the concentration of 
samples were determined based on the linear fitting results from the calibration curve. 
Only fluorescence readings that were lower than the upper limit of calibration curve 
and higher than the limit of quantification (defined as ten times the standard deviation 
of readings from the negative control) were used for quantification. 
 
4.2.9 Determining the source of differential toxicity 
To determine if the unbound PAH polymer contributed to the differential toxicity, the 
aforementioned drop plate counting method was performed to assess the toxicity 
comparing a pair of nanoparticles purified by two different methods near the 
concentration where the more toxic nanoparticle killed a large population of bacterial 
cells and the less toxic nanoparticle showed no compromised bacterial viability. The 
amount of excess PAH polymer present in each pair was determined by fluorescence 
assay. This excess in polymer (ΔPAH concentration) was then added to the less toxic 
particle to identify the critical factors contributing to bacterial toxicity. At least 7 
101 
 
biological replicates were collected for each treatment. Normalized viability values 
were tested for normality using the Shapiro-Wilk normality test,24 and the Grubbs’ test 
was performed on data sets that passed the normality test to identify outliers. In cases 
where data sets did not pass the normality test, nonparametric Kruskal-Wallis test with 
Dunn's multiple comparisons test was used to test statistical significance using 
GraphPad Prism. 
 
4.2.10 Dialysis of different PAH polymers 
To experimentally estimate the amount of PAH polymer remaining after dialysis, 0.5 
mg/mL 15 kDa PAH (Sigma) in 0.5 mM NaCl was dialyzed using 50 kDa dialysis 
membrane without the presence of gold nanoparticles. To test if increasing pore size of 
dialysis membrane and decreasing the molecular weight of polymer can improve the 
PAH removal efficiency, PAH of 3 kDa was obtained from Nittobo, and was dialyzed 
in 0.5 mM NaCl using 300 kDa dialysis membrane. Both solutions were then dialyzed 
through 12 L of water over 3 water exchanges. The resulting solution represented the 
retentate. The concentration of PAH polymer remaining after dialysis was determined 
using the aforementioned fluorescamine assay (see Appendix A.3.8 for details).  
 
4.3 Results and discussion 
 
4.3.1 Characterization of three PAH-AuNPs 
As-synthesized PAH-AuNPs were purified in three different ways: (1) via diafiltration 
(d-PAH-AuNPs), (2) by single centrifugation (c-PAH-AuNPs), or (3) by double 
centrifugation (cc-PAH-AuNPs), as shown in Scheme 4.1. These three differently 
purified PAH-AuNPs were characterized by commonly used NP characterization 
techniques, including TEM, UV-vis spectroscopy, DLS, and ζ-potential measurement. 
TEM sizing showed that they have similar absolute sizes (Figure 4.1(a-c)). A loss of 
AuNPs during centrifugation was observed by comparing the heights of plasmon bands 
in the UV-vis spectra of c- and cc-PAH-AuNPs (Figure 4.1(d)). Slight shifts in the 
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plasmon bands towards longer wavelengths were observed in extinction spectra from 
d-PAH-AuNPs (~531 nm) to c-PAH-AuNPs (~535 nm) to cc-PAH-AuNPs (~537 nm) 
(Figure 4.1(d)). The longer peak wavelength might indicate either a more compacted 
(higher refractive index) PAH layer or a slight aggregation of PAH-AuNPs purified by 
centrifugation25 compared to those purified by diafiltration; however, the Z-average 
(intensity-weighed) determined by DLS showed a slightly larger hydrodynamic size of 
PAH-AuNPs purified by diafiltration than by either method of centrifugation (Figure 
4.1(e)). The mean diameters determined from the DLS multimodal size distribution 
were much smaller than the Z-average; with the polydispersity values as large as ~0.2, 
these data indicate that there might be a small population of heavily aggregated PAH-
AuNPs in all three AuNP suspensions. Overall, c-PAH-AuNPs and cc-PAH-AuNPs 
were not differentiable with these characterization techniques, and d-PAH-AuNPs had 
slight but noticeable differences from PAH-AuNPs purified by centrifugation.  
 
Figure 4. 1 PAH-AuNP characterization. (a-c) TEM image and size distribution of three 
PAH-AuNPs; (d) Extinction spectra of the three PAH-AuNP suspensions; (e) TEM core 
sizes, DLS, and ζ-potential of the three PAH-AuNPs. DLS Z-average is an average 
diameter which is weighted by the intensity of light scattered by each particle, and the 
DLS mean diameter is acquired from the multimodal size distribution. 
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4.3.2 Bacterial toxicity responses differ for the three PAH-AuNP samples 
The bacterium Shewanella oneidensis MR-1 was used to assess the toxicity response 
of three differently purified PAH-AuNPs. Figure 4.2(a) clearly shows that the three 
PAH-AuNPs had orders of magnitude different toxicity towards S. oneidensis. Due to 
the unusual shape of the dose-response curves, sigmoid fitting was not successful on 
all plots, and LC50 (lethal concentration for 50% of the bacterial population) values 
were estimated by visual observation. Diafiltered-PAH-AuNPs showed the highest 
toxicity with an LC50 value near 4.6 µg Au/L, followed by c-PAH-AuNPs with an LC50 
near 250 µg Au/L. Double-centrifuged PAH-AuNPs showed the least toxicity towards 
S. oneidensis with an LC50 between 1200 and 2000 µg Au/L. PAH polymer without 
AuNPs showed an LC50 between 1000 and 2000 µg/L. It is notable that the shape of the 
dose-response curve of the free PAH polymer (without AuNPs, Figure 4.2(b)) was 
similar to those of d-PAH-AuNPs and c-PAH-AuNPs (note that the scales on x-axis for 
AuNPs and PAH polymers are different). Although particle size and potential 
aggregation could result in different toxicity response to nanoparticles,26 the orders of 
magnitude of difference in the toxicity response to these three differently purified PAH-
AuNPs cannot be fully explained by particle size or aggregation, especially as the 
characterization of NPs showed minimal differences among the three types of PAH-
AuNPs. Harper et al. demonstrated that surface-modified AuNPs with more 
centrifugation steps in purification induced lower toxicity to zebrafish embryos;11 this 
observation complements our results on c- and cc-PAH-AuNPs. Thus, it was suspected 
that distinct amounts of impurities from different purification methods were responsible 
for differing toxic responses. 
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Figure 4. 2 Dose-response curves of Shewanella oneidensis MR-1 to (a) the three types 
of PAH-AuNPs and (b) free PAH polymer. Error bars indicate standard error of the 
mean. 
 
 
4.3.3 NMR and XPS indicate unbound PAH polymer 
To understand why the observed differences in toxicity arise, NMR spectroscopy and 
XPS experiments were performed on the three different PAH-AuNP and free PAH 
polymers without AuNPs. 1H NMR experiments were carried out on 10 nmol/L d-PAH-
AuNPs, c-PAH-AuNPs, and cc-PAH-AuNPs, as well as 130 μmol/L of free PAH 
(Figure 4.3(a)). The spectra suggest that the purification methods differ dramatically 
in efficacy, influencing the final concentration of PAH in the nanoparticle solution. Free 
PAH polymer gave rise to three distinct resonances corresponding to its chain group 
methylene protons (-R2-CH2, 1.43 ppm), chain group methine proton (-R3-CH, 
bimodal: 1.87 and 1.96 ppm), and side group methylene protons (-N-CH2, 2.95 ppm). 
The sharp doublet of doublets at 2.4 ppm arises from citrate molecules that are likely 
bound as counter-ions far from the core of the PAH-AuNPs; citrate molecules 
immobilized between the gold surface and the PAH are expected to be far broader.27 
PAH resonances were clearly present for d-PAH-AuNPs and c-PAH-AuNPs; the 
approximate integration was much larger for the d-PAH-AuNPs than the c-PAH-
AuNPs, suggesting that the d-PAH-AuNP sample contained qualitatively more PAH 
(accurate quantification by NMR is challenging with polymers and nanoparticles, partly 
a consequence of line broadening). No obvious resonances indicating the presence of 
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PAH were observed in the cc-PAH-AuNP spectrum. As the positive ζ-potential 
confirms successful wrapping of PAH on the surface of cc-PAH-AuNPs, the absence of 
PAH resonances indicates that the PAH bound to the surface of AuNPs was below the 
NMR detection limit (~1016-1018 nuclei or ~10-5 mol/L). This result reveals that the 
PAH resonances observed in the d- and c-PAH-AuNP spectra do not arise from PAH 
bound to AuNPs, but likely from unbound PAH in suspension.  
 
XPS characterization comparing c-PAH-AuNPs and d-PAH-AuNPs shows two peaks 
for N(1s) at 400 and 402 eV, representing an amine and protonated amine, respectively 
(Figure 4.3(b)).28 The peak areas associated with N and Au, however, differ between 
particles purified by different methods. We quantified these differences through the 
ratio of areas of the N(1s) peak to the Au(4f). The peak area ratio AN(1s)/AAu(4f) varies 
from 0.68 ± 0.03 for single-centrifuged particles to 2.2 ± 0.4 for diafiltered particles, 
indicating a greater amount of PAH present in diafiltered samples, even after being 
pelleted and cleaned via centrifugation (details in the experimental section).  
Additionally, deconvolution of the N(1s) peak gives information about the relative 
protonation states of the PAH amine between the particles. The ANH3+(402eV) /ANH2(400eV) 
ratio of the d-PAH-AuNPs resembles that expected of an aliphatic amine, dominated 
primarily by contribution from 402 eV of the protonated state.28,29 Interestingly, for the 
c-PAH-AuNPs, the ANH3+(402eV) /ANH2(400eV) ratio becomes almost equal, decreasing 
from 5.2 for d-PAH-AuNPs to 1.2 for c-PAH-AuNPs. This change suggests an 
alteration in the local chemical environment of the amines where a higher percentage 
of the amines on the polymer are in their more reduced (unprotonated) form. This 
change likely arises from binding of the PAH polymer to the negative, citrate-coated 
gold surface, as the negative, electron-rich environment near the gold surface can 
donate density to the amines on PAH molecules near the surface. Given that the 
spectrum for the d-PAH-AuNP resembles an ensemble of amines from solution, the 
greater amount of N(1s) detected is likely to arise from unbound PAH polymer in the 
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aqueous solution, while the N(1s) detected in c-PAH-AuNP samples is mainly from 
PAH polymer bound to the negative, citrate-coated gold surface. 
 
 
Figure 4. 3 (a) NMR spectra of 10 nmol/L PAH-AuNPs and 130 µmol/L free PAH 
polymer, showing that a large amount of PAH polymer is present in d-PAH-AuNPs 
compared to c- and cc-PAH-AuNPs. (b) XPS analysis of washed c- and d-PAH-AuNPs 
show that a relatively larger amount of protonated amine exists in d-PAH-AuNPs 
compared to c-PAH-AuNPs. 
 
 
4.3.4 Unbound PAH polymer is responsible for differing toxicity responses 
The amounts of unbound PAH polymer in the three PAH-AuNP suspensions were 
determined using a fluorescence assay using fluorescamine, a dye that reacts with 
primary amine. PAH-AuNPs were pelleted via centrifugation, and the clear 
supernatants were carefully pulled out and subjected to the assay, where the primary 
amines on PAH react with fluorescamine to generate a fluorescent product.  We 
normalized the experimentally determined concentration of unbound PAH (mg/L PAH 
in supernatant) by the mass concentration of AuNPs (mg Au/L), yielding a ratio that 
enables a direct comparison among three AuNP suspensions. After normalization, 
results showed that for per mg Au/L of AuNPs, d-PAH-AuNP, c-PAH-AuNP and cc-
PAH-AuNP suspensions contained 463 ± 27, 7.53 ± 0.20 and 0.49 (0.47-0.51) mg/L of 
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unbound PAH, respectively (Figure 4.4(a)). A similar amount of PAH was detected in 
another batch of PAH-AuNPs purified in the same way, showing the unbound PAH 
amount was consistent across batches (Table A.3.1). Considering the orders of 
magnitude difference in toxicity responses (Figure 4.4(a)), these data suggest that the 
unbound PAH polymer potentially dominates the differential toxicity among the three 
PAH-AuNP preparations. 
 
A bacterial toxicity assay was applied to test this hypothesis. Aliquots of bacterial 
suspension were treated with 30 µg/L d- and c-PAH-AuNPs and revealed that 30 µg/L 
d-PAH-AuNPs killed almost the whole bacterial population while the same 
concentration of c-PAH-AuNPs did not have an observable effect (Figure 4.4(b)). 
Based on the PAH quantification results, the 30 µg/L d-PAH-AuNP suspension 
contained 13.9 ± 0.8 mg/L unbound PAH, and same concentration of c-PAH-AuNP 
suspension contained 0.226 ± 0.006 mg/L; the difference in the amount of unbound 
PAH was 13.7 ± 0.8 mg/L (Figure 4.4(a), Row 2). Thus, if unbound PAH dominates 
the toxicity response, addition of 13.7 ± 0.8 mg/L of PAH into 30 µg Au/L of c-PAH-
AuNPs should show the same toxicity to bacteria as d-PAH-AuNPs. The results were 
as expected: the mixture of 13.8 mg/L PAH (within the range of 13.7 ± 0.8 mg/L 
determined), which is equivalent to the difference in the amount of unbound PAH in 30 
µg/L d- and c-PAH-AuNP suspension, and 30 µg/L c-PAH-AuNP suspension, as well 
as 13.8 mg/L PAH without AuNPs, resulted in the same drastic toxicity response as 30 
µg/L d-PAH-AuNPs (Figure 4.4(b)). 
 
Similar experiments were performed on the pair of c- and cc-PAH-AuNPs. After the 
additional round of centrifugation, the amount of unbound PAH polymer reduced one 
order of magnitude (7.53 versus 0.49, mg/L per mg Au/L of AuNPs) (Figure 4.4(a)). 
Using a similar setup (Figure 4.4(a), Row 3), bacterial viability was tested upon 
exposure of 300 µg/L c- and cc-PAH-AuNPs, 2.13 mg/L PAH, and 300 µg/L cc-PAH-
108 
 
AuNP supplemented with 2.13 mg/L PAH polymer (Figure 4.4(c)). Results were 
similar to those of d- and c-PAH-AuNPs. After the cc-PAH-AuNP suspension was 
supplemented with the extra PAH polymer to match the c-PAH-AuNP batch, the AuNP 
suspension showed the same toxicity as the c-PAH-AuNP suspension. Together, these 
results clearly demonstrate that the differential toxicity between d-, c-, and cc-PAH-
AuNPs can be attributed to the unbound PAH polymer remaining in the PAH-AuNP 
suspensions. 
 
 
Figure 4. 4 (a) Amount of unbound PAH polymer measured in PAH-AuNP suspensions. 
The differences in unbound PAH amount between 30 µg/L d- and c-PAH-AuNPs and 
300 µg/L c- and cc-PAH-AuNPs were calculated. Standard deviations are calculated for 
all values except for the values of cc-PAH-AuNPs, as less than three replicates were 
done due to the limited amount of available materials; ranges are shown instead. 
Toxicity results revealed that unbound PAH polymer is responsible for the differences 
in toxicity between (b) 30 µg/L d- and c-PAH-AuNPs and (c) 300 µg/L c- and cc-PAH-
AuNPs. Equivalent free PAH refers to 13.8 mg/L free PAH in (b) and 2.13 mg/L free 
PAH in (c). Different letters designate statistically significant differences (Dunn's 
multiple comparisons test, post-hoc Kruskal-Wallis test, p<0.05). Error bars indicate 
standard error of the mean. 
 
 
4.3.5 Dialysis membrane is not sufficient in removing unbound PAH 
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The large amount of unbound PAH polymer in the d-PAH-AuNP suspensions was 
clearly due to insufficient purification during diafiltration. As the MWCO for the 
dialysis membrane used in diafiltration was 50 kDa, the 15 kDa PAH polymer should 
be able to permeate the dialysis membrane, and unbound polyelectrolyte remaining in 
the as-synthesized AuNP suspension should be removed. A dialysis experiment using a 
500 mg/L solution of PAH polymer with 0.5 mM NaCl without nanoparticles was 
performed using a 50 kDa dialysis membrane, and the concentration of PAH polymer 
in the dialysis tube was quantified using the aforementioned fluorescence assay. 
Unexpectedly, only 29% of the PAH passed through the dialysis membrane (Table 4.1). 
In previous work, Dalwadi et al. used polyethersulfone ultrafiltration membranes with 
100 and 300 kDa MWCO to filter 9-10 kDa polyvinyl alcohol (PVA), and they 
demonstrated that the dialysis membrane with the 100 kDa MWCO removed less than 
20% of the PVA.30 Membrane fouling by polyelectrolytes has long been known,31 so 
polyelectrolytes like PAH and PVA could potentially cause membrane fouling during 
early stages of dialysis and may result in insufficient permeation of polyelectrolytes 
later in the dialysis time. More importantly, as the dialysis membranes are generally 
intended for proteins that exist in a folded state, an equivalent molecular weight of a 
charged polymer like PAH may be more extended than a protein, resulting in a larger 
hydrodynamic diameter. For example, the 65 kDa protein hemoglobin A has a 
hydrodynamic radius of 3.18 nm.32 By contrast, the hydrodynamic radius of 15 kDa 
PAH polymer was determined to be at least 4.5 nm.33 Thus, a dialysis membrane that 
rejects a protein larger than 50 kDa should also reject PAH of 15 kDa. Additionally, 
because the polymer is polydisperse it is possible that a small portion of polymer with 
shorter length may pass through the dialysis membrane as expected, while the majority 
of polymer molecules with an actual MW at and above 15 kDa are likely retained. 
 
Increasing the ionic strength is believed to screen the charges on polyelectrolyte chains 
and encourage long chains to fold.34 In our nanoparticle synthesis, 1 mM of NaCl was 
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used to facilitate the wrapping of PAH onto small AuNPs according to previous 
research.35 More importantly, adding salt was aimed to assist the permeation of PAH 
polymers through the dialysis membrane, by increasing the flexibility of the polymer 
chains. However, in this work, adding salt did not seem to promote PAH transport, and 
Jachimsak et al. also showed that the hydrodynamic radius of 15 kDa PAH actually 
increased with higher ionic strength.33   
 
A potential solution to remove free polymer is to increase the MWCO of the dialysis 
membrane and/or decrease the molecular weight of the polymer. With this in mind, we 
tested a dialysis membrane with a 300 kDa MWCO on a 3 kDa PAH polymer. The 
resulting data show that this setup removed 92% of the PAH polymer (Table 4.1), 
indicating that increasing membrane MWCO and decreasing polymer size could be a 
strategy for better post-synthesis purification. However, it should be noted that with an 
increasing dialysis membrane pore size, very small nanoparticles could also pass 
through the membrane. Based on the DLS data for the three PAH-AuNPs considered 
herein (Figure 4.1(e)), the 300 kDa membrane with about 20-nm pore size has the 
potential for a good separation between 15 kDa PAH and the 4-nm-diameter PAH-
wrapped AuNPs. Overall, while diafiltration is a good strategy for automation and easy 
scale-up of post-synthesis purification, optimal choices of dialysis membrane and other 
experimental conditions need to be carefully considered. In layer-by-layer techniques, 
many other alternative polyelectrolytes can be used for particle-wrapping, such as PEI 
(polyethyleneimine), PAA (poly(acrylic acid)), PSS (poly(sodium 4-
styrenesulfonate)),36 and because all of these are charged polymers like PAH, they are 
likely to experience similar issues in dialysis. As purification strategies can significantly 
affect the residual amount of polyelectrolytes, it is important to carefully evaluate these 
processes to reveal the source of colloid toxicity and thus minimize adverse biological 
effects. 
 
111 
 
Table 4. 1 The concentrations of remaining PAH polymers after dialysis was 
determined and confirmed that the 50 kDa dialysis membrane used in PAH-AuNP 
purification process was not efficient in removing excess unbound 15 kDa PAH 
polymers. 
 
 15 kDa PAH (Sigma) 
50 kDa dialysis membrane 
3 kDa PAH (Nittobo) 
300 kDa dialysis membrane 
Starting PAH concentration 
before dialysis (mg/L) 
500 500 
PAH concentration detected 
after dialysis (mg/L) 
355 ± 22 40.5 (39.1-41.8) a) 
Leftover % 71.0% 8.10% 
a) Range is shown instead of standard deviation as results from less than three replicates 
were obtained. 
 
 
4.4 Conclusion 
The results presented herein demonstrate that the method chosen for post-synthesis 
purification of nanoparticles has a significant effect on the composition and toxicity of 
the final product. 4-nm-diameter PAH-AuNPs purified by three different methods were 
hard to differentiate via common NP characterization techniques, but surprisingly 
contained different amounts of unbound PAH, left over from the stabilizing 
polyelectrolyte-wrapping process. Diafiltration was the least efficient for PAH removal, 
due to insufficient permeation of the PAH polymer across the 50 kDa MWCO dialysis 
membrane; increasing the MWCO of the dialysis membrane and/or decreasing polymer 
molecular weight greatly improved the removal efficiency. One round of centrifugation 
significantly reduced the amount of PAH leftover compared to diafiltration, and an extra 
round of centrifugation, although it reduced the yield of recovered PAH-AuNPs, 
eliminated most of the unbound PAH. Diafiltered-PAH-AuNPs showed the highest 
toxicity to the bacterium Shewanella oneidensis MR-1, followed by centrifuged- and 
then double-centrifuged-PAH-AuNPs. The differential toxicity correlates quantitatively 
with the different amounts of unbound PAH in these three PAH-AuNP suspensions. 
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Thus, by decreasing the amount of PAH left from synthesis, one can make the PAH-
AuNPs more benign, which is desirable considering the wide application of PAH in 
polyelectrolyte wrapping. These results can be potentially extrapolated to other 
polyelectrolyte-wrapped nanoparticles with careful evaluation of both polyelectrolyte 
toxicity and purification processes. Together, this work shows the importance of 
choosing a proper post-synthetic purification method for nanoparticles to avoid 
undesirable biological effects, and the analytical scheme presented in this study can be 
adapted to investigate various polyelectrolyte-wrapping procedures in colloids. 
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Chapter 5 
A growth-based bacterial viability assay for interference-free and 
high-throughput toxicity screening of nanomaterials 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from: 
Qiu, T. A., Nguyen, T. H. T., Hudson-Smith, N. V., Clement, P. L., Forester, D-C., Frew, 
H., Hang, M. N., Murphy, C. J., Hamers, R. J., Feng, Z. V., Haynes, C. L., Growth-
based bacterial viability assay for interference-free and high-throughput toxicity 
screening of nanomaterials, Analytical Chemistry, 2017, 89, 2057–2064. 
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5.1 Introduction 
Understanding how exposure to nanoparticles influences the growth and development 
of microorganisms is of great concern to communities studying both antimicrobial1 and 
toxicological2,3 properties of these materials. The increasing complexity of engineered 
micro- and nano-materials is driving the need for efficient toxicity screening with 
minimal interference. A number of biological and chemical assays have been developed 
previously to assess the toxicity of particles towards microbes.3 Among these, 
cultivation-based4 and optical5 assays are two of the most widely used methods to assess 
bacterial viability, together with some less common methods such as nucleic acid-based 
assays.6 
 
Among all viability assays, optical methods have the highest potential to be adapted 
into high-throughput formats as they can be performed on standard plate readers. Indeed, 
most of the high-throughput toxicological assays are luminescence-based.7 One widely 
used fluorescence-based bacterial viability assay is the LIVE/DEAD® BacLight 
viability staining, wherein all cells are stained with a green fluorophore, SYTO9, and 
cells with damaged membranes are also stained with a red fluorophore, propidium 
iodide.8 Assays harnessing the bioluminescence of marine bacterium Vibrio fischeri 
have also been engineered into high-throughput format and used for both traditional 
chemical and nanomaterial toxicity screening.9,10 
 
While luminescence-based viability assays are amenable to high-throughput screening 
formats, interference due to the presence of nanoparticles (NPs) is not always negligible. 
Properties such as high surface adsorption capacity, optical absorption, scattering and 
fluorescence of nanomaterials interfere with toxicity assays as was discussed earlier in 
Chapter 1,11,12 and have resulted in conflicting nanoparticle toxicity conclusions in 
mammalian cell lines.13,14 Interference mostly due to the optical properties of various 
nanomaterials was demonstrated using several commonly used mammalian cell 
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viability assays.15 In another example, NPs were shown to enhance or decrease optical 
response in optical assays, depending on the NP/assay combination.16 Since it is almost 
impossible to separate nanoparticles from biological samples without disturbing cell 
viability, nanoparticles often remain in the sample during assays. Thus, the use of 
optical-based viability assays for high-throughput nanotoxicity screening is currently 
limited by potential interference from nanoparticles, and careful control experiments 
are necessary to correctly interpret the results.  
 
Cultivation-based bacterial viability assays include conventional colony counting and 
related methods.5 Cultivability remains the gold standard in microbiology to 
demonstrate bacterial viability. While cultivation-based assays, especially plate-based 
colony counting, are unlikely to suffer from optical interference by nanoparticles, they 
are hard to adapt into a high-throughput format. Efforts have been made to automate 
image analysis in colony counting methods,17 but the experimental procedure remains 
labor-intensive. The minimal inhibitory concentration assay (MIC) has been adapted 
for nanotoxicity screening.18-20 However, growth assays of this type need to be carried 
out in nutrient-rich medium, in which nanoparticles could aggregate and adsorb 
surrounding molecules, thus potentially changing the subsequent effect in exposure.7 
An assay that allows any medium to be used during nanoparticle exposure is desirable.  
 
Herein, we developed a growth-based viability assay that is free of optical interference 
from nanomaterials and is performed in 96-well plates to achieve efficient assessment. 
After exposing bacterial cells to materials, a small portion of exposure mixture that 
contained viable cells and exposure materials was transferred into a large portion of 
fresh growth medium to dilute the mixture and minimize any optical interference by 
nanomaterials. The bacterial growth curves from the fraction of viable cells were 
analyzed, and the viability of bacterial cells after exposure was quantified by the delay 
in the bacterial growth curve. This analysis method was inspired by quantitative 
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polymerase chain reactions (qPCR), wherein the amount of starting material is 
correlated with a delay in the amplification curve. Automated data analysis was 
achieved here by developing algorithms to analyze individual growth curves in R code. 
We tested this assay using both a molecular toxicant (an antibiotic, kanamycin) and a 
variety of NPs with potential for significant optical interference, including gold 
nanoparticles with plasmonic extinction and emerging nanoscale battery materials with 
a rich brown color in solution. Since Gram-negative and Gram-positive are the major 
two categories of bacteria, we tested the assay on both Gram-negative bacterium 
Shewanella oneidensis MR-1 and Gram-positive bacterium Bacillus subtilis SB 491 
along with two B. subtilis mutants. Together, this manuscript demonstrates that this 
interference-free assay is ideal for high-throughput bacterial toxicity screening of 
micro- and nano-sized particles and any other materials that may interfere with optical 
detection.  
 
5.2 Experimental section 
 
5.2.1 Materials and reagents 
Shewanella oneidensis MR-1 was obtained from the laboratory of Professor Jeffrey A. 
Gralnick at University of Minnesota. Bacillus subtilis strains (SB 491, ΔdltA and ΔtagE) 
were purchased from the Bacillus Genetic Stock Center. Kanamycin sulfate solution 
(10 mg/mL) was purchased from ThermoFisher Scientific (Catalog #15160054). 
 
5.2.2 Growth-based viability assay 
The objective of the growth-based viability assay is to quantify the relative amount of 
viable bacterial cells after NP exposure using the delay in growth after samples are 
diluted into fresh growth medium as a metric (Scheme 5.1(a)). A similar setup has been 
used before, where bacterial growth curve ODs were compared at an arbitrary time 
point and only semi-quantitative analysis was performed.21 In this work, prepared 
117 
 
bacterial suspensions (see Appendix A.4.3 for more details) were exposed to NPs or 
antibiotics in a desired exposure medium in parallel with negative controls. This 
negative control (lacking in NP or antibiotic addition) was regarded as 100% viability. 
After the incubation period, the 100%-viable sample was serially diluted to generate 
bacterial suspensions with a range of cell densities that would be used to produce a 
calibration curve. Equal small volumes of all samples were individually transferred and 
diluted 20- to 40-fold into fresh LB medium on a 96-well plate to yield a total volume 
of 200 µL in each well; at least two technical replicates were included on the well plate 
for each condition. The plate was covered with its lid and incubated in a plate reader 
(Synergy 2 Multi-Mode Microplate Reader, BioTek, VT) with or without its edge being 
parafilmed (as will be described later) at 30 °C for S. oneidensis and 37 °C for B. subtilis. 
The plate was shaken for 30 seconds before reading OD600 every 20 minutes over a 
period of 12 hours. As an example, a detailed experimental layout is described in the 
following sections and in Scheme 5.1. 
 
5.2.3 Experimental layout for high-throughput screening 
The experimental layout for a 96-well plate to determine dose-response curves usually 
consists of two sections: one for establishing a calibration curve and a second for the 
high-throughput screening. In some cases, a third section is included that is dedicated 
to residue controls, as shown in Scheme 5.1(b). The layout shown in Scheme 5.1(b) is 
also referred to later as the “original layout”. The whole plate with the “original layout” 
is an experimental run of one biological replicate. Details on other layouts for 
experimental optimization, including the randomized layout and the water evaporation 
control, can be found in Appendix A.4.5 and A.4.6. 
 
Calibration Curve Section. To quantitatively determine cell viability, the calibration 
curve, showing OD as a function of time, was required for every experimental trial 
(grey part of Scheme 5.1(b)). The bacterial suspension regarded as 100% viability was 
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the same as the negative control (i.e. no added NPs or antibiotics). After the same period 
of incubation as those exposed to NPs or antibiotics, the 100%-viability suspension was 
serially diluted, and using a multi-channel pipet, equal volumes of bacterial suspension 
were transferred into pre-added fresh LB medium for growth.  
 
Screening Section. The screening section of the well plate was set up to expose 
bacterial suspensions to chemicals or NPs of interest and obtain viability after exposure 
(yellow part of Scheme 5.1(b)). Concentrated working solutions/suspensions of 
kanamycin or nanomaterials were prepared via serial dilution in a designated well-plate 
column and were then transferred to another column for exposure to bacteria as shown 
in Scheme 5.1(b). After incubation, equal volumes of the antibiotic or NP exposure 
mixtures were transferred into pre-added fresh LB medium for growth using a multi-
channel pipet.  
 
Residue Control Section. When transferring exposed bacterial suspension to fresh LB 
medium, it is not possible to completely separate the bacterial cells from other 
components, such as nanomaterials, that are present. Consequently, a residual amount, 
called “residue” here, will accompany bacterial growth in fresh medium. To examine 
the effect of such residue on bacterial growth, a residue control (green part in Scheme 
5.1(b)) was used. In residue control section, the two exposure components (bacterial 
suspensions and NPs/antibiotics) were “separated” before being diluted into fresh 
medium so that the impacts of bacterial residue and NP/antibiotic residue could be 
delineated. The working solution was exposed to sterile autoclaved Milli-Q water 
instead of to a bacterial suspension, and at the same time, the prepared bacterial 
suspensions were incubated with sterile autoclaved Milli-Q water instead of 
NP/antibiotic working solutions. Once the incubation was complete, the same volume 
as used in other two sections was transferred to fresh LB broth to make up the same 
total volume in each well. The residue control section was done to validate the results 
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from the screening section of the well plate, and it was done either on the same plate 
with the other 2 sections (Scheme 5.1(b)) or a separate customized plate. When it is 
run separately, a calibration curve may not be necessary. 
 
 
Scheme 5. 1 Experimental design of the growth-based viability assay. (a) Illustration 
of growth-based viability assay set-up. (b) A detailed experimental layout for high-
throughput screening. 
 
 
5.2.4 Nanomaterial and antibiotic toxicity screening 
Using user-adapted experimental layouts listed in Table 5.1, this growth-based viability 
assay has been tested on four bacterial strains exposed to various nanomaterials or a 
traditional molecular antibiotic. Characterization of nanomaterials can be found in the 
Table A.4.1 and Figure A.4.1. 
 
5.2.5 Data analysis 
The hypothesis and data analysis of the growth-based viability assay are inspired by 
data analysis in qPCR reactions.25-27 The key principle is that the time needed for a 
population of bacteria to reach a specified cell density at exponential phase is correlated 
with the number of culturable and viable cells at the beginning of bacterial growth. This 
120 
 
specified cell density is a threshold (th) that needs to be defined to determine the time 
needed to reach the “threshold” of cell density; the time at this crossing point is referred 
to as a fractional cycle number (Ct) (Figure 5.1(a)). Here, a cycle number is a user-
defined unit to replace the unit “time” and simplify data analysis. For simplicity, each 
reading of the plate reader is counted as one cycle number. With a calibration curve 
between Ct numbers and log-transformed viability, one can obtain the viability of an 
unknown sample by fitting a Ct number calculated from a growth curve onto the 
calibration curve.  
 
 
Figure 5. 1 Data analysis of the growth-based viability assay. (a) Setting up a threshold 
value to obtain fractional cycle number (Ct) for a single growth curve. (b) Constructing 
calibration curves from the growth curves of the dilution series. The growth curves are 
plotted on a linear scale for better illustration despite the calculation of Ct values being 
done on a log scale as described in the method section. 
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Table 5. 1 Experimental layouts and conditions of toxicity screening on different bacterial strains and various materials. 
 
Material Source Experimental layout Exposure medium 
Exposure 
time 
Dosages Bacterial strain 
Kanamycin Purchased 
Original layout (Scheme 5.1(b)) 
Randomized layout (Scheme A.4.1) 
Original layout with water 
evaporation control (Scheme A.4.2) 
HEPES buffer (d) 15-min 
20, 10, 5, 2.5, 1.25, 
0.625 and 0.312 
mg/L 
Shewanella oneidensis 
MR-1 
PAH-AuNPs (a) Synthesized22 Original layout (Scheme 5.1(b)) HEPES buffer 15-min 
2800, 1400, 700, 
350, 175, 87.5, 43.8 
µg/L 
Shewanella oneidensis 
MR-1 
 NMC (b) Synthesized23 
Customized layout with water 
evaporation control 
Minimal medium with 
sodium lactate (e) 
3-hour 
100, 50, 25, 12.5, 
6.25 mg/L 
Shewanella oneidensis 
MR-1 
MPNH2-AuNPs 
(c) 
Synthesized24 Customized layout HEPES buffer 15-min 
0.50, 5.00, 10.00 
mg/L 
Bacillus subtilis SB491 
(wild type), ΔdltA, 
ΔtagE 
a) 4-nm-diameter poly(allylamine hydrochloride)-wrapped gold NPs; (b) Two different nanoscale lithium nickel manganese cobalt oxide copositions: Li0.61Ni0.23Mn0.55Co0.22O2 
and Li0.52Ni0.14Mn0.72Co0.14O2 ; (c) 9-nm-diameter mercaptopropylamine-capped gold NPs; (d)-(e): see SI for the composition of exposure buffers.
122 
 
Manual analysis of single growth curves. The exponential growth phase of the bacteria 
needs to be located to set a threshold value to obtain Ct numbers for further data analysis. 
In this study, a growth curve was first plotted as optical density versus cycle number, 
with each optical density reading regarded as one cycle. This cycle length was 20 
minutes, and the first reading at t = 0 was regarded as cycle 1. The optical density 
background signal was calculated as the average of the initial optical density readings 
across the bacterial wells and was subtracted from each growth curve. The background-
corrected growth curve was then plotted on a log scale, which facilitated visualization 
of the linear range of the log-transformed plot and the location of the exponential 
growth window. Linear regression was then performed on the log-transformed data 
points within the exponential growth. A threshold value of log10(0.02), which was 
within the linear range, was used, and the cycle number at the crossing point of the fit 
line was calculated as the Ct value of the analyzed growth curve. 
 
Automatic analysis of single growth curves. To achieve faster and more robust Ct 
determination, algorithms were developed and written in R to automate data analysis 
of individual growth curves. Threshold and exponential growth windows were 
determined by algorithms instead of by visual inspection (see Appendix A.4.12 for more 
detail). With the code, users can obtain the Ct values of all growth curves across the 
plate by simply inputting raw data sets from the plate reader. 
 
Constructing calibration curves. The construction of a calibration curve is 
demonstrated in Figure 5.1(b). A threshold value was set for all growth curves, and the 
crossing points were calculated to obtain Ct values as described earlier. Ct values from 
technical replicates were averaged to represent the biological replicate. The averaged 
Ct values were plotted against − log2(𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦), named as d (named from “dilution 
fold” in serial dilution), followed by a linear regression to obtain a calibration curve.  
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Quantifying viability of unknown samples. Similarly, Ct values of the growth curves 
obtained from the screening section were calculated using the same threshold as used 
for the calibration curve, and Ct values from technical replicates were averaged to 
represent the biological replicate. The Ct number was then plugged into the calibration 
curve to calculate d, and the equation: 
𝑣 = 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 = 2−𝑑 
was used to transform d to viability. 
 
5.3 Results and discussion 
 
5.3.1 Correlating the delay of growth curve to cell viability 
The hypothesis behind the development of this growth-based viability assay was that 
the delay of the exponential phase of bacterial growth, for both Gram-negative and 
Gram-positive bacteria, is correlated with the relative amount of bacterial cells at the 
beginning of growth. Mathematical modeling reveals that, with several assumptions 
regarding bacterial growth, there is a linear relationship between Ct values and negative 
log2-transformed viability (𝑑 = − log2 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦) (Equation 5.1): 
𝐶𝑡 =
1
𝑘
∙ 𝑑 + [
𝑇𝑂𝐷 − log(𝑃) − log(𝑁0,0)
𝑘 ∙ log(2)
+ 𝐿]         (5.1) 
Ct: fractional cycle number; k: growth rate (Ct-1); d, negative log2-transformed viability; 
𝑇𝑂𝐷, threshold; 𝑁0,0, the absolute number of viable cells in the 100% viability reference 
at the t = 0; L, length of lag phase; P: a constant. See Appendix A.4.11 for more details 
of the mathematical modeling. 
 
The results from calibration curves show clear linear correlations (R2 > 0.99) between 
Ct values and negative log2-transformed viability in all four bacterial strains tested 
(Figure 5.2), and these calibration curves are reproducible across different 
experimental runs. This result shows the promise of this assay for application to a wide 
variety of culturable bacteria. For S. oneidensis MR-1, the calibration curve was tested 
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from 100% viability (d = 0) to 0.006% (d = 14), and the linearity held (Figure A.4.2). 
This demonstrates that the linear range is quite wide and would be sufficient for most 
toxicity tests. 
 
According to the mathematical model, the slope of the calibration curve is the reciprocal 
of bacterial replication rate at exponential growth (k). The slower a bacterium grows 
(smaller k), the larger the slope of calibration curve is, indicating higher sensitivity of 
Ct values in responding to changes in viability. Results show that among all 4 strains, 
S. oneidensis MR-1 have the highest sensitivity with an average of slope of 1.7 ± 0.2 
Ct. It is possible to tune the sensitivity of the calibration curve by slowing or 
accelerating bacterial growth through adjustments in the growth conditions (e.g. 
composition of growth medium, temperature).  
 
Calibration curves were also obtained for bacterial suspensions of S. oneidensis MR-1 
harvested at mid-log phase and stationary phase (Figure A.4.3). Results show the same 
slope and different intercept for the two calibration curves. The same slope indicates 
the same replication rate of viable bacterial cells in the same medium, agreeing with 
Assumption 1 in the mathematical model (Appendix A.4.11). As Equation 5.1 shows, 
the y-intercept of the fit line depends upon several variables, including the number of 
viable cells in the 100% viability reference at t = 0 (log(𝑁0,0)). The larger intercept in 
the calibration curve from stationary phase-harvested bacteria is likely due to the 
decreased proportion of viable cells at stationary phase. It is known that bacterial cells 
start to become non-viable in the stationary phase, and the optical density measurement 
cannot differentiate between viable and dead cells. Thus, using bacteria harvested 
before entering stationary phase, especially at mid-log phase, is recommended. 
 
 
125 
 
 
Figure 5. 2 Representative calibration curves for four bacterial strains used in this study 
(brown is S.oneidensis MR-1, red is B. subtilis tagE, green is B. subtilis dltA, and 
blue is B. subtilis SB 491). The abscissa refers to the negative log2-transformed viability, 
and ordinate indicates the Ct number calculated from growth curves. Solid lines indicate 
the linear regression of data points (R2 > 0.99). 
 
 
5.3.2 High-throughput toxicity screening of antibiotics and nanomaterials 
Dose-response curves were acquired from the GBV assay as described earlier using 
different exposure conditions (Table 5.1, Figure 5.3). The dose-response curves for 
kanamycin, an antibiotic, and PAH-AuNPs are compared to those obtained using a 
conventional plate colony counting method (Figure 5.3(a) and 5.3(b)). Results show 
that the dose-response curves from the two assays are similar, but do not perfectly 
overlap. The dose-response curves from the GBV are shifted slightly to the right 
compared to those from the plate colony counting assay, indicating slightly higher 
viabilities determined using the GBV assay compared to those from colony counting 
under the same dosages. This may be due to different growth conditions of the exposed 
bacteria (solid nutrient plate versus liquid medium); previous reports show that liquid 
media performs better than solid media for the recovery of stress-injured cells,28 and 
bacterial cells could be stressed during transfer from liquid medium to solid medium-
filled plates for plate colony counting.29 Of note, the GBV shows similar or less data 
variation than plate colony counting, reflected by error bars, with fewer biological 
replicates performed. 
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Figure 5.3(c) shows the results of using the GBV assay for toxicity screening of NMC 
nanomaterials on S. oneidensis MR-1, and Figure 5.3(d) shows a screening of MPNH2-
AuNP toxicity towards 3 B. subtilis strains. It should be noted that the exposure time 
and medium for NMC toxicity screening were different from those for kanamycin and 
PAH-AuNPs on S. oneidensis MR-1. Additionally, both NMC and MPNH2-AuNP 
screening were done using slight variations on the aforementioned experimental layouts 
(to meet user requirements and experimental limitations). The ability to easily vary the 
medium and experimental layout demonstrate the versatility of this GBV assay platform, 
and the assay worked equally well for both the Gram-positive and Gram-negative 
bacterial strains we chose.  
 
 
Figure 5. 3 Dose-response curves for S. oneidensis MR-1 responding to (a) PAH-
AuNPs, (b) kanamycin and (c) two different composition NMC nanomaterials 
(Li0.61Ni0.23Mn0.55Co0.22O2 and Li0.52Ni0.14Mn0.72Co0.14O2)23 and (d) B. subtilis SB491, 
ΔdltA mutant, and ΔtagE mutant responding to MPNH2-AuNPs. Solid symbols with 
solid lines indicate data from GBV assays while hollow symbols with dashed lines 
indicate comparative data from plate counting. Error bars indicate standard error of the 
mean in (a)-(c) and range in (d). In all experiments, ≥ 6 biological replicates were 
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collected for plate colony counting assays, and ≥ 3 replicates, except for (d), were 
collected for GBV assays. 
 
 
5.3.3 Negligible interference from antibiotic or NP residue  
In an exposure of planktonic bacterial cells in liquid medium with soluble small 
molecules or dispersible colloids, it is almost impossible to separate bacterial cells from 
exposure materials. Thus, in most high-throughput assays, materials stay in the 
exposure mixture for later steps, potentially resulting in interference with the assay 
read-out. For example, the 4-nm-daimeter PAH-AuNPs used in this study have strong 
plasmonic extinction with a peak at approximately 530 nm. As optical density is usually 
measured as the extinction at 600 nm, the plasmonic extinction of AuNPs can be a 
significant source of optical interference. A 2.8 mg/L PAH-AuNP suspension shows 
extinction of about 0.5. With optical density readings usually less than 2, the optical 
interference from 2.8 mg/L AuNPs is not negligible. 
 
In the GBV assay, the exposure mixture is diluted into fresh growth medium, thus 
minimizing both optical and toxic interference from exposure materials. After a 20-fold 
dilution of 2.8 mg/L AuNPs, the residual AuNP concentration in fresh growth medium 
is 140 µg/L, which has an OD600 of approximately 0.02. To further eliminate any optical 
interference from NPs, the baseline OD of each individual growth curve is subtracted 
from the raw optical density reading to create a normalized growth curve in further 
analysis. 
 
It is still possible that the residue after dilution can impact bacterial growth after dilution 
into the fresh growth medium. This concern is addressed by the residue control section 
described in the rationale of the GBV experimental design. Figure 5.4 shows results 
from the GBV assay residue control section for PAH-AuNPs and kanamycin exposure 
to S. oneidensis. The relative percentage change of residue-exposed samples compared 
to the corresponding control were calculated as: 
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𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 (%) =
𝐶𝑡,𝑒𝑥𝑝𝑜𝑠𝑒𝑑 − 𝐶𝑡,𝑠𝑎𝑚𝑝𝑙𝑒
𝐶𝑡,𝑠𝑎𝑚𝑝𝑙𝑒
× 100 
and one-way ANOVA plus post-hoc Tukey’s test were performed. No statistically 
significant difference is revealed, indicating that the residues of neither PAH-AuNPs 
nor kanamycin impact bacterial growth. A stricter control experiment (referred as 
“orthogonal residue control”, more details in Appendix A.4.10) further showed that the 
residues do not affect bacterial growth starting at different cell densities (Figure A.4.4). 
In a scenario where the effect of residue is detected, two strategies can be implemented 
to minimize the interference: 1) larger dilution fold can be used (e.g. switching 20-fold 
dilution to 40-fold) to reduce the amount of residue in the fresh growth medium, and/or 
2) the dosage can be reduced below toxic levels. 
 
 
Figure 5. 4 Residue from PAH-AuNP (black square) or antibiotic (blue dot) exposure 
did not affect the growth of S. oneidensis after dilution into fresh medium. Error bars 
represent standard error of the mean of 3 (PAH-AuNP) and 7 (kanamycin) biological 
replicates. No statistical significance was found among the growth controls that 
correspond to negative control and various exposure dosages (Tukey’s test, α=0.05). 
 
 
5.3.4 Reducing variation by adding a water evaporation control 
In GBV toxicity screening experiments using the original layout (Scheme 5.1(b)), it 
became obvious that the viabilities calculated for negative control samples were often 
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greater than 1 when the distribution of measured viability for negative control should 
be centered at 1. Figure 5.5(a) shows that the log-transformed viability values for 
negative controls from the original layout were significantly different from zero (log(1)). 
Such bias was suspected to be due to systematic errors.  
 
Performing standard plate control experiments aimed to identify any systematic 
instrumental imperfection, such as non-uniform heating. Results showed that in both 
trials, smaller Ct values were observed at the left side of the plate, while larger Ct 
numbers were detected for wells in Row A and Column 12 (Figure A.4.5(a)). A 
randomized layout was implemented to minimize the impact of different positions on 
the plate (Scheme A.4.1). Figure 5.5(a) shows that the randomized layout decreased 
the bias, although not statistically significant, compared to the original layout. 
 
Water evaporation in edge wells (Rows A and H, Columns 1 and 12) was suspected to 
affect the Ct determination by altering the optical densities and nutrient concentrations 
in wells. Analysis of Ct values from standard plates (whole plate) shows that, if we 
exclude the edge wells in data analysis, the range of all Ct values across the plate 
decreases, yielding an improved coefficient of variation (CV %) (Table A.4.2). A 
control experiment demonstrates that water evaporation is most significant in the edge 
wells (Figure A.4.6). Thus, a water evaporation control, where the edge wells were 
filled with water, was implemented to reduce such variation (Scheme A.4.2). While the 
reduction in number of wells for experimental conditions (from 96 to 60 wells available) 
is not ideal, results show that the water evaporation control efficiently reduces the 
variations of Ct values on the standard plates (Table A.4.2) and brings the log-
transformed viability of negative control samples closer to zero (Figure 5.5(a)). Despite 
this improvement, the log-transformed viability of negative controls in water 
evaporation control still shows a statistically significant difference from zero (One-
sample t test, p < 0.05), indicating room for further improvement. Additional control 
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experiments show that the order when transferring and diluting bacterial suspension to 
nutrient-rich medium could affect the intercept of calibration curves (Figure A.4.7), 
indicating that it might be helpful to randomize the order of liquid transfer to further 
improve the accuracy. 
 
Figure 5.5(b) shows the kanamycin dose-response curves for S. oneidensis MR-1 
determined from three different experimental layouts. Data points are fitted into 
sigmoid dose-response curves, and IC50 values are determined to be 3.44, 3.13, and 1.97 
mg/L for toxicity screening with original, randomized, and water evaporation control 
layouts, respectively. The dose-response curve from the water evaporation control is 
also plotted with that from plate colony counting method (Figure 5.3(b)). The results 
show that the IC50 values from the three dose-response curves are significantly different 
from each other (Extra sum-of-square F test, p < 0.05). The dose-response curve from 
the layout accounting for water evaporation is the closest to that determined using the 
traditional plate colony counting assay (Figure 5.3(b)). In addition, no viability larger 
than 1 was measured when using the layout with the water evaporation control. Thus, 
the layout with the water evaporation control is considered to be the best layout. 
 
 
Figure 5. 5 Effects of randomized layout and water evaporation controls on the GBV 
assay compared to the original layout. (a) A summary of log-transformed viability 
calculations of negative controls on each plate from various setups. The water 
evaporation control resulted in an average value that has a statistically significant 
difference compared to the original layout (Tukey’s multiple comparison test, p < 0.05). 
Individual data points are plotted with standard deviations. (b) Kanamycin dose-
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response curves resulting from the three different experimental layouts with sigmoid 
fittings. Solid lines indicate the sigmoid fitting, and error bars indicate standard error 
of the mean. 
 
 
5.3.5 Fast and robust automated data analysis for Ct determination 
The manual data analysis, as stated in Experimental section, is time-consuming. 
Moreover, as the linear range of log-transformed growth curve and the threshold values 
are visually observed and manually selected, the manual data analysis is subject to user 
bias. To achieve faster and more robust data analysis, computer algorithms were 
developed in this work by exploiting the similarity between bacterial replication and 
nucleic acid amplification. Analysis of DNA amplification curves in qPCR has been 
extensively explored and optimized.25-27 In a qPCR reaction, a DNA template doubles 
after one amplification cycle, and analogously, in bacterial exponential growth, a 
bacterium splits into two after its doubling time. The similarity between these two 
processes allows adaptation of algorithms from qPCR data analysis to analyze bacterial 
growth curves quantitatively (see Appendix A.4.12 for more details).  
 
Results from automated and manual data analysis are compared by plotting calibration 
curves for the same data set (Figure 5.6(a)). In our algorithms, thresholds were 
determined by three different methods, referred to as secondary derivative maximum 
(SDM), mid-point, and fit-point methods. The slopes determined from manual analysis 
and automated analysis with 3 different thresholding methods were compared, and they 
are not significantly different from each other (Extra sum-of-squares F test, p as 0.05), 
indicating automated data analysis, which takes less than 1 minute in the R program 
(see R codes in Appendix A.4.13), agrees well with results from manual fitting; this is 
true for both Gram-negative and Gram-positive bacteria.  
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Figure 5.6. Comparing results from three different thresholding methods in automated 
data analysis. (a) A representative demonstration of calibration curves determined using 
manual fitting and different threshold methods in automatic analysis. Slopes are not 
different from each other in any of the four fittings. (b) No difference between the 
variation of Ct values is determined between three different threshold methods on 
standard plates. Data points are from standard plate with water evaporation control and 
standard plates (whole plate) with edge wells excluded in data analysis. 
 
Variation of Ct values on standard plates determined from the three different 
thresholding methods is also compared (Figure 5.6(b)), and no difference is observed 
(Tukey’s multiple comparison test, p as 0.05). Combined with the analysis of 
calibration curves (Figure 5.6(a)), it is clear that all three thresholding methods in this 
automated data analysis can be used. Since the fit-point thresholding method requires a 
stable baseline with at least 3 data points to calculate a standard deviation, and the SDM 
thresholding method results in a threshold at the edge of the exponential growth, which 
sometimes leads to a crossing point beyond the linear range of exponential window, the 
mid-point thresholding method is recommended for future use. 
 
5.4 Conclusion 
The results presented herein show that by greatly diluting exposed bacterial cells into 
fresh growth medium and analyzing the subsequent growth profile of remaining viable 
cells, we can quantitatively correlate cell viability to the delay of bacterial growth after 
dilution. The large dilution ensures minimal optical interference and toxic effect from 
nanomaterials in the exposure mixture. The delay in the bacterial growth curve was 
quantified by measuring the point at which a growth curve surpasses a threshold value. 
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Data analysis of growth curves was inspired by qPCR, due to the similarity between 
bacteria replication and DNA amplification. Automated data analysis was achieved by 
developing algorithms in R code and showed fast and robust determination of antibiotic 
or NP impact on bacteria. Excitingly, this assay is confirmed to work in 2 different 
strains plus 2 mutants, including Gram-negative and Gram-positive bacteria, and 
various materials ranging from molecular antibiotics to ligand-stabilized colloids to 
complex metal oxide NPs. The main potential challenge in adapting this method to 
studies with other microorganisms lies in organism replication patterns; for example, if 
an organism replicates using a method other than simple binary splitting or exhibits 
extremely slow growth, this assay would have to be adapted. Nonetheless, this assay 
shows great potential to be applied to all culturable bacteria and a wide range of 
potential toxicants for high-throughput and fast toxicity assessment.  
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Chapter 6 
DNA damage as a toxicity mechanism of NMC (LixNi1/3Mn1/3Co1/3O2) 
nanomaterial to bacterium Shewanella oneidensis MR-1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from: 
Qiu, T. A., Guidolin, V., Hoang, K. N., Pho, T., Carrà, A., Lynn, T. G., Villalta, P. W., 
Feng, Z. V., Balbo, S., Haynes, C. L., DNA damage as a toxicity mechanism of NMC 
(LixNi1/3Mn1/3Co1/3O2) nanomaterial to bacteria Shewanella oneidensis MR-1 and 
Bacillus subtilis, 2018, in preparation. 
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6.1 Introduction 
Lithium-ion batteries (LIB) have been a focus as a promising high-density energy 
storage solution for electrical devices and vehicles in the last decades. One key 
component determining the capacity of LIBs is the cathode material. Compared to 
conventional LiCoO2, layered nickel-rich lithium transition-metal oxides, LiNi1-xMxO2 
(M as transition metals), have attracted attention as a high energy density cathode 
material.1 Lithium nickel manganese cobalt oxide (LixNiyMnzCo1-y-zO2, NMC) 
represents a class of lithium transition-metal oxide materials with high power 
performance that is being used at large scale in hybrid electric vehicles.2-4 By replacing 
cobalt in LiCoO2 with nickel and manganese, NMC materials are shown to deliver a 
high discharge capacity of more than 200 mAh/g with great stability, exceeding 
requirements needed for hybrid electric vehicle batteries.2 The size scale of NMC 
ranges from nanometers to micrometers and can transform between these scales via 
aggregation or stress-induced fracture;5 nanoscale battery materials are expected to 
have improved performance due to shortened diffusion paths and increased surface 
areas.6 
 
As the high energy density makes them suitable for large-scale applications such as 
electrical vehicles and energy storage systems, waste from LIBs is not well--managed 
due to lack of motivation and infrastructure for recycling.7 With projected electric 
vehicle use and sales, the amount of LIB waste is expected to increase, but only 42% 
of the waste can be properly recycled using current technology.8 While an economically 
sound battery recycling strategy needs to be developed,9,10 it is also urgent to evaluate 
the risk of these metal-containing battery materials being released into environment in 
a proactive manner. As an example, leaching of metals was found from spent LIBs, 
potentially being a source of toxicity towards environmental organisms.11 In contrast to 
the urgent need, very limited information is available on the potential health and 
environmental effects of battery materials. Our recent studies have shown adverse 
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biological effects from exposure of nanoscale NMC materials, including inhibition of 
bacterial growth of Shewanella oneidensis MR-1, an environmentally relevant 
bacterium that was introduced in Chapter 2-4,5,12 and impacts on survival, reproduction 
and gene expression in Daphnia magna, an aquatic invertebrate introduced in Chapter 
3.13 The toxicity mechanism of nanoscale NMC on bacterial growth inhibition was 
determined to be mainly dissolution to toxic nickel and cobalt ions, while Daphnia 
magna experienced disruption that couldn’t be totally attributed to dissolved ions. 
 
Genotoxicity, a mode of toxicity on the DNA level, is shown to be induced by NP 
exposure in various cell lines and organisms such as bacteria, human cells, fish and 
plants.14-18 Mechanisms of genotoxicity induced by nanoparticles (NPs) vary case-by-
case, including DNA methylation variations,19 oxidative DNA adduct formation,20 
DNA strand breakage,21 and occasionally mutagenesis.22 These mechanisms can 
happen via direct interaction of DNA with NPs taken up by cells or indirect mechanisms 
without direct DNA-NP physical interaction, such as generation of free radicals and 
dissolution to ions. In fact, Bhabra et al. showed that even in the presence of a barrier 
composed of a human carcinoma cell line, cobalt-chromium NPs were able to cause 
DNA damage in human fibroblast cells across the cellular barrier through intercellular 
communications and transport of dissolved metal ions.23 In our previous studies, time-
dependent dissolution of nickel and cobalt ions from nanoscale NMC was determined 
in bacterial culture media.5 As nickel and cobalt appear to induce genotoxicity,24-26 
combined with the observation of bacterial phenotype change upon continuous nano-
NMC exposure (unpublished data), we postulate that the inhibition of bacterial growth 
upon nanoscale NMC exposure is mediated via damage to bacterial DNA induced by 
dissolved nickel and cobalt ions. 
 
In this study, we investigated bacterial DNA damage upon NMC exposure using an 
adapted alkaline Comet assay for bacterial DNA strand breakage27 and a high-resolution 
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mass spectrometry-based DNA adductomics approach.28 The Comet assay visualizes 
the “tails” of stained DNA molecules from each single cell, where longer tails indicate 
higher levels of DNA strand breakage. A sensitive and rapid tool to assess DNA damage, 
the Comet assay has been applied widely to study strand breakage induced by NPs.29 
Here we expanded the use of Comet assays to measure bacterial cell response to NP 
exposure. DNA adducts are chemical modifications, including redox reaction or fusion 
of molecular species onto DNA molecules, that have been informative for risk 
assessment of carcinogens.30,31 Many studies have used DNA adduct formation in the 
bacterium Salmonella typhimurium to study mutagenesis mechanisms and evaluate the 
risk of chemical mutagenicity,32-34 with studies of similar purpose expanding to other 
microbial species, such as Escherichia coli.35,36 However, the implication of DNA 
adduct formation in ecologically relevant organisms, including environmental 
microbes,37 is studied to a much smaller extent compared to studies concerning human 
health. Herein we aimed to measure DNA adduct formation in the ecologically relevant 
bacterium, Shewanella oneidensis MR-1, to explore the impact of nanoscale NMC 
exposure to bacterial DNA and its environmental implications. 
 
Currently, the limited pool of DNA adduct studies in nanotoxicology have focused on 
detecting a single DNA modification, 8-hydroxy-2' -deoxyguanosine (8-OHdG, 
sometimes referred as 8-oxo-dG), which is indicative of oxidative stress.38-40 Recently 
developed DNA adductomic approaches provide possibilities to detect other DNA 
modifications beyond 8-OHdG and reveal unique molecular mechanisms beyond 
oxidative stress.30 Although limited, studies have used DNA adductomics to investigate 
modes of genotoxicity in mice upon iron oxide NP exposure,41,42 and adductomics were 
also applied on a soil bacterium.37 To our knowledge, the study presented herein is the 
first one that applies DNA adductomics on bacterial species upon NP exposure. We 
applied a high-resolution DNA adductomic approach using tandem mass spectrometry, 
where the neutral loss of deoxyribose from single modified nucleosides triggered the 
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next level of fragmentation to identify the structural identity of DNA adducts.28 
Successful application of DNA adductomic approaches was confirmed on bacterial 
DNA. Combined with assays on reactive oxygen species (ROS), Ni/Co metal ion 
uptake, and NMC toxicity, we determined that DNA damage appeared in the form of 
DNA double-strand breakage but not DNA adduct formation, and the observed 
genotoxicity is possibly through indirect mechanism of metal ion uptake into cells, but 
less likely through generation of intracellular ROS. 
 
6.2 Experimental 
 
6.2.1 Materials  
Nanoscale NMC materials were provided by the Hamers lab at University of Wisconsin, 
Madison. DifcoTM LB broth (Miller) and DifcoTM agar (granulated) were purchased 
from Becton, Dickinson, and Company. 2′,7′-Dichlorofluorescin diacetate (DCFH2-DA) 
was purchased from both Sigma Aldrich (Cat. No.: D6883) and ThermoFisher 
Scientific (Cat. No.: D399). Newport Green DCF diacetate was purchased from 
ThermoFisher Scientific (Cat. No.: N7991). NiSO4·6H2O was purchased from Acros 
Organics (Cat. No.: B00875). CoCl2·6H2O was purchased from Mallinckrodt (Cat. No.: 
B00791). Anhydrous DMSO was purchased from ThermoFisher Scientific (Cat. No.: 
D12345). Hydrogen peroxide (30% w/w) was purchased from Fisher Scientific (Cat. 
No.: H325-100). Dulbecco's phosphate-buffered saline (DPBS) was purchased from 
Mediatech, Inc. All Milli-Q water used had a resistance around 18.0 MΩ·cm. Tris-
EDTA (TE) buffer was composed of 10 mM Tris, 1 mM EDTA, brought to pH 8.0 with 
HCl. Lysozyme was purchased from Sigma Aldrich (Cat. No.: L6876). Isopropanol 
(IPA) was purchased from ThermoFisher Scientific. Tris-MgCl2 buffer was composed 
of 10 mM Tris, 5 mM MgCl2, brought to pH of 7.  
 
6.2.2 Medium preparation  
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LB broth: 25 grams of pre-mixed Difco LB power was dissolved in 1 liter of Milli-Q 
water and autoclaved. Minimal medium with sodium lactate (MM with lactate): Each 
liter of minimal medium contains 0.68 g NaCl, 0.3 g KCl, 0.285 g MgCl2∙6H2O, 0.3975 
g Na2SO4, 0.15 g NH4Cl, 2.383 g HEPES, 0.0125 g Na2HPO4 and 0.0056 g CaCl2. Part 
I stock contains 20x concentration of NaCl, KCl, MgCl2∙6H2O, Na2SO4, NH4Cl, and 
HEPES. Part II stock contains 100x concentration of Na2HPO4 and Part III stock 
contains CaCl2, both sterile filtered. To make 1 liter of 1x minimal medium solution, 50 
mL Part I stock was mixed with 930 mL Milli-Q water, and pH was adjusted to 7.2~7.3 
using HCl and NaOH solutions. The solution was autoclaved and cooled down to room 
temperature, and 10 mL of both Part II and Part III stock was added; this solution is 
called minimal medium (MM) in this study. Immediately before use, 14 mL of sodium 
DL-lactate syrup 60% w/w aq. soln was mixed with the minimal medium to make a 
total volume of 1000 mL, referred to as MM with lactate. 
 
6.2.3 Bacterial culture 
Shewanella oneidensis MR-1 BAA-1096 (S. oneidensis) was purchased from ATCC. 
Frozen stocks of bacterial cells were prepared by 1:1 mixing mid-log phase bacterial 
suspension in LB with 50% w/w sterile glycerol stored in a -80 °C freezer. S. oneidensis 
was plated from a frozen stock onto an 15% w/w agar plate and incubated at 30-32 °C 
overnight, and the formed colonies were used for subsequent bacterial experiments. 
 
6.2.4 Abiotic ROS generation from NMC  
DCFH2-DA from Sigma Aldrich was dissolved in anhydrous DMSO to a concentration 
of 20 mM, divided into 100 µL aliquots and stored at -20 °C in a desiccator. Upon usage, 
DCFH2-DA DMSO stock was thawed and diluted 1000-fold into MM with lactate. 
NMC was weighed and dissolved in freshly prepared MM with sodium lactate with a 
stock concentration of 4 mg/mL. The prepared NMC suspension was aged for 10 days 
on a bench, and part of the NMC stock suspension was diluted 10-fold using fresh MM 
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with lactate. On a black wall clear bottom 96-well assay plate, 195 µL of diluted 
DCFH2-DA solution was added into all 96 wells. At time zero (t = 0), 5 µL of NMC 
suspensions of two concentrations plus negative control (MM with lactate) and positive 
control (30% w/w hydrogen peroxide solution) were quickly added in triplicate to the 
first row of wells that already contained diluted DCFH2-DA, and the plate was 
immediately sent for fluorescence reading at excitation/emission (Ex/Em) of 485/525 
nm on a Synergy 2 Multi-Mode Microplate Reader (BioTek, VT). Every 30 minutes, 
the same blank, NMC suspension, and hydrogen peroxide solution were added to a new 
row and immediately sent for fluorescence reading. 
 
6.2.5 Intracellular ROS detection with DCFH2-DA 
Bacterial colonies from an agar plate incubated overnight were inoculated into 10 mL 
fresh LB broth. After 4-5 hours, bacterial suspension at mid- or late-log phase was 
centrifuged at 2,000 × g for 5 minutes. After removing supernatant, the cell pellet was 
re-suspended in DPBS buffer. DMSO stock of DCFH2-DA from ThermoFisher 
Scientific was thawed at room temperature and diluted 1000-fold into bacterial 
suspension in DPBS buffer, resulting in a final concentration of 20 µM DCFH2-DA. 
The bacterial suspension containing DCFH2-DA was wrapped in aluminum foil and 
incubated in a 32 °C shaker for 1 hour. After dye loading, the bacterial suspension was 
centrifuged at 3,000 × g for 10 minutes, and the pellet was re-suspended in an equal 
volume of MM with lactate, followed by a second round of centrifugation for a second 
washing. After the second round of centrifugation, the bacterial suspension was re-
suspended again in an equal volume of MM with lactate. About 72-hours prior to 
exposure, NMC was weighed and suspended in fresh MM with lactate, sonicated in a 
bath sonicator for 15 minutes, and sat on a bench in the dark at ambient conditions until 
use. Dye-loaded cells were then 9:1 mixed with NMC suspension plus negative control 
(MM with lactate) and positive control (hydrogen peroxide) for a 15-min exposure in 
triplicate with a total volume of 1 mL. After exposure, the mixture was centrifuged at 
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10,000 × g for 5 minutes in a microcentrifuge, and the resulting pellet was re-suspended 
in 1 mL MM with lactate. A second round of centrifugation was done, followed by final 
re-suspension of pellets into 200 µL MM with lactate. The resulted suspensions were 
transferred to a 96-well assay plate to read both optical density absorbance at 600 nm 
and fluorescence at Ex/Em = 493/522 nm on a Synergy H1 Hybrid Multi-Mode 
Microplate Reader (BioTek, VT). 
 
6.2.6 Intracellular metal ion uptake detection with Newport Green DCF 
diacetate  
Newport Green DCF diacetate (NPG-Ac) was dissolved in anhydrous DMSO to make 
a 2 mM stock. Bacterial preparation for NPG-Ac dye loading was the same as dye 
loading of DCFH2-DA, except for the dilution fold of the dye stock into bacterial 
suspension; after a 400-fold dilution, the final concentration for NPG-Ac dye loading 
was 5 µM. Dye-loaded bacterial suspension was mixed with 72-hour aged NMC 
suspension or varying concentrations of NiSO4 or CoCl2 plus negative control (MM 
with lactate) for a 30-min exposure in triplicate with a total volume of 1 mL. The 
washing steps were also the same as those used in the intracellular ROS experiments. 
The resulting suspensions were transferred to a 96-well plate to read both optical 
density at 600 nm (OD600) and fluorescence at Ex/Em = 505/535 nm on a Synergy H1 
Hybrid Multi-Mode Microplate Reader (BioTek, VT). 
 
6.2.7 Bacterial growth inhibition and viability test upon NMC exposure  
Various concentrations of NMC were exposed to bacterial cells grown in MM with 
lactate at mid-log phase. Bacterial colonies from an agar plate incubated overnight were 
inoculated into 10 mL fresh LB broth and harvested after 4-5 hours at mid- or late-log 
phase by centrifugation at 2,000 × g for 10 minutes. The pellet was re-suspended in 
fresh MM with lactate, and the OD600 of the cell suspension was measured using a 
Spectronic 20 Spectrophotometer. Cells were then diluted into a large volume of MM 
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with lactate in a 500 mL Erlenmeyer flask with calculated optical density of 0.01, and 
the optical density of the diluted cell suspension was measured by transferring 200 µL 
into a 96-well plate and reading absorbance at 600 nm on a Synergy H1 Hybrid Multi-
Mode Microplate Reader (BioTek, VT). Diluted bacterial suspension was shaken at 300 
rpm in a 32 °C orbital shaker overnight until the raw optical density reading reached 
~0.12, indicating that the bacterial population was approximately halfway through the 
exponential growth phase. At this point, NMC was weighed and suspended in MM with 
lactate and sonicated in a bath sonicator for 15 minutes. While waiting for sonication 
to be done, the bacterial suspension was divided into aliquots of 7.8 mL in glass culture 
tubes. NMC suspensions of varying concentrations were then spiked into culture tubes 
for exposure. Exposure was done in triplicate, and the positions of different conditions 
were randomized on the tube rack. To monitor growth, 200 µL from each tube was 
transferred onto a 96-well plate at different time points; the tubes were vortexed for 
several seconds and vigorously shaken prior to liquid transfer to ensure even suspension 
of NMC and cells. The transferred aliquots were immediately taken to a Synergy H1 
Hybrid Multi-Mode Microplate Reader (BioTek, VT) to read OD600. Coupled with the 
growth inhibition test, a growth-based viability test was performed as described in 
Chapter 5.43 Both at 1-hour and 8-hour after adding NMC, 200 µL of bacterial 
suspension was transferred to a clear sterile transparent 96-well plate with a lid for the 
growth-based viability assay. Negative control groups were used as 100% reference in 
building calibration curves, and MM with lactate was used to test contamination. A 
water evaporation control was implemented by surrounding re-growth area with wells 
filled with liquid, and positions were randomized. Data were analyzed using the R code 
published in the previous study, as presented in Appendix A.4.13 in this thesis. 
 
6.2.8 Comet assay for DNA strand breakage 
Single cell gel electrophoresis on NMC-treated S. oneidensis was conducted following 
published protocols with minor changes.44,45 Ten microliters of the NMC-treated cell 
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suspension was mixed in 100 µL of 0.5% low-melting agarose (LMA) solution. Forty 
µL of the suspension was pipetted onto a Comet assay microscope slide (Travigen®) 
and spread evenly in a well. Once solidified at 4 °C, a 0.5% lysozyme-LMA layer was 
placed on top of the gel and solidified. The assembled slide was then incubated at 30 °C 
for 30 minutes. The slide was then sequentially immersed in a lysing solution (2.5 M 
NaCl, 100.0 mM EDTA, 10.0 mM Tris -HCl, 1% sodium N-lauryl sarcosine, 0.6% 
Triton® X-100, pH 10.0) for 1 hour in the dark, and an enzyme digestion solution (2.5 
M NaCl, 10.0 mM EDTA, 10.0 mM Tris-HCl, and 0.5 mg/mL proteinase K, pH 7.4) at 
37 °C for 2 hours. Electrophoresis was performed in an electrophoresis buffer (sodium 
acetate and Tris at pH 9.0) at 12 V for 30 minutes while being chilled. The slide was 
then washed and dehydrated with 1.0 M ammonium acetate in ethanol, then absolute 
ethanol, and was left at room temperature to dry in the dark. The samples were then 
rehydrated in freshly prepared 5% DMSO in10 mM NaH2PO4 solution and stained with 
50.0 µL of 1.0 µM YOYO-1 in 5% DMSO.  After air-drying in the dark for 5 minutes, 
the stack of microgel was imaged with a fluorescent microscope (100x, Ex/Em = 
491/509 nm). ImageJ was used to analyze the DNA tail lengths. 
 
6.2.9 DNA extraction from S. oneidensis cells  
DNA extraction was done using Gentra Puregene Yeast/Bacteria Kit (Qiagen), and the 
protocol was optimized to extract bacterial DNA with high yield for the adductomics 
study. Bacterial cells were harvested via centrifugation. The resulting pellets were 
suspended in 20 mg/mL lysozyme solution in TE buffer (approximately 300 µL per 1 x 
109 cells) and incubated at room temperature (RT) for 10 minutes while shaking. 
Lysozyme-treated cells were pelleted via centrifugation for 1 min at 16,000 × g at 4 °C, 
followed by careful removal of supernatant with a micropipet. 300 µL of Cell Lysis 
Solution was added per pellet and mixed with cells by pipetting up and down. The 
mixture quickly became sticky, and the pellet was partially resuspended. After 5 
minutes of rest at RT, 1.5 µL RNase A Solution from the kit was added and mixed by 
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inverting the tubes 25 times. The mixtures were incubated at RT for 2 hours without 
shaking. Samples were then quickly cooled down on ice for 1 minute, followed by 
addition of 100 µL Protein Precipitation Solution and vigorous vortexing for 20 seconds 
at high speed. The samples were then incubated on ice for 10 minutes and centrifuged 
for 3 minutes at 16,000 × g at 4 °C. In new, clean 1.5 mL microcentrifuge tubes, the 
supernatant was carefully poured into 300 µL isopropanol (IPA), and the resulting 
solution was gently mixed by slowly inverting tubes 50 times. White floating 
substances, the DNA, started to appear during mixing. To collect precipitated DNA, the 
mixture was centrifuged for 1 min at 16,000 × g at 4 °C, followed by two washing steps 
using 300 µL of 70% and 100% IPA. After careful removal of supernatant, tubes 
containing DNA at bottom were drained on a clean piece of absorbent paper and 
allowed to air dry. To measure concentration, DNA pellets were dissolved in Tris-MgCl2 
buffer overnight in a 4 °C fridge, and the concentration was measured using a 
NanoDrop One spectrometer with a standard of A260/A280 ~1.8. 
 
6.2.10 Direct exposure of NMC to extracted bacterial DNA  
Bacteria were grown in LB broth until mid-log phase and harvested by centrifugation 
for 30 seconds at 16,000 × g at 4 °C, followed by DNA extraction as described above. 
NMC was weighed and suspended in Tris-MgCl2 buffer and sonicated in a bath 
sonicator for 15 minutes. The total DNA amount in each sample was adjusted to ~50 
µg, and DNA was mixed with freshly prepared NMC suspension for a final NMC 
concentration of 50 mg/L, followed by incubation at 4 °C for 48 hours. One replicate 
was done in the direct exposure. The resulting mixture after exposure was used for DNA 
adductomic sample preparation. 
 
6.2.11 NMC exposure to bacterial cells for DNA adductomics  
The exposure was done similar to that in the bacterial growth inhibition assay. Instead 
of using varying concentrations of NMC, only the selected 5 mg/L exposure 
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concentration was used in addition to the negative control. Three replicates were used 
in the experiment. After being grown in large volume in flask to mid-log phase, 21.9 
mL bacterial suspension was aliquoted into 50 mL sterile conical tubes, followed by 
addition of freshly prepared NMC suspension. Bacterial growth was monitored over 
time by transferring 200 µL aliquots and measuring OD600. At 8-hour post-exposure, an 
additional 200 µL aliquot was used for a growth-based viability assay, and the rest of 
bacterial suspensions were centrifuged at 4,000 × g for 20 minutes. Cell pellets were 
saved at -80 °C until being thawed for DNA extraction, followed by sample preparation 
for DNA adductomics. 
 
6.2.12 Sample preparation for DNA adductomics  
DNA digestion. Concentration of DNA dissolved in Tris-MgCl2 buffer was quantified 
using a UV/vis spectrophotometer. A two-step DNA digestion was performed to digest 
macromolecules into single nucleosides using DNase (from E. coli, Aldrich), 
phospodiesterase-1 (PDE-1) (from Crotalus adamanteus, Aldrich) and alkaline 
phosphatase (ALP) (from Pichia pastoris, Aldrich). All the enzymes were purified by 
using a double filtration membrane Amico Ultra (0.5 mL, cutoff 10 k Da) prior to use. 
The first step of hydrolysis was done using only DNase, followed by a second step 
using the full enzyme mixture. Both steps incubated samples for 24 hours at RT. Per 1 
µg of DNA, 0.5 Units of DNase was used in the first step, and the second step used 0.5 
U, 0.2 U and 0.02 mU of DNase, ALP and PDE-1, respectively. After the two-step 
hydrolysis, enzymes were removed from the mixture by using an Amicon Microcone 
single filtration membrane (0.5 mL, cutoff 10 kDa). The digestion yield was assessed 
by measuring the concentration of dG via an LC/UV measurement. 
 
dG quantitation. An HPLC Ultimate 3000 equipped with a reverse phase column, Luna 
C18 (250x0.5 mm, 5 µm, 100 Å) was used to separate the four 2’-deoxyribonucleosides 
(dC, dG, dT, dA) and quantify the amount of dG. A gradient of two mobile phase, H2O 
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(A) and methanol (MeOH, B), was used. Operated at 40 °C with a flow rate of 15 
µL·min-1, the system started elution with an isocratic step at 5% B for 3 minutes, 
followed by a first linear gradient of 0.58 % B·min-1 (12 min), a second linear gradient 
of 27.67 % B·min-1 (3 min) and it concluded with a second isocratic step at 95 % B (3 
min). The column was re-equilibrated for 9 minutes using 5% B. Absorbance at 254 nm 
was used to monitor elution. Using a calibration curve consisting of eight standard 
concentrations (0.0625, 0.125, 0.25, 0.50, 1.00, 2.00, 4.0, 8.0 ng/µL pf dG), the amount 
of dG in digested DNA samples was quantified. 
 
Hydrophobic reversed phase fraction collection. To exclude signals from unmodified 
deoxyribonucleosides (dC, dG, dT, dA) and enrich analytes of interest (i. e. DNA 
adducts) for the followed LC/MS3 measurement, separation and fraction collection 
using chromatography was performed, followed by sample concentration and 
reconstitution. An HPLC (Ultimate 3000, Thermo Scientific, Waltham, MA) equipped 
with a C18-Column (4.6 x 250 mm, 100Ǻ, 5µm Luna-Phenomenex, Torrace, CA) was 
used for fraction collection, using mobile phase H2O (A) and MeOH (B) and operating 
at two different scenarios, I and II, for DNA from direct NMC exposure and DNA 
extracted from NMC-exposed cells, respectively. Scenario I ran at 25°C with a flow 
rate of 1.0 mL·min-1. The elution program involved an isocratic step at 2% of B (5 min), 
followed by a linear gradient of 0.7 %B·min-1 (25 min) and a second isocratic step at 
100% of B (15 min). At the end of the elution, the LC-system was equilibrated in 
isocratic condition (2% of B) for 20 min. Scenario II ran at 4°C with a flow rate of 1.0 
mL·min-1.The elution program involved an isocratic step at 2% of B (5 min), followed 
by a series of linear gradients of 0.86% B·min-1 (6 min), 0.14% B·min-1 (28 min), 4.6% 
B·min-1 (5 min), 13% B·min-1 (5 min), and an isocratic step at 100% of B (5 min). At 
the end of the elution, the LC-system was equilibrated in isocratic conditions (2% of B) 
for 20 min. Two different wavelengths (190 nm and 254 nm) were used to monitor 
elution. In Scenario I, eluted fractions after the last nucleoside peak (dA) were collected. 
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In Scenario II, fraction collection started at 10 min and ended at 60 min of the program, 
and only fractions between nucleoside peaks were collected. Collected fractions from 
one sample were combined, dried in a SpeedVac concentrator, and stored at -20 °C until 
LC/MS3 adductomic analysis. Two isotopic standards, 15N-N6-Me-dA and 15N-N2-Et-
dG, were added during DNA digestion and sample concentration for the purpose of 
quality control. For DNA from direct NMC exposure, two additional isotopic standards, 
D4-POB-dT and D4-POB-dG were also used.28 
 
6.2.13 LC/MS3 adductomic analysis  
The dried DNA samples were reconstituted in 20 µL of LC-MS water (LCMS grade, 
Fluka) and then analyzed with a NanoUPLC system (Ultimate 3000, Thermo Scientific, 
Waltham, MA) coupled to an Orbitrap mass detector (Fusion-Thermo Scientific, 
Waltham, MA). The UPLC system operated with a 5-µL loop. The chromatographic 
separation was performed with an RP-column created by hand packing a commercially 
available fused-silica emitter (230x0.075mm, 15 µm orifice, New Objective, Woburn 
MA) with C18 stationary phase (5 µm, 100Ǻ, Luna-Phenomenex, Torrace, CA). The 
mobile phase consists of formic acid (0.05 %v/v in H2O, phase-A) and acetonitrile 
(100%v/v, phase-B). The elution program involved an isocratic step (2 % of B for 5 
min at 1µL·min-1), followed by a linear gradient of B (1.5 %·min-1 for 25 min at 0.3 
µL·min-1), and it concluded with a washing isocratic step, performed at 98% of B for 5 
min at 0.3µL·min-1. At the end of the elution program, the LC-system was equilibrated 
for 5 min in isocratic conditions (2% of B, 1 µL·min-1). In the course of the LC run, the 
injection valve switched at 6 min, excluding the sample loop from hydraulic path. This 
operation allowed performance of several washes of the injection system, avoiding 
carryover and preventing memory effects. The LC system was interfaced to the MS-
detector using a Nanoflex ESI ion source (Nanoflex Thermo Scientific, Waltham, MA). 
The source operated in positive ion mode at RT conditions. The electrospray voltage 
was set at 2.5 kV and the temperature of the ion tube was set up at 350 °C. The overall 
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ion optics were optimized monitoring the background signal 371.1012 m/z 
(oligosilorxane, [C2H6SiO]5). 
 
The MS-analyses consist of three detection events: full scan, untargeted data dependent 
MS2-acquisition (dd-MS2) and a neutral loss MS3-data acquisition (NL-MS3). The full 
scan (100-1000 m/z) was performed using the front quadrupole to fill up the C-Trap, 
which worked with a maximum injection time of 50 ms and automatic gain control 
(AGC) of 5.104. The MS-spectra were acquired by the Orbitrap at resolution of 60000 
(ref. 400 m/z). The five most abundant ions detected during each full scan event were 
picked to trigger the dd-MS2 fragmentation events. The mass tolerance required to 
trigger the MS2 data acquisition was set at 5 ppm. A dynamic exclusion of 20s, and an 
intensity threshold of 104 counts were introduced to better manage the instrumental 
dwell time. In the course of the dd-MS2 acquisitions, the front quadrupole was used to 
isolate each individual top 5 precursor ions (isolation width ± 1.5 m/z). The 
fragmentations were performed in the high-pressure stage of the linear ion trap (LIT), 
which operated with a normalized collision energy of 30 % CID and an activation time 
of 10 ms. In order to measure the accurate mass of the fragment ions, the MS2 spectra 
were recorded with the Orbitrap detector, which operated with a resolution of 15000 
(ref. 400 m/z) and a max injection time of 200 ms. During the course of the NL-MS3 
data acquisitions, the ion trap was used to isolate the three most abundant MS2-fragment 
ions (isolation width of ±3.0 m/z), which gave the neutral loss signal comparable to the 
release of the deoxyribose moiety (-dR; 116.0474 ± 0.0006 m/z, 5ppm). The MS3-
fragmentations were performed with the ion routing multipole, which operated with a 
normalized collision energy of 50% HCD. The MS3-spectra were recorded with the 
Orbitrap, which performed a single microscan with a resolution of 15000 (ref. 400 m/z) 
and operated with injection time of 300 ms.  
 
6.2.14 Adductomic data analysis 
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Data on putative DNA adducts were extracted from spectra acquired from LC/MS3 
using Xcalibur Qual Browser. Generally, three levels of evidence were acquired to 
confirm a putative DNA adduct: the m/z values of precursor ([M+H]+) in full scan, 
fragment after neutral loss in the precursor ion ([MH-dR]+) in MS2, and other detected 
fragments in MS3 that are signatures for the fragment detected in MS2, and ideally the 
retention time should make sense as well considering the polarity of the putative DNA 
adducts. For semi-quantification of a putative DNA adduct in a specific sample, the ion 
count intensity of the m/z of interest in full scan with a mass range of 5 ppm was used, 
and the intensity was further normalized using the amount of dG determined in that 
specific sample. In analysis of adductomic data from single replicate (DNA directly 
exposed to NMC), all three levels of evidence from tandem mass spectrometry were 
applied to determine the existence of putative DNA adducts. To analyze data acquired 
from triplicates (DNA extracted from exposed bacterial cells), putative DNA adducts 
confirmed by three levels of MS (full scan/MS2/MS3) were first summarized. If a 
putative adduct appeared in more than two of the three replicates in either control or 
exposed groups, new searches on signature fragments in MS2 of the rest of replicates 
that did not show MS3 spectra were further done to support the confirmation of that 
putative adduct. If signature fragments were found in MS2, the putative DNA adduct 
was regarded as confirmed; if not, the data point was regarded as “not found” and not 
included in calculating the average for triplicates. In plotting triplicate data, individual 
data points plus average were plotted versus both retention time (min) and the m/z 
values of precursor ions. 
 
6.3 Results and discussion 
 
6.3.1 NMC induced ROS generation abiotically 
Intracellular ROS detection with 2',7'-dichlorodihydrofluorescein diacetate (DCFH2-
DA, also known as 2 ′ ,7 ′-dichlorofluorescin diacetate) is widely applied. The two 
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acetate groups, which makes the molecule cell-permeant, are expected to be hydrolyzed 
by esterase in cell plasma. The resultant 2',7'-dichlorodihydrofluorescein (DCFH2) is 
non-fluorescent until being oxidized by various ROS when it is converted into highly 
fluorescent 2',7'-dichlorofluorescein (DCF).46 This reaction is depicted in Figure 6.1(a). 
Ideally, the reactions should only happen in cell plasma. However, it has been shown 
that this reaction can happen spontaneously in aqueous solution;47,48 in fact, the probe 
was initially developed to measure H2O2 in cell-free systems.47 Figure 6.1(b) describes 
ROS generation in MM with lactate without the presence of cells. Compared to H2O2-
treated DCFH2-DA in solution, NMC-treated samples showed relatively slow but 
steady increase in fluorescence intensity, indicating formation of the fluorescent 
product DCF. We suspect that the continuous oxidation of DCFH2 with H2O2/NMC 
treatment kept moving the reaction equilibrium to the right side, forming more reactive 
DCFH2 and thus more DCF over time. It is worth noting that the shapes of fluorescence 
intensity increase for H2O2 and NMC were quite different. This might indicate that, 
different from direct oxidation of DCFH2 by H2O2, NMC induced oxidation in an 
indirect manner, possibly through generation of ROS via reactions between aqueous 
media and NMC surfaces or released metal ions.5 
 
 
Figure 6. 1 (a) Reaction for DCFH2-DA hydrolysis and oxidation into fluorescent DCF 
product. (b) Fluorescence intensity over time for 20 µM DCFH2-DA in MM with lactate 
upon adding different reagents; for clarity, only average values were plotted (n=3). (c) 
Fluorescence intensity of DCFH2-DA-loaded bacterial cells after incubating with NMC 
(positive controls were not shown); each data point represents an average value from 
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an individual experiment. No statistical significance was determined (one-way ANOVA, 
post-hoc Dunnett’s multiple comparison, α=0.05; H2O2 positive controls were not 
included in the statistical tests)  
 
 
Using the same dye, DCFH2-DA, intracellular ROS generation induced by treatment 
with NMC was measured. Since the dye can react with ROS without cells, extensive 
washing was implemented to exclude fluorescence signals outside cells. As described 
in the Experimental section, bacterial cells were loaded with DCFH2-DA prior to 
exposure to capture the generation of transient ROS during exposure. Positive control 
groups treated with H2O2 showed increased fluorescence, indicating that the dye was 
successfully taken up into cells (data not shown). It is worth mentioning that among all 
experimental trials, not all trials showed successful dye loading, and thus only trials in 
which positive control groups showed significant increase in fluorescence were used 
for plotting and statistical tests (Figure 6.1(c)).  While exposure to 5 mg/L 72-hour 
aged NMC for a short time (15-min) did not show response in ROS generation, NMC 
exposure to 50 mg/L or greater doses appeared to increase the average fluorescence 
intensity compared to control groups in a dose-dependent manner (Figure 6.1(c)). 
However, the increase was not statistically significant, which might be attributed to the 
short-term exposure (15-min). Thus, it is not conclusive from the DCFH2-DA test 
whether NMC caused oxidative stress in bacterial cells.  Overall, ROS detection using 
DCFH2-DA clearly showed NMC-generated ROS in bacterial media, but not 
necessarily increase the level of intracellular ROS in bacterial cells.  
 
6.3.2 Intracellular Ni/Co ions were detected upon exposure 
Newport Green DCF diacetate (NPG-Ac) is a cell permeable, Zn2+- (but not Ca2+-) 
sensitive probe, making it ideal to monitor Zn2+ influx into neurons.49 Similar to 
DCFH2-DA, upon entering cells, the diacetate groups on NPG-Ac are cleaved by 
cellular esterases, and binding of metal ions with the cleaved dye turns on fluorescence 
that can be detected. Besides Zn2+, the Newport Green dye was also found to respond 
152 
 
to transition metal ions, including Cu(I), Ni(II), Cd(II), Co(II), and Fe(II) but not Mn(II) 
or Fe(III).50 This makes NPG-Ac an excellent choice to monitor metal ion uptake 
induced by NMC, whose toxicity to S. oneidensis was identified as attributable to the 
release of nickel and cobalt, but not manganese, ions.5 In fact, the NPG-Ac dye has 
been used previously to detect transition metal ion uptake in neurons.51  
 
To validate the assay, we first exposed bacterial cells pre-loaded with dye with gradients 
of aqueous Ni(II) or Co(II) (Figure 6.2(a)). The NPG dye showed dose-dependent 
fluorescence response to the exposure to both metal ions, and at the same concentrations, 
Ni(II) ions induced higher response than Co(II) ions. The higher sensitivity towards 
Ni(II) could be due to the higher sensitivity of the NPG dye when responding to Ni(II) 
abiotically,50 potentially differential uptake of the two ions into bacterial cells, or a 
mixed effect. We then followed the same protocol to load dye and expose to a gradient 
of concentrations of nanoscale NMC. As expected, results showed an NMC dose-
dependent fluorescence response, indicating uptake of Ni(II) and/or Co(II) ions (Figure 
6.2(b)). It should be noted that the NPG-Ac dye is not able to differentiate between 
Ni(II) and Co(II) ions, but only a mixed effect; neither is it quantitative. ICP-MS is a 
technique capable of quantitatively determining a mixture of ions, but we did not 
choose this technique because ICP-MS cannot differentiate among metals inside or 
outside cells because it is almost impossible to separate cells from NMC materials. 
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Figure 6. 2 Fluorescence intensity of NPG-Ac-loaded bacterial cells after incubating 
with different concentrations of (a) Ni/Co ions or (b) NMC. In (a), standard deviation 
was plotted from the triplicates in one experimental run. In (b), each data point 
represents an average value of the triplicates in an individual experimental run, and the 
average of multiple experiments is shown. Stars denote statistical significance (one-
way ANOVA, post-hoc Dunnett’s multiple comparison, α=0.05).  
 
6.3.3 NMC exposure caused dose-dependent growth inhibition 
We started nanoscale NMC exposure at the mid-log phase of bacterial growth instead 
of at the beginning as bacterial cells actively replicate during exponential growth; thus, 
the impact on DNA during log phase would have a high possibility to lead to detrimental 
consequences. After spiking NMC into bacterial suspension, a dose-dependent growth 
inhibition was observed (Figure 6.3(a)(b)). A growth-based viability assay was coupled 
at different time points post-exposure to complement optical density measurements, as 
optical density detects intact cells but cannot differentiate viable from non-viable cells 
(Figure 6.3(c)). After 1-hour exposure, both normalized optical density and bacterial 
viability showed no effect from NMC exposure. However, 8 hours post-exposure, dose-
dependent effects were observed for both bacterial growth and viability, indicating 
NMC toxicity developed over time. Interestingly, while the optical density at 8-hour 50 
mg/L post-exposure indicated about half the number of cells present compared to the 
control, the viability test showed only about 10% of viable cell numbers compared to 
control. The discrepancy showed that not all cells present at 8-hour 50 mg/L post-
exposure were viable, and, as detailed in Chapter 1, it is important to have two 
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measurements to complement each other to reveal toxicity. 
 
 
Figure 6. 3 (a) Dosing NMC at mid-log phase of bacterial growth, showing normalized 
optical density over time before and after adding NMC. For clarity, individual data 
points and errors of triplicates are not shown. (b) A magnification of the exposure 
window. (c) Viability of bacterial populations compared to control at different time 
points post-exposure. Standard deviations are shown in (b) and (c) (n=3). 
 
 
6.3.4 NMC exposure induced DNA double-strand breakage but no change in 
adduct formation 
From the growth inhibition and viability assay, 5 mg/L was determined to be a sub-
lethal dosage used for DNA damage assays, and the exposure for the DNA damage 
assay was done following the same procedure outlined for the aforementioned toxicity 
assays. DNA strand breakage was measured using the Comet assay, a single-cell 
electrophoresis technique that has been used to assess nanoparticle genotoxicity.52 For 
the Comet assay on mammalian cells, the shape of stained DNA molecules looks like a 
comet, giving the assay its name. Different from mammalian cells, during 
electrophoresis, bacterial DNA molecules will migrate and stretch, forming “tails” 
instead of “comets”, and the tail lengths of these stretched DNA molecules represent 
the extend of DNA strand breakage.27 Representative images of undamaged (Figure 
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6.4(a)) and damaged bacterial DNA (Figure 6.4(b)(c)) upon NMC exposure are shown. 
To quantify DNA strand breakage, the lengths of migrated or stretched DNA molecules 
upon electrophoresis were measured, and the average tail length of NMC-treated groups 
was compared to that of control groups. Figure 6.4(d) shows that, compared to control 
groups, longer DNA tails were observed in bacterial cells exposed to both 5 and 50 
mg/L NMC for 8 hours, indicating DNA strand breakage. Interestingly, there was no 
significant difference between tail length for 5 and 50 mg/L NMC-exposed cells. 
 
 
Figure 6. 4 Representative images from the Comet assay of bacterial cells exposed to 
(a) negative control, (b) 5 mg/L NMC, or (c) 50 mg/L NMC for 8 hours. DNA tail 
lengths counted from images were combined and compared in (d), showing statistically 
significant increases (p<0.0001) in DNA tail length upon NMC exposure. 
 
DNA adducts refer to chemical modifications of DNA molecules, formed via redox 
reaction or fusion of molecular species. DNA adduct formation is informative of DNA 
damage mechanisms, and specific DNA adducts have been used as biomarkers in 
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molecular epidemiology and cancer studies.30 We used a high-resolution mass 
spectrometry-based DNA adductomics approach to measure the formation of DNA 
adducts in bacteria. For the targeted approach, a list of endogenous DNA adducts was 
used in mass spectrometry screening. For untargeted screening, all ions resulting from 
a neutral loss of deoxyribose were further fragmented and recorded. To validate the 
method and detect potentially maximized effects on DNA upon NMC exposure, direct 
exposure of extracted DNA to NMC was performed. Figure 6.5 shows normalized 
intensity of each putative DNA adduct detected in DNA directly exposed to NMC 
versus the m/z values of precursor ions, while precursor ions detected with the same 
m/z but different retention times were plotted together. The targeted approach with an 
inclusion list showed detection of multiple putative adducts in one run. Three out of 
four isotopic standards were confirmed. High levels of N6-Me-dA were shown in both 
control and exposed samples, consistent with previous literature on bacterial DNA 
methylation.53 Generally, we determined that this adductomics approach worked on 
bacterial DNA. No notable changes were observed between control and exposed 
bacterial DNA, indicating that direct exposure of NMC, even for a long period of 48 
hours at a high concentration of 50 mg/L, did not elicit changes in DNA adduct 
formation. This is contradictory to the earlier observation that NMC will cause 
oxidative stress via generation of ROS. As only fractions after the eluted dA peak were 
collected, it was possible that we did not fully collect oxidative stress-related DNA 
adducts, as they are likely to be more hydrophilic than dA and thus eluted earlier than 
the dA peak.  
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Figure 6. 5 Putative DNA adducts identified using LC/MS3 adductomics in bacterial 
DNA directly exposed to nanoscale NMC. Green dots are internal standards detected. 
Red solid dots refer to putative adducts detected in NMC-exposed DNA and black 
hollow dots indicates adducts in unexposed DNA. One replicate was used in the direct 
exposure. 
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Figure 6. 6 Putative DNA adducts identified using LC/MS3 adductomics in DNA 
extracted from NMC-exposed bacterial cells. Retention times are indicated on the x-
axis, and the m/z and names of putative DNA adducts are marked at x-axis as well. Red 
solid dots refer to putative adducts detected in DNA samples extracted from NMC-
exposed bacteria, and black hollow dots show adducts from DNA extracted from 
unexposed bacteria. The exposure was done in triplicate, and the average of the 
triplicates are shown in red (exposed) and black (control) lines. 
 
We then exposed NMC to bacterial cells at mid-log phase and harvested cells before 
they fully entered stationary phase. A “sub-lethal” concentration, 5 mg/L, that showed 
neither inhibition of bacterial growth nor decreased viability was chosen as we 
preferred to avoid collecting DNA from dead cells, plus the fact that DNA strand 
breakage was already shown in the Comet assay at this concentration. We also collected 
all fractions in between peaks of the four 2’-deoxyribonucleosides (dC, dG, dT, dA) so 
that hydrophilic adducts could be collected as well. Shown in Figure 6.6, again, no 
significant changes were observed in levels of various DNA adducts upon NMC 
exposure, including oxidative stress-related ones. Adding together, the results from two 
different DNA adductomic experiments showed that DNA adduct formation was not 
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likely to be the mechanism contributing to DNA strand breakage observed in the Comet 
assay. To further explore potential DNA damage mechanisms that might lead to strand 
breakage, such as inhibition of DNA repair and disruption of transcription,54 gene 
expression level changes on DNA repair-related proteins will be studied. 
 
6.4 Conclusion 
The potential wide application of nanoscale lithium nickel manganese cobalt oxide 
(LixNiyMnzCo1-y-zO2, NMC) as a cathode material in lithium-ion batteries calls for 
evaluation of its risk when being released into the environment. Previous studies 
showed that NMC induced inhibition of bacterial growth of an ecologically beneficial 
bacterium, Shewanella oneidensis MR-1, via dissolution of nickel and cobalt ions. 
Considering the genotoxic effects of nickel and cobalt, we evaluated bacterial DNA 
damage upon NMC exposure as a potential toxicity mechanism. We found DNA strand 
breakage via the Comet assay, and successfully applied, for the first time, a high-
resolution mass spectrometry-based DNA adductomics approach to study bacterial 
DNA adducts upon NP exposure. Results showed that sub-lethal concentrations of 
NMC exposure induced DNA strand breakage, but no significant changes were 
observed in levels of various DNA adducts. Combined with evidence that clearly 
indicated Ni/Co metal ion uptake but less evidently inferred oxidative stress, we 
concluded DNA damage as a toxicity mechanism of NMC exposure to bacterial cells 
possibly via transition metal ion uptake and potentially ROS. 
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Chapter 7 
Conclusion and outlook 
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7.1 Conclusion and outlook 
 
Decades ago, DDT, a famous pesticide that was later found to be a persistent toxic 
pollutant, harmed our environment because of its extensive use without careful 
evaluation of its potential ecological risk. As materials with novel properties and 
activities, nanoscale materials and nano-enabled products have been under explosive 
development in the past decades, and thus, their environmental risks need to be 
proactively evaluated before wide application. Compared to performing toxicity assays 
on every nanomaterial that is being produced, a predictive model that links 
nanomaterial properties to the outcome of biological exposure can guide safer 
nanoparticle design in a more efficient manner. This thesis contributed to the 
establishment of predictive models by developing high-throughput toxicity screening 
assays that can avoid nanomaterial interference and investigating biological response 
on molecular levels, including biochemical processes, gene expression and DNA 
damage, upon various nanomaterial exposure using an ecologically relevant bacterial 
model, Shewanella oneidensis MR-1. Combining thorough NP characterization and 
biological measurement, we concluded that the response of bacterial cells on the 
molecular level can be dominated by surface modification (surface charge), 
environmental conditions such as surrounding medium and light, purification strategy, 
ion release, and the intrinsic properties of NP core composition. Analytical techniques 
from simple optical assays (fluorescence/colorimetric/absorbance) to complex -omics 
measurements were combined to obtain a comprehensive understanding of nanotoxicity 
at the molecular level. 
 
Looking forward, we believe that the field of nanotoxicology is entering a new era. 
Cutting-edge bioanalytical techniques, such as sub-diffraction microscopy and -omics, 
are being used to reveal unprecedent details about nanoparticle characterization, nano-
bio interactions, and biological responses, and more analytical assays are being adapted 
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and developed to overcome NP interference and improve toxicity assessment. Studies 
are more focused on molecular mechanisms underlying nanotoxicity instead of 
conventional toxicity endpoint assays to understand the causal relationship among NP 
properties, surrounding environment, and the biological organism of interest. 
Interdisciplinary collaboration among materials scientists, chemists, biologists, 
computational and theoretical scientists, and bioinformatic scientists will keep paving 
the way to a comprehensive picture of nano-bio interactions and the establishment of 
predictive models among NP properties, biological consequences, and environmental 
implications. In this thesis, we also provided our perspectives as analytical chemists on 
the challenges in the field of nanotoxicology for the next decade. We look forward to 
the next decade of nanotoxicology and believe that this thesis has contributed to solving 
the grand challenge of understanding nano-bio interactions. 
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Appendices 
 
A.1  Chapter 2 Supporting Information 
 
A.1.1 TiO2 nanoparticle synthesis and characterization 
TiO2 nanoparticles were synthesized using a sol-gel method developed by Isley and 
Penn (Isley, S. L.; Penn, R. L. J Phys Chem C 2008, 112, 4469-4474). In an ice bath, 
75 mL of isopropyl alcohol (Fisher, HPLC Grade) and 7.5 mL of titanium isopropoxide 
(Ti-Iso, Aldrich) were added to a 250 mL round bottom flask with stirring. The reaction 
was then chilled for 30 minutes. A nitric acid solution of pH -0.34 was prepared with 
3.790 mL of Milli-Q water and 0.630 mL of 68.0~70.0% nitric acid (BDH, ARISTAR). 
The acid solution was added dropwise to the isopropyl alcohol/Ti-Iso solution with 
continuous stirring. After adding all the acid, the reaction vessel was brought to room 
temperature and then heated to boiling, followed by a 24-hour reflux in an oil bath at 
85-90 °C. 
 
The resulting solution was then transferred to a Fisherbrand regenerated cellulose 
dialysis membrane with a molecular weight cut-off of 12,000-14,000 Da for a ten-day 
dialysis in Milli-Q water to remove small-molecule reaction by-products and leftover 
nitric acid. Over ten days, the water was changed at least 15 times. After dialysis, 8 mL 
of nanoparticle suspension and 15 mL of Milli-Q water were mixed and loaded into the 
Teflon chamber of a Parr Instrument autoclave bomb for hydrothermal aging. The 
suspension was aged in an oven at 200°C for 48 hours and then taken out to cool down 
to room temperature. A nanoparticle powder was obtained after all the water in the 
suspension was evaporated. A pre-weighed amount was suspended in, and then 
sonicated at room temperature for 3.5 hours to obtain a TiO2 nanoparticle suspension 
stock with a concentration of 5 mg/mL. 
 
A.1.2 Actinometry of UV illumination 
The UV lamp used in all UV exposure experiments was a 150 W 10,000 K AqualiteTM 
metal halide lamp from Ushino America, Inc. It has a broad emission spectrum 
simulating the appearance of sunlight near the equator in ocean depths of approximately 
5 meters. A potassium ferrioxalate actinometer was applied to monitor the photon flux 
of the UV lamp. The procedure was adapted from the IUPAC Technical Report (Kuhn, 
H. J.; Braslavsky, S. E.; Schmidt, R. Pure Appl Chem 2004, 76, 2105-2146). 
K3[Fe(C2O4)3]  ∙3H2O crystals were firstly synthesized in house. 180 mL of 1.5 M 
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K2C2O4 solution and 60 mL of 1.5 M FeCl3 solution were mixed together, and crystals 
were recrystallized three times from the mixture with warm water, dried at 45 °C and 
kept in the dark. The resultant crystals were green in color. A 0.1% 1, 10-phenanthroline 
solution (stored in the dark) was prepared along with a 100 mL acidic buffer containing 
8.2 g CH3COONa and 1 mL concentrated H2SO4. 2.947 grams of K3[Fe(C2O4)3] ∙3H2O 
crystals were dissolved in 100 mL of 0.5 M H2SO4 and diluted to 1 L to create a 0.006 
M solution. The absorption spectrum of the solution from 300 to 900 nm was obtained 
using a DH-2000 Mikropack spectrometer with deuterium and halogen light source. 3 
mL (𝑉1) of the solution was irradiated by the UV lamp for about 6 minutes (𝑡) under 
sufficient stirring. 4 mL of the 0.1% 1, 10-phenanthroline solution and 0.5 mL of the 
acidic buffer were mixed in a 10 mL (𝑉3) volumetric flask, followed by the addition of 
1 mL (𝑉2) of the irradiated solution. This procedure was repeated for the dark reference, 
the same solution without irradiation. After diluting the solution to 10 mL (𝑉3), the 
mixture was incubated in the dark for one hour until full color development was 
achieved, and the absorbance spectra of both the dark reference and the irradiated 
samples were measured. This experiment was done in triplicate with all steps performed 
under dark red light. All water used in this procedure refers to DI water. 
Photon flux (𝐼) was calculated using the equations below: 
𝐼 =
∆𝑛
10−3 ∙ Φ ∙ 𝑉1 ∙ 𝑡
 
∆𝑛 =
10−3 ∙ 𝑉1 ∙ 𝑉3 ∙ 𝐶𝑡
𝑉2
 
𝐶𝑡 =
𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒(510 𝑛𝑚)
𝜀(510 𝑛𝑚) ∙ 𝑙
 
Φ: quantum yield was chosen to be 1.16 as our lamp centers at 380-405 nm according 
to the product specification; t: irradiation time, 360 seconds; 𝑙: length of the cuvette, 1 
cm; 𝜀(510 𝑛𝑚): 11100 𝑑𝑚3 ∙ 𝑚𝑜𝑙−1 ∙ 𝑐𝑚−1. The average solution absorbance at 510 
nm was applied in this calculation; 𝐶𝑡: concentration of ferrous iron after dilution in 
molarity (𝑚𝑜𝑙 ∙ 𝑑𝑚−3); ∆𝑛: ferrous ion photo-generated in moles (𝑚𝑜𝑙). 
 
The final intensity  𝐼  was calculated to be 2.54 × 10−6 𝐸𝑖𝑛𝑠𝑡𝑒𝑖𝑛 ∙ 𝐿−1 ∙ 𝑠−1 . 
Considering the irradiated volume to be 3 mL and the wavelength as 400 nm, the energy 
of photon flux was calculated to be 0.23 𝐽 ∙ 𝑠−1. The solar irradiation on earth surface 
is approximately 1.4 𝑊/𝑚2 . Assuming the irradiation area to be 1 𝑐𝑚2 
(approximately the irradiated area of the test tubes in this study), the solar energy is 
estimated to be 0.00014 𝐽 ∙ 𝑠−1. Thus, our irradiation intensity in this experiment is 
much higher than the average solar energy. 
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A.1.3 Hyperspectral imaging of TiO2 NP-exposed bacterial cells 
Hyperspectral microscopy instrumentation from CytoViva, Inc. provides dark field 
hyperspectral imaging capability, which can provide full spectra from every pixel in a 
2D image, enabling comparison of spectral differences across pixels within a field of 
view with a spectral resolution of 2 nm. Nanoparticles can be identified via their unique 
spectral response based on the materials that they are composed of, as different 
materials have different spectral characteristics. This technique does not require any 
staining or tagging. 
 
TiO2 nanoparticles were re-suspended in LB medium to reach a final concentration of 
100 mg/L. Bacterial suspensions were grown overnight to stationary phase and diluted 
10-fold into the TiO2 NP suspension of LB broth. After sufficient mixing, about 3 µL 
of either the TiO2 suspension in LB broth or the TiO2 NP-exposed bacterial suspension 
were dropped onto a glass slide, covered with cover slips, and sealed using nail 
polishing to avoid water evaporation. These samples were then brought to the 
hyperspectral microscope. A library of TiO2 NP spectra was created as a reference. 
Then, hyperspectral images of bacteria with added TiO2 suspension was created as 
shown in Figure S2(a), wherein each pixel was compared with the TiO2 NP spectra 
library with a certain threshold. Pixels that had high similarity with the reference 
spectrum were highlighted as shown in Figure S2(b). The large aggregate has a good 
spectral match to known TiO2 NP aggregates, while bacterial cells only attached to the 
edge of the huge aggregate. 
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Figure A.1.1. TEM images of TiO2 nanoparticles in (a) Milli-Q water and (b) LB broth. 
(c) The hydrodynamic diameters of nanoparticles are stable with time. Error bars show 
the standard deviation of material replicates (n=3). (d) Multimodal size distribution of 
TiO2 nanoparticles in Milli-Q water and LB broth shows that a portion of TiO2 
nanoparticles aggregate in LB broth. 
 
 
Figure A.1.2. TiO2 NPs aggregate in LB broth and bacterial cells attach to the edge of 
the TiO2 aggregate. (a) Dark field image of TiO2 NP-exposed cells in LB broth (full 
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hyperspectral spectrum available but not shown for each pixel); (b) Highlighted area 
indicating pixels with high spectral similarity to the reference TiO2 NP spectrum. 
 
 
Figure A.1.3. Riboflavin levels upon 100 mg/L TiO2 NP and/or UV light exposure with 
the presence of antioxidant (a) N-acetylcysteine (NAC) for 1 hour or (b) glutathione 
(GSH) for 6 hours. Adding antioxidant did not recover the riboflavin levels influenced 
by UV illumination. Different letter designations denote statistically significant 
differences between groups (one-way ANOVA followed by a post-hoc Tukey’s test, 
p<0.05). 
 
A.2  Chapter 3 Supporting Information 
 
A.2.1 Ligand control estimation: PAH-AuNPs 
Ahead of organism exposure, PAH-AuNPs were purified by centrifugation, making it 
possible for PAH free ligand to be left over in the PAH-AuNP suspension. To estimate 
the presence of free PAH ligand in the nanoparticle suspension, a fluorescence 
quantification method was used to determine primary amine content (Bantan-Polak, T.; 
Kassai, M.; Grant, K. B. Anal Biochem 2001, 297, 128-136). 
 
In this procedure, 0.01 g fluorescamine (Sigma-Aldrich) was dissolved in 10 mL 
acetonitrile to reach a concentration of 0.1% (w/v). 0.05 M sodium borate buffer was 
prepared by dissolving 5.03 g Na2B4O7 in 500 mL MilliQ water followed by the 
adjustment of pH to approximately 8 using 12 M HCl. PAH-AuNP suspension was 
188 
 
centrifuged at 66,000 g for 45 minutes at 4 °C to pellet all AuNPs, and the clear 
supernatant was removed from the centrifugation tubes. 120 L samples were mixed with 
20 µL of borate buffer on a 96-well plate, and 60 µL of fluorescamine solution was 
lastly added to the mixture. The reaction was incubated at room temperature for 5 
minutes, and the fluorescence intensity was measured by plate reader with Eex/Eem = 
425 nm/480 nm. A calibration curve using a series of PAH solutions of known 
concentrations was created every time before sample measurement, and the 
concentration of PAH in samples were calculated based the fitting results from linear 
regression. 
 
The amount of PAH free ligand in 30 µg/L PAH-AuNP suspension was determined to 
be 210 (192 to 228) µg/L. In addition, the amount of PAH ligand on NP surface was 
estimated to be 2.7 µg/L (PAH charge density on AuNP surface: 12.8 charge/nm2 
determined by XPS2), based on the same calculation as below for MPA-AuNPs. Thus, 
a 10-fold PAH free ligand control (300 µg/L PAH free ligand in the case of 30 µg/L 
PAH-AuNPs) was chosen in this study to represent the effect of PAH free ligand in 
PAH-AuNP suspension.  
 
A.2.2 Ligand control estimation: MPA-AuNPs 
Excessive MPA free ligand from synthesis were expected to be eliminated by 
diafiltration, and the total MPA ligand present in MPA-AuNP suspension was estimated 
to be the amount of MPA ligand attached to NP surface. The surface charge density of 
MPA-AuNPs was determined to be 5.6 𝑐ℎ𝑎𝑟𝑔𝑒 ∙ 𝑛𝑚−2  by XPS (Torelli, M. D.; 
Putans, R. A.; Tan, Y.; Lohse, S. E.; Murphy, C. J.; Hamers, R. J. Acs Appl Mater Inter 
2015, 7, 1720-1725). 
 
Calculating number of AuNPs per liter: 
𝐴𝑢𝑁𝑃 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟 ~ 4 𝑛𝑚 
𝑉𝑜𝑙𝑢𝑚𝑒 𝑝𝑒𝑟 𝐴𝑢𝑁𝑃 =
4
3
𝜋(
𝐴𝑢𝑁𝑃 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟
2
)3 = 33.5 𝑛𝑚3 = 3.35 × 10−20 𝑐𝑚3 
𝑀𝑎𝑠𝑠 𝑝𝑒𝑟 𝐴𝑢𝑁𝑃 = 𝐷𝑒𝑛𝑠𝑖𝑡𝑦 × 𝑉𝑜𝑙𝑢𝑚𝑒 𝑝𝑒𝑟𝐴𝑢𝑁𝑃
= 19.3 𝑔 ∙ 𝑐𝑚−3 × 3.35 × 10−20 𝑐𝑚3 = 6.47 × 10−19 𝑔 
𝑁𝑀𝑃𝐴−𝐴𝑢𝑁𝑃𝑠 = 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑀𝑃𝐴 − 𝐴𝑢𝑁𝑃𝑠 𝑝𝑒𝑟 𝑙𝑖𝑡𝑒𝑟 =
5 𝑚𝑔 ∙ 𝐿−1
6.47 × 10−19 𝑔
= 7.73 × 1015 𝐿−1 
Calculating the mass of total amount of surface ligand: 
𝐿𝑖𝑔𝑎𝑛𝑑 𝑎𝑚𝑜𝑢𝑛𝑡 𝑝𝑒𝑟 𝐴𝑢𝑁𝑃 = 𝐶ℎ𝑎𝑟𝑔𝑒 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 × 𝑆𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎 
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𝑀𝐿𝑖𝑔𝑎𝑛𝑑 = 𝑇𝑜𝑡𝑎𝑙 𝑙𝑖𝑔𝑎𝑛𝑑 𝑚𝑎𝑠𝑠 𝑜𝑛 𝑁𝑃𝑠
=
𝑁𝐴𝑢𝑁𝑃𝑠 × 𝐿𝑖𝑔𝑎𝑛𝑑 𝑎𝑚𝑜𝑢𝑛𝑡 𝑝𝑒𝑟 𝐴𝑢𝑁𝑃
𝐴𝑣𝑜𝑔𝑎𝑑𝑟𝑜 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡
× 𝑀𝑊𝐿𝑖𝑔𝑎𝑛𝑑 𝑈𝑛𝑖𝑡 
𝑀𝑃𝐴 𝑙𝑖𝑔𝑎𝑛𝑑 𝑝𝑒𝑟 𝐴𝑢𝑁𝑃 = 5.6 𝑐ℎ𝑎𝑟𝑔𝑒 ∙ 𝑛𝑚−2 × 4𝜋 (
4 𝑛𝑚
2
)
2
= 2.8 × 102 
𝑀𝑀𝑃𝐴 𝑙𝑖𝑔𝑎𝑛𝑑 =
2.8 × 102 × (7.73 × 1015 𝐿−1)
6.02 × 1023 𝑚𝑜𝑙−1
× 106.14 𝑔 ∙ 𝑚𝑜𝑙−1 = 0.38 𝑚𝑔 ∙ 𝐿−1
< 5 𝑚𝑔 ∙ 𝐿−1 
Based on the calculation above, the equivalent mass concentration of MPA ligand was 
an excessive estimation of the actual MPA ligand present in the suspension. 
 
A.2.3 Bacterial doubling time estimation 
A rough estimation of S. oneidensis doubling time in the growth medium used in this 
study was calculated as below. Assuming that cell oxygen uptake (M) is proportional to 
the cell number (N), at exponential growth phase: 
𝑀 = 𝑀0 × 2
𝑘𝑡 (1) 
𝑁 = 𝑁0 × 2
𝑘𝑡   (2) 
k: growth rate at exponential phase (hour-1); t: time (hour); T=1/k: doubling time (hour); 
N: cell number; N0: original cell number; M: cell oxygen uptake; M0: original cell 
oxygen uptake. Take first derivative of equation (2): 
𝑁𝑡
′ = 𝑁0 × (𝑘𝑙𝑛2) × 2
𝑘𝑡 (3) 
The first derivative was calculated in GraphPad, Prism. Two different time points from 
exponential phase, t1 and t2, and the first derivative at these two time points were 
substituted into equation (3) to get the ratio: 
𝑁𝑡1
′
𝑁𝑡2
′ = 2
𝑘(𝑡1−𝑡2)  (4) 
The growth rate at exponential phase (k) was calculated from equation (4) followed by 
the calculation of doubling time (T): 
𝑇 =
1
𝑘
 
Plugging values from different traces in various experimental runs yielded bacterial 
doubling times between 2-3 hours. 
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Figure A.2.1. TEM image of (a) PAH-AuNPs and (b) MPA-AuNPs before exposure to 
either organism. 
 
 
Figure A.2.2. Inhibition on oxygen uptake of S. oneidensis upon MPA-AuNP and the 
respective ligand exposure. Error bars showed standard error of the mean (n=2). Stars 
indicate significant difference between treated and control groups (unpaired t-test, p < 
0.05). 
 
A.3  Chapter 4 Supporting Information 
 
A.3.1 Materials 
All materials were used as received, unless otherwise indicated. Gold tetrachloroaurate 
trihydrate (HAuCl4•3H2O), sodium borohydride (NaBH4), and trisodium citrate were 
(a) (b) 
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obtained from Sigma Aldrich. Nanoparticle reactions were performed in new 
polyethylene centrifuge tubes, new glass vials, or glassware cleaned with aqua regia 
(Caution! extremely corrosive, explosion hazard, handle with extreme caution). All 
water used for NP synthesis was ultrapure deionized water collected from Barnstead 
NANOPURE water filtration systems (Resistance at least 17.8 MΩ·cm). All water used 
for nanoparticle characterization and bacterial toxicity assays was Milli-Q water 
(Resistance 18.2 MΩ·cm) or autoclaved Milli-Q water.  
 
A.3.2 PAH-AuNP synthesis 
PAH-AuNPs were synthesized by polyelectrolyte-wrapping of 4-nm-diameter citrate-
AuNPs. In a typical flow reactor synthesis as described before (Lohse, S. E.; Eller, J. 
R.; Sivapalan, S. T.; Plews, M. R.; Murphy, C. J. ACS Nano 2013, 7, 4135-4150), 20 
mL of HAuCl4 (0.01 M) and 6 mL of sodium citrate (0.1 M) were combined in a 2 L 
Erlenmeyer flask containing 1600 mL of nanopure water. In a second 2 L Erlenmeyer 
flask, 1614 mL of water was chilled in an ice-water bath. Then, 12 mL of chilled 
aqueous NaBH4 (0.1 M) was added to the cold flask, which was swirled briefly. A flow 
line was placed into each 2 L flasks and the flow reactor pump was started at a setting 
of 40 mL/min. Once the two solutions combined in the flow reactor line, the solution 
turned a light red-brown and the synthesized particles were collected in a 4 L 
polyethylene bottle with gentle stirring. The resulting citrate-AuNP solution was then 
stirred for at least 3 h. The 4-nm-diameter citrate-AuNPs were then wrapped with 15 
kDa PAH to prepare 4-nm-diameter PAH-AuNPs. To the approximately 3.2 L of as-
synthesized particles, 32.0 mL of NaCl (100 mM) and 100.0 mL of a PAH solution (10 
mg/mL in 1 mM NaCl) were added with vigorous stirring. The nanoparticles were then 
allowed to stir overnight in the wrapping solution. 
 
A.3.3 UV-vis Spectroscopy 
The concentration and degree of aggregation of AuNP suspensions were evaluated 
using UV-vis extinction spectroscopy (Mikropack DH-2000 UV-vis-NIR spectrometer). 
PAH-AuNP stock suspensions were diluted 20-fold in Milli-Q water for UV-vis 
measurement. The molar concentration of the AuNP suspensions was calculated by 
dividing the extinction at 450 nm by the extinction coefficient of 4-nm-diameter AuNPs 
(7.41 × 107 M-1) (Orendorff, C. J.; Murphy, C. J. J. Phys. Chem. B 2006, 110, 3990-
3994). The mass concentration of AuNP suspension was determined based on the 
product of molar concentration and the molar mass of 4-nm-diameter AuNP (defined 
as the mass of 1 mole 4-nm-AuNPs, 3.90 × 105 g/mol). The mass concentration of PAH-
AuNPs in this manuscript refers to the mass concentration of gold alone, not including 
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the mass of surface modification (citrate and PAH). 
 
A.3.4 Transmission Electron Microscopy (TEM) 
To prepare the samples for TEM analysis, PAH-AuNP suspensions were diluted in 
Milli-Q water to approximately 1 mg Au/L and sonicated for 5 minutes. Then, a 2 µL 
aliquot was drop-cast onto a 200 mesh copper grid with Formvar and carbon supports 
from Ted Pella, Inc. (Redding, CA). The grid was air-dried near an open 65 °C oven for 
5 minutes. An FEI Tecnai T12 transmission electron microscope with an operating 
voltage of 120 kV was used to acquire images of the samples. To perform size analysis 
of PAH-AuNPs, the diameters of over 500 nanoparticles were measured from the 
collected TEM images using ImageJ (National Institutes of Health). The average and 
standard deviation of these measurements were presented as the nanoparticle diameter 
(average ± standard deviation). 
 
A.3.5 Dynamic Light Scattering (DLS) and ζ-potential 
A Brookhaven ZetaPALS instrument was used for DLS and ζ-potential measurements. 
PAH-AuNP stock suspensions were diluted 20-fold in Milli-Q water for the 
measurements. For DLS, the intensity-weighted average diameter was reported as “Z-
average”, and the mean diameter from the multimodal distribution was also reported. 
For each specific PAH-AuNP data set, the same AuNP suspension was used across UV-
vis, DLS, and ζ-potential measurements. 
 
A.3.6 Drop plate counting for bacterial toxicity assay 
An adapted assay from the traditional plate-counting method was used to measure the 
bacterial toxicity of PAH-AuNPs and PAH polymer (Herigstad, B.; Hamilton, M.; 
Heersink, J. J. Microbiol. Methods 2001, 44, 121-129). Shewanella oneidensis MR-1 
was plated on an agar plate and incubated overnight. A controlled number of bacterial 
colonies was inoculated into fresh LB (Miller) broth, and the inoculum was agitated on 
a 32 °C orbital shaker at 300 rpm until mid-log phase (optical density (OD600) between 
0.6~1). Bacterial cells were harvested by centrifugation at 750 × g for 10 minutes. The 
pellet was washed using an equal volume of sterile Dulbecco's phosphate-buffered 
saline (DPBS) buffer, and centrifuged at 750 × g again for 10 minutes. Cells were finally 
re-suspended in a 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer 
of pH 7.4 containing 2 mM HEPES and 25 mM NaCl. The cell suspension was diluted 
with HEPES buffer to reach a final optical density of ~0.05 (~107 cells/mL). To set up 
an exposure, a NP suspension at 10 times the intended exposure concentration was 
mixed 1:9 (v:v) with the OD600~0.05 bacterial suspension in HEPES buffer and 
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incubated for 15 minutes; autoclaved Milli-Q water was used instead of NP suspension 
to set up a negative control. A 10-fold serial dilution was then performed to dilute the 
sample to a proper cell density. In a biosafety cabinet, aliquots of 10 µL diluted samples 
were dropped onto the surface of a sterile LB agar plate, and the drops were allowed to 
fully absorb into the agar. At least 3 consecutive dilutions (e.g. the 103-, 104- and 105-
fold dilution of the original sample) were plated for each individual sample, and 
between 4-7 drops were plated for each dilution. Plates were incubated overnight, and 
then individual colonies were counted for each drop on a plate counter. The dilution 
that resulted in 3-35 colonies per drop was regarded as the best dilution fold for that 
specific sample, and the number of colonies for the drop from that dilution was used 
for further analysis. 
 
A.3.7 Data analysis of drop plate counting 
A treated or control sample of bacterial suspension was regarded as a biological 
replicate. A biological replicate was diluted to the best dilution fold, and all drops pulled 
from that best dilution from that biological replicate were regarded as technical 
replicates. The numbers of bacterial colonies from technical replicates were averaged, 
divided by the volume of the drop (10 µL) and then multiplied by the corresponding 
dilution factor to obtain the colony-forming unit density (CFUs/mL) of the original 
biological replicate. To combine data points from different experimental runs, for every 
individual experimental run, the average colony-forming unit of the biological 
replicates from the control group was calculated, and the colony-forming unit of every 
sample in that experimental run was divided by the average of control groups. 
Normalized CFUs from different experimental runs were then combined and used for 
further statistical analysis. In most of the cases in this study, at least 7 biological 
replicates were run for each treatment. 
 
A.3.8 Determining the amount of PAH polymer in the retentate after dialysis 
After dialysis of PAH polymers, the concentration of PAH polymer remaining was 
determined using the aforementioned fluorescamine assay. To make calibration curves, 
two different PAH polymers (15k from Sigma or 3k from Nittobo) were separately 
weighed and dissolved in Milli-Q water to make standard solutions of 1 mg/mL. The 
standard solutions were then diluted in Milli-Q water to make a final concentration of 
200 mg/L. Calibration curves were collected for both PAH polymers, and linear regions 
were located. For each dialyzed sample, different volumes of dialyzed sample ranging 
from 2 µL to 120 µL was added to react with fluorescamine to collect a fluorescence 
vs. sample volume curve, and the linear region of each curve was located. Only readings 
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from the linear region of the sample curve and higher than the limit of quantification 
was used for quantification using the calibration curve. For the dialyzed 15 kDa Sigma 
PAH sample, 6 readings were used and the average and standard deviation were 
reported. For the dialyzed 3 kDa Nittobo PAH sample, 2 readings were used and the 
average and range were reported. 
 
Table A.3.1. The amount of unbound PAH in PAH-AuNP suspensions determined in 
two different AuNP batches synthesized in different time. 
  d-PAH-AuNP c-PAH-AuNP cc-PAH-AuNP 
Unbound PAH in 
AuNP suspension 
(mg/L per mg/L of 
NPs) 
Batch 16 469 ± 34 7.65 ± 0.28 0.57 (0.55-0.59) a) 
Batch 7 a) 559 (529-589) 7.0 (6.4-7.6) 0.46 (0.45-0.47) 
a) Range is shown instead of standard deviation as results from less than three replicates 
were obtained. 
 
 
A.4  Chapter 5 Supporting Information 
 
A.4.1 Materials and reagents 
DifcoTM LB broth (Miller) and DifcoTM agar (granulated) were purchased from Becton, 
Dickinson, and Company. Dulbecco's phosphate-buffered saline (DPBS) was 
purchased from Mediatech, Inc. 
 
A.4.2 Exposure medium used in this study 
Sodium chloride (NaCl) and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES) were purchased from Sigma Aldrich. Magnesium chloride hexhydrate 
(MgCl2∙6H2O), ammonium chloride (NH4Cl), calcium chloride (CaCl2), and 1 N 
hydrochloric acid (HCl) were purchased from Fisher Scientific. Potassium chloride 
(KCl) was purchased from Mallinckrodt Baker Inc. Sodium sulfate (Na2SO4) was 
purchased from Para Scientific Co. Sodium hydroxide (NaOH) pellets were purchased 
from Macron Fine Chemicals. Dibasic sodium phosphate (Na2HPO4) was purchased 
from Riedel-de Haën. Sodium DL- lactate 60% w/w aqueous solution was purchased 
from Alfa Aesar. Difco™ Luria-Bertani (LB) broth, Miller and Difco™ agar, granulated 
were purchased from BD. Sterile Dulbecco's phosphate-buffered saline (DPBS) was 
purchased from Mediatech, Inc. 
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HEPES buffer: In MilliQ water, 2 mM HEPES and 25 mM NaCl were dissolved. The 
solution was adjusted to pH 7.4, followed by filtering with a 0.22 µm cellulose acetate 
sterile filter (Corning Inc., NY). 
 
Minimal medium with sodium lactate: In 1 liter Milli-Q water, 0.68 g NaCl, 0.3 g KCl, 
0.285 g MgCl2∙6H2O, 0.3975 g Na2SO4, 0.15 g NH4Cl, 2.383 g HEPES was dissolved, 
and the pH of the solution was adjusted to 7.2~7.3 using HCl and NaOH solutions. The 
solution was autoclaved and cooled down, and 0.0125 g Na2HPO4 and 0.0056 g CaCl2 
were then added; this solution was called minimal medium. Immediately before use, 14 
mL of sodium DL-lactate syrup 60% w/w aq. soln was mixed with the minimal medium 
to make a total volume of 1000 mL, and the minimal medium with sodium lactate was 
finally used for subsequent studies. 
 
A.4.3 Bacterial culture and preparation 
Shewanella oneidensis MR-1 was plated on an agar plate and incubated at 30-32 °C 
overnight. Bacterial colonies were inoculated into fresh LB (Miller) broth, and the 
inoculum was agitated on a 30-32 °C orbital shaker at 300 rpm until harvesting. The 
bacterial suspension was harvested before entering stationary phase (optical density 
(OD600) between 0.6~1.4), and collected via centrifugation at 750 × g for 10 minutes. 
The pellet was washed using an equal volume of sterile DPBS as the amount of LB and 
centrifuged at 750 × g for 10 minutes again. The washed cells were finally re-suspended 
in exposure medium, either HEPES buffer or minimal medium with lactate, and diluted 
to reach a final optical density of ~0.05 (~107 cells/mL), as the prepared bacterial 
suspension for later use. 
 
While very similar, the preparation of bacterial suspensions had slight difference for 
different exposure conditions. S. oneidensis MR-1 were grown in LB broth as described 
in the main text. Before the bacterial suspension entered the stationary phase, 10 mL of 
bacterial suspension in LB broth was centrifuged at 2000 rpm (931 × g) for 10 minutes, 
and the supernatant was removed. The bacterial pellet was re-dispersed in 10 mL of 
0.85% (w/w) NaCl in autoclaved Milli-Q water and centrifuged down again. The 
supernatant was removed, the bacterial pellet was re-suspended in minimal medium 
with sodium lactate, and the optical density was adjusted to about 0.1 for exposure. 
NMC nanomaterials were weighed, re-dispersed in autoclaved water, followed by 10-
min sonication immediately before use. During 3-hour exposure, bacterial suspensions 
were left at room temperature. 
196 
 
 
Bacillus subtilis SB491 (wild type), Bacillus subtilis ∆dltA (mutant strain), and Bacillus 
subtilis ∆tagE (mutant strain), were plated on agar plates to grow at 37 °C overnight. 
Bacterial colonies were inoculated into fresh LB (Miller) broth to grow for 12-18 hours 
at 37°C and 300 rpm agitation. The bacterial suspensions were harvested before 
entering stationary phase (optical density (OD600)) between 0.2~0.8, and followed the 
same steps as for S. oneidensis MR-1 for washing and re-suspension before nanoparticle 
exposures. 
 
A.4.4 Plate colony counting assay 
A traditional plate counting assay was performed to measure the toxicity response of S. 
oneidensis MR-1 exposed to kanamycin or PAH-AuNPs; results were used to compare 
with those from the growth-based viability assay. A drop plate assay adapted from a 
traditional plate counting method was used for S. oneidensis MR-1.1 Bacteria were 
cultured, harvested, re-suspended in HEPES buffer with OD ~ 0.05, and subjected to 
either antiobiotic or NPs. The S. oneidensis MR-1 suspension was exposed to 0.25, 1, 
5, and 10 mg/L kanamycin or 0, 30, 78.6, 131, 250, 300 or 600 µg Au/L PAH-AuNPs. 
Results were analyzed as described in previous work (Qiu, T. A.; Torelli, M. D.; 
Vartanian, A. M.; Rackstraw, N. B.; Buchman, J. T.; Jacob, L. M.; Murphy, C. J.; 
Hamers, R. J.; Haynes, C. L. Anal. Chem. 2016, DOI: 10.1021/acs.analchem.6b04161). 
 
A.4.5 Randomized experimental layout 
To reduce variation from any instrumental errors, such as transfer errors from multi-
channel pipets and possible inconsistent conditions at different positions in the plate 
reader, a randomized experimental layout was implemented (Scheme A.4.1). In this 
work, random sequences were generated using the sample function in R (statistical 
modeling and analysis software), and assigned to the wells and columns. The numbers 
in each sequence indicated the order of serial dilution or large dilution into LB broth. 
As the order of serial dilution and growth wells were randomized, the experimental 
procedure was kept the same as the original experimental layout described in Scheme 
5.1b. 
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Scheme A.4.1. An example of the randomized layout for high-throughput screening. 
 
 
A.4.6 Water evaporation control 
To correct for the loss of water in the wells on the edge of the plate, a water evaporation 
control was implemented. In experiments with the water evaporation control, the wells 
on the edge were supplied with 200 µL of autoclaved water, instead of being used for 
bacterial growth. The remaining wells were used for exposure and bacterial growth, and 
the edges of the plate were parafilmed before being positioned on the plate reader stage. 
A detailed experimental layout can be found in Scheme A.4.2. 
 
 
Scheme A.4.2. An experimental layout with water evaporation control. Grey wells are 
filled with 200 µL autoclaved water for use as evaporation control. Column 1 was first 
used for bacterial serial dilution. After bacterial suspensions were transferred to growth 
columns on the well plate (Column 2-3), autoclaved water was added to make up to a 
volume of 200 µL. 
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A.4.7 Standard plate 
Standard plates were used to examine variations in bacterial growth across all wells on 
a 96-well plate. In wells to be tested, equal volumes of prepared bacterial suspension, 
either 5 or 10 µL, were diluted into fresh LB medium to make up a total volume of 200 
µL. Two kinds of standard plate were used in this study: whole plate (all 96 wells are 
used), and standard plate with evaporation control (36 of edge wells filled with water, 
60 of inner wells used to growth bacteria). 
 
A.4.8 Testing bacteria harvested at different growth stages  
S. oneidensis MR-1 was plated on a solid agar plate and inoculated into fresh LB 
medium at different time points. Two inocula in different tubes were agitated in the 
orbital shaker overnight or several hours and harvested at the same time when they each 
reached stationary phase or mid-log phase, respectively. Both harvested bacterial 
suspensions were washed in sterile Dulbecco's phosphate-buffered saline (DPBS) and 
re-suspended in HEPES buffer, and the optical density for the final bacterial suspension 
for exposure were both adjusted to ~0.05. Prepared bacterial suspensions were then 
used to generate the calibration curve for the GBV assay. 
 
A.4.9 Measuring water loss on plate 
To each well of a 96-well plate, 200 µL of Milli-Q water was added. The plate was 
covered with a lid and incubated in the plate reader at 37 °C for 20 hours. After 20 hours, 
the plate was removed, and each well was sequentially dried using a piece of KimWipe. 
The of mass of the plate was recorded after each well was dried, and the result is shown 
in Figure A.4.6. 
 
A.4.10 Orthogonal residue control 
The residue control stated in the Experimental section only tests the effect of residues 
on bacterial suspensions at 100% viability. However, it is possible that the same amount 
of residue that do not affect bacterial growth starting at 100% viability can affect the 
growth curve starting with less number of cells. In this case, a “bended” calibration 
curve at the lower viability end is expected, when all wells containing different number 
of bacterial cells in calibration curve are tested with the same amount of residue added. 
An orthogonal residue control was designed to address such concern (Scheme A.4.3) 
and tested for kanamycin exposure. In the layout, Row A was used for serial dilution of 
kanamycin solution, and Column 1 was used to perform serial dilution of bacterial 
suspension, as in calibration curve section. In the rest of wells, a portion from Row A 
was transferred to other rows, and the same volume from Column 1 was transferred to 
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other columns, generating calibration curves that resulted from treatment with residues. 
 
 
Scheme A.4.3: Plate layout of a stricter residue control, referred as “orthogonal residue 
control”. This layout shows an example layout to test if the residue of kanamycin will 
affect the growth starting with different amount of cells. 
 
A.4.11 Mathematical modeling of bacterial exponential phase 
Variables in this modeling are defined as: t: time lapsed in bacterial growth; N0: number 
of cells at t=0; N(t): number of cells at time t; E: bacterial replication efficiency; k: 
bacterial population growth rate at exponential growth; L: length of lag phase (same 
unit as t) 
Bacterial lag phase and exponential phase growth model: 
𝑁(𝑡) = {
𝑁0 ∙ (1 + 𝐸)
𝑘(𝑡−𝐿), 𝑡 ≥ 𝐿
𝑁0, 0 ≤ 𝑡 < 𝐿
 
Set a threshold for cell numbers, TN. Let 
𝑇𝑁 = log[𝑁(𝐶𝑡)] 
Ct refers to the “fractional cycle number at threshold” when the cell numbers reach TN. 
Here, “cycle number” is a user-defined unit to replace unit “time” and simplify data 
analysis. For example, in our study, since the plate reads optical density every 20 
minutes, 1 cycle number is equivalent to 20 minutes. During the exponential growth 
phase,  𝑡 ≥ 𝐿, and Ct is calculated as: 
𝑇𝑁 = log 𝑁(𝐶𝑡) = log[ 𝑁0 ∙ (1 + 𝐸)
𝑘(𝐶𝑡−𝐿)] 
∴ 𝐶𝑡 =
𝑇𝑁 − log (𝑁0)
𝑘 ∙ log (1 + 𝐸)
+ 𝐿 
Viability refers to the percentage of bacterial cell amount (𝑁0,𝑖) at t = 0 compared to the 
100% viability reference (𝑁0,0) at t = 0, so viability of a specific sample i can be defined 
as: 𝑣𝑖 =
𝑁0,𝑖
𝑁0,0
 (𝑣0 = 1). 
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∴ 𝐶𝑡,𝑖 =
𝑇𝑁 − log (𝑁0,𝑖)
𝑘𝑖 ∙ log (1 + 𝐸𝑖)
+ 𝐿𝑖 
∴ 𝐶𝑡,𝑖 =
𝑇𝑁 − log (𝑁0,0 × 𝑣𝑖)
𝑘𝑖 ∙ log (1 + 𝐸𝑖)
+ 𝐿𝑖
= [−
1
𝑘𝑖 ∙ log (1 + 𝐸𝑖)
] ∙ log 𝑣𝑖 + [
𝑇𝑁 − log (𝑁0,0)
𝑘𝑖 ∙ log (1 + 𝐸𝑖)
+ 𝐿𝑖] 
Let 𝑣𝑖 = 2
−𝑑𝑖 
∴ 𝐶𝑡,𝑖 = [
log (2)
𝑘𝑖 ∙ log (1 + 𝐸𝑖)
] ∙ 𝑑𝑖 + [
𝑇𝑁 − log(𝑁0,0)
𝑘𝑖 ∙ log(1 + 𝐸𝑖)
+ 𝐿𝑖] (∗) 
Assumption 1: In the same medium, the same bacterial strain will have a similar growth 
rate during the exponential growth phase (𝑘𝑖 ≅ 𝑘). 
Assumption 2: During the exponential growth phase, all bacterial cells in the 
suspension will replicate (𝐸 ≅ 1). 
Assumption 3: In one experimental run (on the same plate), the length of lag phase for 
the same bacterial strain will be the same (𝐿𝑖 ≅ 𝐿). 
Based on these 3 assumptions above, equation (*) can be approximated as: 
𝐶𝑡,𝑖 =
1
𝑘
∙ 𝑑𝑖 + [
𝑇𝑁 − log(𝑁0,0)
𝑘 ∙ log(2)
+ 𝐿] 
To transform cell number (N) to measurable parameters, another assumption is made: 
Assumption 4: The optical density reading at 600 nm (OD600, simplified as OD) is 
proportional to the density of cell numbers in a bacterial cell suspension (𝑂𝐷(𝑡) = 𝑃 ∙
𝑁(𝑡), P is a correcting factor). 
Make threshold of OD reading 
𝑇𝑂𝐷 = log 𝑂𝐷(𝐶𝑡) 
∴ 𝑇𝑁 = log 𝑁(𝐶𝑡) = log
𝑂𝐷(𝐶𝑡)
𝑃
= 𝑇𝑂𝐷 − log(𝑃) 
𝐶𝑡,𝑖 =
1
𝑘
∙ 𝑑𝑖 + [
𝑇𝑂𝐷 − log(𝑃) − log(𝑁0,0)
𝑘 ∙ log(2)
+ 𝐿] 
In data analysis, 𝑇𝑂𝐷 is set as a constant for every plate, P and 𝑁0,0 are unknown but 
are also constants for the same plate. By using a calibration curve on every plate, the 
linear regression between 𝐶𝑡,𝑖 𝑣𝑒𝑟𝑠𝑢𝑠 𝑑𝑖  can be obtained, and the 𝑑𝑖  value of a 
certain treatment i could be extrapolated by calculating 𝐶𝑡,𝑖 of that treatment. 
 
A.4.12 Algorithms for Ct determination of individual growth curves 
Inspired by the data analysis on qPCR amplification plot, algorithms were developed 
for Ct determination, consisting of (1) determining the starting point of exponential 
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phase (SPE), (2) determining the end point of exponential phase (EPE), (3) linear 
regression of the log-transformed exponential growth window, and (4) determining 
threshold values (th) for the plate. The algorithms were written in R for this manuscript, 
and a detailed tutorial for using these R codes was also written (see original R codes). 
 
Determining the Starting Point of Exponential phase (SPE). In our study, a statistical 
estimation of SPE is achieved by inspecting externally studentized residuals in the 
linear regression of data points at the beginning of bacterial growth (Tichopad, A.; 
Dilger, M.; Schwarz, G.; Pfaffl, M. W. Nucleic Acids Res. 2003, 31). Raw data for 
optical density readings are used. After excluding the first reading, which is usually 
above the baseline, the linear regression is first performed on the first three observations. 
An outlier of such fitting is identified by comparing the externally studentized residuals 
with the Student t Distribution. If the last data point is not an outlier, the next 
observation is added for the next round of linear regression and outlier identification. 
When two consecutive outliers are identified, the latter outlier is then identified as the 
SPE data point, and the cycle number of this data point is returned as the SPE value. In 
the R code attached, the algorithm is carried out in two functions: 
FindInfluentialDataPoint(x,y) and FindSPE_v2(x,y). 
 
Determine the End Point of Exponential phase (EPE). The EPE is calculated by finding 
the secondary derivative maximum (SDM) of the growth curve (Zhao, S.; Fernald, R. 
D. J. Comput. Biol. 2005, 12, 1047-1064). Since the data points are discrete in growth 
curves and efforts failed to fit the growth curve with a traditional sigmoid, a finite 
difference approximation for discrete plots is used to calculate the standard second 
order centered approximation (LeVeque, R. Finite Difference Methods for Ordinary and 
Partial Differential Equations; Society for Industrial and Applied Mathematics, 2007):  
𝐷2𝑢(?̅?) =
1
ℎ
((
𝑢(?̅? + ℎ) − 𝑢(?̅?)
ℎ
) − (
𝑢(?̅?) − 𝑢(?̅? − ℎ)
ℎ
)) 
𝑢(?̅?) refers to the measured value at variable ?̅?, and h refers to the step length. Here, 
the step length is 1 as cycle numbers, which are integers, are used as variables. Thus, 
the equation is simplified as: 
𝑆𝐷𝑛 = 𝐷
2𝑢(𝑛) = 𝑢(𝑛 + 1) − 2 × 𝑢(𝑛) + 𝑢(𝑛 − 1) 
𝑆𝐷𝑛 refers to the second order centered approximation. To find the maximum and 
eliminate the fluctuations near the baseline, a box-car smoothing with 5 nearby data 
points is applied: 
𝑆𝐷𝑛,𝑠𝑚𝑜𝑜𝑡ℎ = (𝑆𝐷𝑛−2 + 𝑆𝐷𝑛−1 + 𝑆𝐷𝑛 + 𝑆𝐷𝑛+1 + 𝑆𝐷𝑛+2)/5 
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After smoothing, the cycle number where 𝑆𝐷𝑛,𝑠𝑚𝑜𝑜𝑡ℎ𝑒𝑑  reaches the maximum is 
returned as SDM, which is regarded as EPE in the algorithm. In the R code attached, 
this algorithm is carried out in function FindSDM_v3(x,y). 
 
Linear regression of the log-transformed exponential growth window. An original 
exponential growth window is located from the SPE to the EPE values determined 
earlier. After log2 transformation of background-subtracted optical density readings, 
adjustment of the exponential window is made based on user-set fine-tuning parameters 
and the attempt to not include invalid values due to the log2 transformation (See tutorial 
and R code for more information). Linear regression is performed and evaluated on the 
log2-transformed exponential window. A manual fitting, where observations in between 
a pre-set window are used instead of the algorithm-determined window for linear 
regression, is triggered if the length of exponential window is less than 3 data points or 
the r square value of the linear regression is less than 0.99. A series of output values, 
including slope and intercept of the linear regressions, are recorded for the following 
Ct determination. In the R code attached, this algorithm is carried out in function 
LinearFitting_v2(x,y,name). 
 
Determining threshold values (th). Three different strategies are used to determine the 
threshold value for the whole plate: SDM, mid-point, and fit-point (Heid, C. A.; Stevens, 
J.; Livak, K. J.; Williams, P. M. Genome Res. 1996, 6, 986-994). The threshold values, 
referred as th.SDM, th.midpoint and th.fitpoint, are calculated as equations below.  
𝑡ℎ. 𝑆𝐷𝑀 =
∑ log (𝑂𝐷𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑎𝑡 𝑆𝐷𝑀)
𝑛
1
𝑛
 
𝑡ℎ. 𝑚𝑖𝑑𝑝𝑜𝑖𝑛𝑡 =
∑ [log(𝑂𝐷𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑎𝑡 𝑆𝑃𝐸) + 𝑙𝑜𝑔(𝑂𝐷𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑎𝑡 𝑆𝐷𝑀)
𝑛
1 ]/2
𝑛
 
𝑡ℎ. 𝑓𝑖𝑡𝑝𝑜𝑖𝑛𝑡 =
∑ log10(10 × 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒)  
𝑛
1
𝑛
 
Briefly, with cycle numbers of SPE and SDM determined and adjusted earlier, threshold 
of SDM is determined as the average of all log-transformed normalized OD reading 
(𝑂𝐷𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑) at their own SDM cycle number. For the threshold of mid-point, log-
transformed normalized OD readings at SPE and SDM are averaged first to get a mid-
point value, and all mid-point values across the plate are averaged to get the threshold 
of midpoint. It should be noted that the growth curves which are manually fitted are not 
used for threshold calculation. For the threshold of fit-point, the average of log10-
transformed ten times standard deviation of baseline, which is defined from the second 
data point to SPE, is calculated. 
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Ct determination. Ct values from three different threshold values were determined, 
referred to as ct.SDM, ct.midpoint and ct.fitpoint in the R code. For each growth curve, 
threshold values are plugged in the linear regression, and Ct values corresponding to 
different threshold values are determined at the crossing point of threshold and linear 
fitting of the exponential growth window. Determination of thresholds and Ct values 
are carried out in function GBV(data) in the R code attached. 
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Table A.4.1. Nanoparticle characterization of gold nanoparticles used in this study. 
Material 
Core size 
(nm)* 
Z-
average 
(nm)** 
ζ-potential 
(mV)*** 
Absorption 
peak 
wavelength 
(nm) 
Color of 
colloid 
Refer
ence 
PAH-
AuNPs (a) 
4.5 ± 1.2 
(N=557) 
197 ± 4 +66 ± 2 535 
Deep 
purple 
1 
MPNH2-
AuNPs (b) 
8.9 ± 3.0 
(N ≥ 250) 
38.4 ± 
0.6 
+27 ± 7 521 
Navy 
blue 
(c) 
a) Poly(allylamine hydrochloride)-wrapped gold NPs; (b) Mercaptopropylamine-capped gold NPs. 
*Determined by TEM. **Hydrodynamic diameter in MilliQ water determined by dynamic light 
scattering. ***In MilliQ water. 
(c) Feng, Z. V.; Gunsolus, I. L.; Qiu, T. A.; Hurley, K. R.; Nyberg, L. H.; Frew, H.; Johnson, K. P.; 
Vartanian, A. M.; Jacob, L. M.; Lohse, S. E.; Torelli, M. D.; Hamers, R. J.; Murphy, C. J.; Haynes, C. L. 
Chem. Sci. 2015, 6, 5186-5196 
 
 
Table A.4.2. Water evaporation control reduces the variation among wells on standard 
plates. All numbers are Ct values except for percentage coefficient of variation (CV %). 
  
Ctmax
-Ctmin 
Standard 
Deviation 
CV %  
Ctmax
-Ctmin 
Standard 
Deviation 
CV % 
Standard 
plate 
(Whole 
plate) 
Trial 1 1.131 0.224 1.94 
Exclude 
wells at 
edges 
0.735 0.152 1.32 
Trial 2 1.268 0.216 1.63 0.639 0.133 1.01 
Standard 
plate with 
water 
evaporation 
control 
Trial 1 -- -- --  0.874 0.169 1.36 
Trial 2 -- -- --  0.607 0.129 1.06 
Trial 3 -- -- --  0.944 0.169 1.52 
Trial 4 -- -- --  0.841 0.166 1.50 
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Figure A.4.1.  Analysis of NMC nano-sheets using scanning electron microscopy 
(SEM) images and transmission electron microscopy (TEM) images in the inset for a.) 
Li0.61Ni0.23Mn0.55Co0.22O2, b.) Li0.52Ni0.14Mn0.72Co0.14O2. 
 
 
Figure A.4.2. Testing the linear range of the calibration curve for S. oneidensis MR-1. 
 
 
10 nm	100 n
10 nm	100 n
5 nm	
5 nm	
A	
B	
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Figure A.4.3. Comparison of calibration curves from S. oneidensis MR-1 harvested at 
mid-log phase and stationary phase. 
 
 
Figure A.4.4. Calibration curves from the orthogonal residue control show that the 
existence of residues does not affect calibration curve. All linear regressions show R2 > 
0.99. Concentrations in legends refer to the amount of kanamycin residue 
accompanying bacterial growth. 
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Figure A.4.5. Heat maps of standard plates (a) without or (b) with water evaporation 
control. The minimal and maximal value on each plate was marked with black bold 
frames. 
 
 
Figure A.4.6. Percentage of water mass left after the plate was incubated at 37 °C for 
21 hours.   
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Figure A.4.7. Calibration curves were obtained from the same plate with water 
evaporation control, and the y-intercepts from linear fitting were plotted versus the 
transfer order during experiment. In trial 1 and 2, the transferring order was from 
Column 2 to 11, left to right, and the position for each transfer in trial 3 and 4 was 
randomized to eliminate the effect of different positions on plate. Linear regression with 
outlier elimination of y-intercept versus transfer order reveals slopes that are 
significantly different zero for all four trials (Extra sum-of-squares F test, p < 0.05). 
This indicate that the transferring order in GBV assay can affect the final Ct 
determination. 
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A.4.13   R codes for automated data analysis 
 
R code: function FindInfluentialDataPoint(x,y) 
FindInfluentialDataPoint <- function(x,y) { 
    if (!length(x)==length(y)) { 
        message("x and y have different sizes") 
        break 
    } 
    n <- length(x) 
    lm.out <- lm(y~x) ## Linear regression 
    stu.del.res <- rstudent(lm.out) ## Find externally studentized residues, aka student 
deleted residues 
    #print(stu.del.res) 
    p.values <- 2*pt(-abs(stu.del.res),df=n-2) ## pt is the cumulative t distribution 
(df=n-1-p, p=1) 
    return(p.values<0.05) 
} 
 
R code: function FindSPE.v2(x,y) 
FindSPE.v2 <- function(x,y) {  ## Find the starting point of exponential (SPE) phase 
    ## x: cycle numbers 
    ## y: raw optical density readings 
    ## Source the function to determine influential data point 
    source("FindInfluentialDataPoint.r") 
    ## Get number of data points for each sample (the number of observations) 
    n <- length(x) 
    ## Find SPE 
    SPE.index <- 0 
    outlier <- c(rep(FALSE, n)) ## the string to temporarily save outlier results 
    for (j in c(3:n)) { 
        outlier[j] <- FindInfluentialDataPoint(x[2:j],y[2:j])[j-1] 
        ## It would return NA sometimes when an infinite p value is calculated. 
        if (is.na(outlier[j])) { outlier[j] <- FALSE } 
        if (outlier[j]==TRUE) { 
            if (outlier[j-1]==TRUE && y[j]>0) { 
                SPE.index <- j  ## SPE found 
                break 
            } 
        } 
        if (j == n) { 
            SPE.index <- NA 
        } 
    } 
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    ## Return the index of SPE value 
    return(SPE.index) 
} 
 
R code: function FindSDM.v3(x,y) 
FindSDM.v3 <- function(x,y) {   
    ## Find the Second Derivative Maximum (SDM) using finite difference 
approximation 
    ## x: cycle numbers 
    ## y: raw optical density readings 
    ## Get number of data points for each sample (the number of observations) 
    n <- length(x) 
    ## Calculate standard second order centered approximation 
    ## SD[1], SD[2] and SD[n] will always be 0 (not calculated) 
    SD <- c(rep(0,n))  
    SD.boxcar <- c(rep(0,n)) 
    for (j in c(3:(n-1))) { SD[j] = y[j-1] - 2*y[j] + y[j+1] } ## Calculate standard second 
order centered approximation 
    ## Box-car smoothing 
    for (i in c(3:(n-2))) { SD.boxcar[i] = mean(SD[(i-2):(i+2)])} 
    SDM.index <- which(SD.boxcar==max(SD.boxcar))[1] #+ 1 
    ## Return the index of SDM 
    return(SDM.index) 
} 
 
R code: function LinearFitting.v2(x,y,name) 
LinearFitting.v2 <- function(x,y,name) {  ## Linear fitting of exponential growth 
window 
    ## x: cycle numbers 
    ## y: raw optical density readings 
    ## You can set your working directory at the beginning of the function 
    #setwd("your path") 
    ## Get number of data points for each sample (the number of observations) 
    n <- length(x) 
    ## Source functions to calculate SPE and SDM 
    source("FindInfluentialDataPoint.r") 
    source("FindSPE_v2.r") 
    source("FindSDM_v3.r") 
    ## Fine tuning parameters 
    background <- c(2:4) 
    pre.set.window.len <- 5 
    manual.window.upper <- -1.5 
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    manual.window.lower <- -2.5 
    unstable.baseline <- c(1) 
    expand.SDM <- 0 
         
    ## Determine if there is a growth 
    growth <- TRUE 
    raw.slope <- summary(lm(y~x))$coefficients[2,1] 
    raw.Pr <- summary(lm(y~x))$coefficients[2,4] 
    if ( raw.slope<=0 || raw.Pr>=0.05) { growth <- FALSE } 
     
    ## Find SPE, SDM, and exponential growth window (from SPE to SDM) 
    SPE <- FindSPE.v2(x,y) 
    SDM <- FindSDM.v3(x,y) 
    exp.window <- SDM - SPE + 1 
     
    ## If the SPE is NA, then the exp.window is NA, there is no growth 
    if ( is.na(exp.window) ) { growth <- FALSE } 
     
    ## If there is no growth, return everything as NA, and leave the function 
    if ( !growth ) { 
        results <- list(SPE=NA, SDM=NA, exp.window=NA, SPE.adj=NA, 
SDM.adj=NA, 
                        exp.window.adj=NA, slope=NA, intercept=NA, 
r.square=NA, bad.fit=NA, 
                        bg.sd=NA, manual.fit=NA) 
        return(as.data.frame(results)) 
    } 
     
    ## Initialize .adjs & linear regression parameters 
    SPE.adj <- SPE # not NA at this point 
    SDM.adj <- SDM # not NA at this point 
    exp.window.adj <- exp.window # not NA at this point 
    lm.temp <- NA 
    slope <- NA 
    intercept <- NA 
    r.square <- NA 
    bad.fit <- NA 
    ## For bad.fit: FALSE for a real fit with r2>0.99. NA for "no-growth". 
    manual.fit <- 0 
    ## For manual.fit: 0 represents FALSE (original SPE&SDM used), 1 represents 
expanded window,  
        ## 2 represents SPE adjusted based on NA/Inf values, 3 represents manual fit 
using a pre-set window 
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    ## Normalize 
    y.n <- y - mean(y[background]) # Background was set as the average of raw OD 
readings at user-defined baseline. 
     
    ## Logarithmic 
    y.log <- log(y.n, base=10) 
     
    ## Adjust exponentila growth window if it is less than a pre-set number. 
    if ( exp.window > 0 && exp.window < pre.set.window.len) { 
        SDM.adj <- SDM + expand.SDM 
        SPE.adj <- SPE - ( ( pre.set.window.len - expand.SDM ) - exp.window ) 
        exp.window.adj <- pre.set.window.len 
        manual.fit <- 1 
    } 
     
    ## Adjust SPE so that it doesn't have NA or Inf after it. 
    y.log.na.index <- which(is.na(y.log)) 
    y.log.inf.index <- which(is.infinite(y.log)) 
    if ( length(y.log.na.index)>0 || length(y.log.inf.index)>0 ) { 
        last.na.or.inf <- max(y.log.na.index, y.log.inf.index) 
    } else { 
        last.na.or.inf <- 0 
    } 
    if ( SPE.adj <= last.na.or.inf ) { 
        SPE.adj <- last.na.or.inf + 1 
        exp.window.adj <- SDM.adj - SPE.adj + 1 
        manual.fit <- 2 
    } 
     
    ## Calculate the standard deviation of baseline (for fit point threshold calculation) 
    if ( sum(!complete.cases(y[2:(SPE.adj-1)]))==0 ) { bg.sd <- sd(y[2:(SPE.adj-1)]) } 
    else { bg.sd <- NA } 
     
    ## Locate exponential growth window 
    #growth.1 <- !is.na(SPE.adj) && !is.na(SDM.adj) && (exp.window.adj>=3) 
    small.window <- FALSE 
    if ( exp.window.adj>=3 ) { # Linear regression doesn't happen if it's a small 
window (<=3) 
        y.l <- y.log[SPE.adj:SDM.adj] 
        x.l <- x[SPE.adj:SDM.adj] 
        #growth.2 <- (sum(is.na(y.l))==0) && (sum(is.infinite(y.l))==0) 
        lm.temp <- lm(y.l~x.l) 
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        if ( !is.na(summary(lm.temp)$r.squared) ) { 
            if ( summary(lm.temp)$r.squared<0.99 ) { bad.fit <- TRUE } else 
{ bad.fit <- FALSE} 
        } else { 
            bad.fit <- TRUE 
        } 
         
    } else { 
        small.window <- TRUE 
    } 
     
    ## Manual fit triggerred if it is a bad fit or if exponential window <3. 
    if ( bad.fit==TRUE || small.window==TRUE) { 
        manual.window <- which(y.log[-
(unstable.baseline)]<=manual.window.upper & y.log[-
(unstable.baseline)]>=manual.window.lower)+length(unstable.baseline) 
        ## Manually set up the window. CAUTION! Always needs to be tuned. 
        #print(manual.window) 
        if ( length(manual.window)>=3 ) { # Linear regression doesn't happen if it's 
a small window (<=3) 
            y.l <- y.log[manual.window] 
            x.l <- x[manual.window] 
            SPE.adj <- manual.window[1] 
            SDM.adj <- manual.window[length(manual.window)] 
            exp.window.adj <- length(manual.window) 
            manual.fit <- 3 
            lm.temp <- lm(y.l~x.l) 
            if ( summary(lm.temp)$r.squared < 0.99 ) { bad.fit <- TRUE } else 
{ bad.fit <- FALSE} 
        } 
    } 
     
    ## Outputs 
    if ( !class(lm.temp)=="lm" ) { # which means the linear fitting never happened, 
probably because the window is <=0. 
        slope <- NA 
        intercept <- NA 
        r.square <- NA 
        bad.fit <- NA 
    } else { 
        slope <- coefficients(lm.temp)[2] 
        names(slope) <- NULL 
        intercept <- coefficients(lm.temp)[1] 
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        names(intercept) <- NULL 
        r.square <- summary(lm.temp)$r.squared 
        ## If the adjusted exponential window is too small for a linear regression, it's 
a bad fit. 
        #if ( r.square < 0.99 || exp.window.adj <=2 ) { bad.fit <- TRUE } else { bad.fit 
<- FALSE } 
        ## Plot final figures 
        plot(y.log~x) 
        abline(lm.temp) 
        abline(v=c(SPE.adj,SDM.adj)) 
        abline(v=c(SPE, SDM), col="red") 
        text(n,-2,name) 
    } 
     
    ## Put results together and return a data frame 
    results <- list(SPE=SPE, SDM=SDM, exp.window=exp.window, 
SPE.adj=SPE.adj, SDM.adj=SDM.adj, 
                    exp.window.adj=exp.window.adj, slope=slope, 
intercept=intercept, r.square=r.square, bad.fit=bad.fit, 
                    bg.sd=bg.sd, manual.fit=manual.fit) 
    #print(results) 
    return(as.data.frame(results)) 
} 
 
R code: function GBV(data) 
GBV <- function(data) {  ## Find threshold and determine Ct 
    ## data: the input dataframe of Cycle vs. raw OD reading 
     
    ## Working directory -- needs to be reset if switch computer/folder. 
    #setwd("your path") 
     
    #dir.create(paste(getwd(),"/Plots", sep="")) 
    source("LinearFitting_v2.r") 
     
    sample_num <- ncol(data) - 1    ## number of samples in this dataframe 
    if ( colnames(data)[1] != "Cycle") { 
        colnames(data)[1] <- "Cycle" 
        message("First column renamed as 'Cycle'.") 
    } 
     
    x <- data$Cycle   ## x is the vector for cycle numbers 
    n <- length(x)  ## n is the number of data points for each sample (the number of 
observations) 
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    if (n < 10) { 
        message("Not enough data point (n < 10). Program terminated.") 
        break 
    } 
     
    ## Acquire SPE, SDM, and linear fitting of individual data points 
    output <- NA 
    for (i in c(1:sample_num)) { 
        y <- data[[i+1]] 
        plot(y~x) 
        text(n,range(y)[1], colnames(data)[i+1]) 
        sample.name <- colnames(data)[i+1] 
        results <- data.frame(Name=sample.name, 
LinearFitting.v2(x,y,sample.name)) 
        ## Print names of each sample. The position of labels can be adjusted. 
        #if (!is.na(results$slope)) { text(n,-2,colnames(data)[i+1]) } 
        output <- rbind(output, results) 
        if (i == 1) { output <- output[-1,]} 
        rownames(output)[i] <- colnames(data)[i+1] 
    } 
    #print(output) 
     
    ## Calculate individual threshold values (only the ones with a good fit (r2>0.99)) 
to acquire average threshold across plate. 
    fun.lm <- function(slope, x, intercept, bad.fit) { 
        if ( !is.na(bad.fit) ) { 
            if ( !bad.fit ) { return(slope*x+intercept) } 
            else { return(NA) } 
        } 
        else { return(NA) } 
    }  
    th.SPE <- mapply(fun.lm, output$slope, output$SPE.adj, output$intercept, 
output$bad.fit, SIMPLIFY=TRUE) 
    th.SDM <- mapply(fun.lm, output$slope, output$SDM.adj, output$intercept, 
output$bad.fit, SIMPLIFY=TRUE) 
    th.midpoint <- mapply(function(x,y){return((x+y)/2)}, th.SPE, th.SDM, 
SIMPLIFY=TRUE) 
    fun.fitpoint <- function(sd, manual.fit) { 
        if ( !is.na(sd) && !is.na(manual.fit)) { 
            if ( manual.fit<=2 && !(sd==0) ) { return(log(10*sd, base=10)) } 
            else { return(NA) } 
        } 
        else { return(NA) } 
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    } 
    th.fitpoint <- mapply(fun.fitpoint, output$bg.sd, output$manual.fit, 
SIMPLIFY=TRUE) 
     
    ## Calculate threshold values for three different methods 
    th.ave.SDM <- mean(th.SDM, na.rm=TRUE) 
    th.ave.midpoint <- mean(th.midpoint, na.rm=TRUE) 
    th.ave.fitpoint <- mean(th.fitpoint, na.rm=TRUE) 
     
    ## The percentage of data points used to calculate threshold values 
    effective.points.th <- 
sum(complete.cases(th.SDM))/sum(complete.cases(output$slope))  
     
    ## The percentage of total manual fit to all linear fitting that happened with a 
slope>0 
    total.manual.fit <- 
length(which(output$manual.fit==3))/length(which(output$slope>0)) 
     
    ## Determine Ct based on threshold 
    fun.ct <- function(y, intercept, slope) { 
        if ( !is.na(slope) ) { 
            if ( slope>0 ) { return((y-intercept)/slope) } 
            else { return(NA) } 
        } else { return(NA) } 
    } 
    ct.SDM <- mapply(fun.ct, th.ave.SDM, output$intercept, output$slope, 
SIMPLIFY=TRUE) 
    ct.midpoint <- mapply(fun.ct, th.ave.midpoint, output$intercept, output$slope, 
SIMPLIFY=TRUE) 
    ct.fitpoint <- mapply(fun.ct, th.ave.fitpoint, output$intercept, output$slope, 
SIMPLIFY=TRUE) 
 
    ## Put output together and write in "Results.csv" 
    output <- data.frame(output, th.SDM, th.midpoint, th.fitpoint, ct.SDM, 
ct.midpoint, ct.fitpoint) 
    final.output <- list(output, th.ave.SDM=th.ave.SDM, 
th.ave.midpoint=th.ave.midpoint,  
                         th.ave.fitpoint=th.ave.fitpoint, 
effective.points.th=effective.points.th, total.manual.fit=total.manual.fit) 
    write.csv(final.output, "Results.csv", row.names =FALSE) 
    return(final.output) 
} 
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Mentor to Dona-Carla Forester on bacterial toxicity assays and magnetic nanoparticle synthesis. 
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Undergraduate Researcher Mentor, Haynes Lab         Jun. 2015 – Aug. 2015 
Mentor to Nathan Rackstraw on measuring the toxicity of functionalized gold nanoparticles to 
Shewanella oneidensis using drop plate counting method. 
 
Undergraduate Researcher Mentor, Haynes Lab                Jun. 2014 – Aug. 2014 
Mentor to Ky Christenson on Shewanella oneidensis RNA extraction, riboflavin measurement via 
HPLC, and bacterial biofilm formation. 
 
Teaching Assistant, University of Minnesota           Sep. 2013 – Dec. 2013 
Course: Modern Instrumental Methods of Chemical Analysis Lecture 
Assisted in an advanced analytical chemistry class. Responsibilities included helping with the 
maintenance of class website, assisting students with assignments, and grading problem sets, 
quizzes, and portions of exams. 
 
Teaching Assistant, University of Minnesota          Sep. 2012 – May 2013 
Course: Organic Chemistry Lab 
Taught a fundamental organic chemistry laboratory for the study, synthesis, isolation, purification 
and characterization of various organic compounds. Responsibilities included lab tutoring, 
conducting lab discussion, after-class office hours, and grading lab reports and assignments. 
 
HONORS AND AWARDS 
Mary Haga Travel Award, Xi Chapter of Graduate Women in Science           2017 
Agnes Hansen Travel Award, Xi Chapter of Graduate Women in Science       2014 
Graduation with Honors: College Graduation Excellence Award, Beijing        2012 
Graduation with Honors: College Graduation Excellence Award, Peking University    2012 
Wu Si Scholarship, Peking University              2010, 2011 
Summer Research Scholarship, REU Program, University of Michigan          2010 
2nd prize in the Challenge Cup, Wu Si Youth Science Competition, Peking University   2010 
Merit Student, Peking University                   2009, 2010 
Founder Scholarship, Peking University              2009 
 
PROFESSIONAL AFFILIATIONS 
American Chemical Society 
Society of Environmental Toxicology and Chemistry 
 
OUTREACH AND COMMUNITY SERVICE 
Volunteer for the various outreach activities including (but not limited to): 
West 7th Community Center Outreach, St Paul               Jul. 2013, 2015, 2016 
Sustainability Action! Open House, University of Minnesota    Aug. 2013, 2014, 2016 
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Energy and U, University of Minnesota                                May 2014 
Green Chemistry and Green Engineering, Minnesota State Fair       Aug. 2013, 2014 
Math and Science Family Fun Fair, University of Minnesota        Nov. 2012 
ACS Outreach: Chemists-in-the-Library, Minneapolis                 Aug. 2012 
Member of Student Board in the Center of Sustainable Nanotechnology      Jun. 2015 – Present 
Lab Safety Officer of the Haynes Lab                  Jan. 2015 – Sep. 2016 
Member of the Analysis and Compliance Committee, Joint Safety Team     Sep. 2015 – Sep. 2016 
Blogger for Center of Sustainable Nanotechnology website:            Aug. 2013 – Present 
• Bacteria in the Shell: A Nano-bio Hybrid for Solar Energy Capture 
• Using Gene Expression to Learn About Nanoparticle Toxicity 
(ScienceSeeker Editor’s Picks) 
• Theres plenty of room at the bottom…for ART! 
• Space Elevator: A Lasting Dream for a Sky-Reaching Tree 
• Forensic Nanotechnology: a scientific whodunit 
President, Peking University Alumni Association at U of Minnesota       Sep. 2015 – Sep. 2017 
English-to-Chinese translator for a Chinese popular science website      May 2013 – Sep. 2013 
 
 
